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Chapter 1 
General introduction, aim and structure of the thesis 
8 Chapter 2 
Bladder function and pathology of the overactive bladder syndrome (OAB) 
The function of the bladder seems to be rather simple. Urine is transported by 
the ureters towards the bladder to be stored» Once the bladder gets stretched to a 
certain degree of bladder filling, the brain gets a signal that the bladder needs to 
empty [1]. In order to void, the bladder wall is equipped with muscle fibres 
(detrusor muscle). Emptying the bladder is more complex than one would 
expect. While the detrusor muscle contracts, the sphincter around the urethra, 
has to relax. This mechanism is controlled at several different levels, in the 
brainstem, spine and in ganglia around the bladder [2]. 
Micturition is the result of a complicated signalling pathway, involving 
brainstem, spinal cord, and a signalling mechanism in the urinary bladder itself 
[2]. Especially our understanding of the afferent signalling pathway from the 
bladder to the central nervous system is still scanty. It now becomes apparent 
that the urothelium is involved in the micturition process by playing an 
important role in the afferent signalling [3]. The urothelium is not a passive 
barrier between urine and detrusor muscle alone; it is a highly specialized 
structure involved in antigen presentation, modulation of the micturition, 
metabolic secretion, inflammatory regulation, and sensory afferent functioning 
[3,4]. The urothelium can respond to thermal, mechanical, and chemical stimuli 
and it acts as a transducer, releasing chemicals that target adjacent bladder cells, 
interstitial cells and sensory neurons [3, 4]. 
Control of the urinary bladder is of considerable clinical importance and has 
been the focus of a great deal of attention from both clinicians and basic 
scientists. Over the past century, experimental work on human bladder function 
has focused primarily on cystometric in vivo investigations and cellular, 
molecular and morphological studies of biopsy material. Because experiments 
in humans and on human tissue rises legal, moral and ethical dilemmas, such 
studies are inherently limited. For example, it is not possible to study the 
cellular processes experimentally in the CNS that control micturition in humans. 
Also it also is becoming extremely difficult to acquire significant amounts of 
bladder tissue from healthy normal subjects for investigation of cellular and 
physiological events. Thus, basic science has resorted to using tissue from 
animal models to gain insight into the principles governing integrated control of 
the lower urinary tract and its cellular components. 
In normal subjects, bladder sensation increases as the bladder fills [5]. In 
patients with OAB, these sensations can be excessive, more frequent, and lead 
to urgency (the sudden and compelling desire to void that cannot be postponed) 
and urgency incontinence (inability to keep urine in the bladder). OAB is a 
symptom complex that comprises storage symptoms of urgency with or without 
urgency incontinence, frequency (voiding more often than 8 times in a 24-hour 
period) and nocturia [6]. These symptoms are suggestive for but not of 
diagnostic value for detrusor overactivity (urodynamically demonstrable 
involuntary bladder contractions) if there is no proven infection or other 
obvious pathology. OAB can, therefore, clearly distinct from urodynamically 
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proven detrusor overactivity, although the majority of people with OAB are 
thought to have this underlying diagnosis. 
The prevalence of OAB increases with age [7]. From the epidemiological 
studies conducted to date, it can be concluded that of those patients with OAB, 
approximately one-third are troubled by incontinence (OAB fiwet') and two-
thirds are not (OAB 'dry') [8, 9]. More recent data from the EPIC (European 
Prospective Investigation into Cancer and Nutrition) study suggest that the 
prevalence of OAB symptoms (using the 2002 International Continence Society 
(ICS) definition [10]) is close to 12% in the community, and of these sufferers, 
approximately 50% experience significant bother from their symptoms [11]. For 
the majority of patients, the patient history, physical examination, self-reported 
questionnaires and urine-analysis are sufficient to establish a working diagnosis 
of OAB. The majority of patients with OAB can be treated successfully with a 
combination of behavioural and pharmacological treatment. Behavioural 
treatment consists of bladder training, timed voiding, dietary modification, 
pelvic floor muscle exercises and behavioural modification, such as reduced 
intake of alcohol, caffeine, fizzy drinks and total fluid consumption. Burgio et 
al have shown that the combination of behavioural and pharmacological 
therapy is more effective than either therapy alone [12]. 
The activity of the bladder during the filling phase is central to the origins of 
sensation [13]. Therefore, it seems obvious that the physiology of the filling 
phase and the cells responsible for this sensation should be examined to 
understand the causes of urgency and urgency incontinence. It is still widely 
thought that the human bladder is not active during the filling phase. 
Furthermore, it has become generally accepted that any detrusor activity during 
filling is pathological. However, this is not actually true. There is a body of 
evidence indicating that the bladders of healthy young subjects are capable of 
generating phasic increases in pressure during the filling phase [13]. The 
original observations of Mosso and Pellacani on nonrhythmic contractions in 
the human bladder before voiding were made more than 120 years ago [14]. In 
animals, the situation is clearer. It has been known for over a century that the 
bladder is active during filling: again, the original observations of this 
phenomenon in cats were made already in 1892, by Sherrington [15]. 
Sherrington also showed that this phasic activity originated in the absence of 
any CNS input and occurred when the bladder was removed and maintained in 
vitro [15]. Therefore a plausible conclusion is that this autonomous activity is 
inherent property of the bladder wall. 
There are two distinct patterns of detrusor contractions: one associated with the 
overall contractions of the detrusor similar to the micturition contraction and the 
other generating complex phasic activity [13]. The different patterns are likely 
to be originated in different generative systems. In order to understand these 
mechanisms it is necessary to identify the cell types which play a role in both 
these systems. It is hypothesised that the autonomous contractions are 
responsible for the bladder sensation. If this indeed is the case, then an 
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upregulation of these autonomous contractions may result in increased 
sensations which in turn may be responsible for the OAB syndrome [13]. 
Therefore it is of utmost importance to know which cell types play key roles in 
this mechanism and how we can interfere pharmacologically with this 
mechanism. 
Autonomous activity in the isolated bladder increases as the bladder is filled 
[13]. This suggest the possibility of 'local reflex' mechanisms active in the 
bladder wall that may be involved in some way in modulating detrusor activity 
[13]. The components of such a reflex are unknown. One possibility involves 
sensory nerves. Sensory nerve endings lie in the suburothelial spaces, and in 
many tissues these axons produce collaterals that remain in the tissue [16]. Such 
a micro anatomical arrangement was first described by Bayliss in 1901 to 
account for local vasodilator reflexes in the skin [17]. Activation of the afferent 
fibres results in antidromic activation of the collaterals, which then have their 
effect on the tissue. This local axonal reflex has been suspected in many other 
tissues, including the bladder (see Maggi and Meli for a review) [18]. However 
it has been suggested that other components should also be considered. It was 
suggested recently that interstitial cells in the suburothelial space might serve 
some form of sensory function [13], It is not known how these cells contribute 
to sensation and how this mechanism may operate physiologically, but they 
could play a role in volume responses. 
When the complex mechanism of filling and emptying the bladder becomes 
disordered, several functional complaints arise. The patients complain of 
urgency, frequency and incontinence. The underlying pathophysiology of OAB 
is not entirely understood. OAB has been attributed to neurogenic factors 
resulting in diminished inhibition of the micturition reflex or myogenic factors 
affecting the detrusor muscle itself [19]. A more recent hypothesis emphasizes 
the sensory role of the epithelium in response to bladder wall distension or 
epithelial or subepithelial sensitivity to multiple neurotransmitters including 
acetylcholine [20]. The autonomous bladder hypothesis described above states 
that the detrusor has a modular built-up [13], Each module is defined by the 
area supplied by individual intramural bladder ganglia, or by a node of 
interstitial cells, which collectively are termed the myovesical plexus [13], 
There can be synchronization of activity between modules. Activity could be 
propagated through the intramural nerve or interstitial cell networks, or by 
direct communication between muscle cells. This theory suggests that, during 
normal bladder filling, there is autonomous activity with non-micturition 
contractions and phasic sensory discharge [13]. These basic mechanisms can 
become modified in pathological conditions, causing a shift in balance either by 
excessive excitatory inputs or failure of inhibiting inputs, leading to 
inappropriate augmentation of autonomous activity and predisposing to detrusor 
overactivity [21]. Furthermore, any factor that enhances communication 
between modules will predispose to detrusor overactivity. Therefore a cell type 
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which has a crucial role in the autonomous bladder hypothesis is the interstitial 
cell (IC) [22]. 
History oflCs 
In 1893 Cajal described a novel cell type in the gut [23]. He named these cells 
the interstitial cells, and they are presently known as the interstitial cells of 
Cajal (ICC). It can be found in the text books that these cells play an important 
role in gastrointestinal motility [24]. Based on morphological and in vitro 
physiological studies, ICC are believed to be pacemaker cells generating slow 
waves to serve as mediators in neural transmission and may also act as 
mechanoreceptors [24]. Thuneberg (1982) hypothesised that interstitial cells of 
Cajal in the gut act as pacemaker cells for gastrointestinal motor activity [22]. 
The ICC generate electrical slow waves, which passively transmit to 
gastrointestinal smooth muscle, they mediate cholinergic and nitrergic 
neurotransmission, they set the smooth muscle membrane potential and 
membrane gradient, and they also appear to be involved in mechano-
transduction [24]. The current definition of a gastrointestinal ICC requires the 
surface expression of c-Kit (a cytokine receptor kind of protein) on a cell type 
that has at least two processes [25]. At the electron microscopy level, 
characteristics of ICC include the presence of intermediate filaments, numerous 
mitochondria and gap junctions [25], 
Recognition of common principles of ICC organization (confinement to specific 
locations in relation to smooth muscle layers; formation of extensive cellular 
networks through tight coupling of overlapping thin processes; innervation 
patterns; characteristic patterns of contact with smooth muscle cells) and 
ultrastructure (myoid features: basal lamina, caveolae, rich in sER and 
mitochondria, often prominent filament bundles and dense bands/ bodies) has 
allowed Thuneberg et al to identify ICC in the gastointestinal (GI) musculature 
[22]. However, variation in organization and ultrastructure is significant, 
between species and regions of the GI tract [26]. 
More recently ICs with many of the morphological and electrical features of 
ICCs have been discovered in other organs [27], These cells have been 
identified in the ureter, bladder, urethra, vas deferens, fallopian tube, blood 
vessels, lymphatics, pancreas, prostate, penis, mammary gland, and 
myocardium [27], In the renal pelvis and proximal ureter ICs have been 
identified and it has been demonstrated that these cells contribute to peristaltic 
contractions [28]. Cells with similar morphological characteristics have been 
found in the wall of blood vessels [29], These vascular ICs demonstrated 
A I 
rhythmical Ca oscillations associated with membrane depolarisations, which 
suggests that vascular ICs may act as pacemakers for smooth muscle cells [29]. 
Besides the putative pacemaker function, ICs might have other physiological 
roles, depending on tissue type (e.g. intercellular signalling, immune 
surveillance, steroid sensors) [30]. 
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In 1996, Smet et al characterised a cell type in the bladder wall of the human 
and the guinea pig which he characterised it as being stellate and spider-like in 
appearance with extended long cytoplasmic processes with extensive dendritic 
arborizations [31], These cells responded to nitric oxide with a rise of cGMP 
[31]. This represents the potential physiological targets of neuronally released 
nitric oxide in the bladder, since activation of soluble guanylate cyclase, and a 
consequent rise in intracellular cGMP, mediate many of the effects of this 
transmitter [31]. Smet et al called this cell-type an IC [31]. It was immediately 
recognized that these cells bore a striking resemblance to the ICC in the 
digestive tract [31]. 
ICs markers and function 
The definition of ICs in the bladder is not straightforward. The morphology of 
these cells is similar to the ICC; however, they have also features in common 
with myofibroblasts. Both ICC and myofibroblasts are specialized fibroblasts 
[32]. The similarity in morphology of ICs with these other cells has resulted in 
the presently existing confusion about what are precisely ICs in the bladder, 
because in the literature on bladder physiology all four terms are used to 
indicate these cells. 
Fibroblasts and myofibroblasts are characterized by several features: spindle- or 
stellate-cell morphology, a palely eosinophilic cytoplasm, and an abundant 
pericellular matrix [33]. The immunophenotype of myofibroblasts is: vimentin 
positive, alpha-smooth-muscle actin positive, smooth-muscle myosin negative, 
non-muscle myosin positive, virtually no desmin and fibronectin positive [33]. 
Ultrastructurally the myofibroblast has a prominent rough endoplasmic 
reticulum, a Golgi apparatus producing collagen secretion granules, peripheral 
myofilaments, fibronexus junctions and gap junctions [33, 34]. These features 
are similarly found in ICs in the bladder [35]. Therefore, clear-cut criteria for 
distinguishing between the different cell types are not available [35]. It has been 
suggested that these cells belong to the same population of cells of 
mesenchymal origin, which are adapted to special functional needs in their own 
micro-environment [35]. This latter suggestion appears to be especially true for 
the ICs in the bladder wall, as many different subpopulations of these cells have 
already been observed. 
Phasic changes in pressure occur in bladders which are not associated with 
micturition [36]. Spontaneous intravesical pressure changes can be recorded 
from bladders in vitro or bladders in vivo isolated from the central nervous 
system suggesting that the bladder itself is capable of this autonomous activity 
[36]. Experiments using isolated cells and muscle strips indicate that the smooth 
muscle cells can generate spontaneous activity [37]. The bladder consists of a 
complex organisation of structures within the wall involving active elements 
including pacemaker regions, conductive pathways and contractile units in 
conjunction with regions of inactivity and passive stretch [38]. 
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Hashitani points out that ICs in the bladder are not a simple analogy of ICCs in 
the gut, which act as electrical pacemaker, but represent an example of cell-type 
specific variability amongst tissues which is accounted for by the individual 
characteristics of each organ [39]. In the detrusor smooth muscle layer, ICs 
generate spontaneous excitations independent from the smooth muscle 
excitation [40], The fundamental role of the ICs in the bladder lies in the 
integration of signals between populations of cells, and thus, a relation between 
changes in ICs and the OAB syndrome is very likely [38]. Bladder overactivity 
may result from increased excitability in detrusor smooth muscles [41], The 
detrusor smooth muscle bundles are surrounded by ICs which integrate signals 
between different populations of cells and influence the detrusor muscle activity 
[42], Hence there may be a relationship between detrusor overactivity and the 
ICs lying around the muscle bundles. However, overall contractility of detrusor 
smooth muscles does not only rely on the pacemaking activity of ICs, also 
nerves may play an important role in the excitability of the muscle cells and the 
smooth muscles may also have their own excitability mechanism. 
In order to further identify the different types of interstitial cells we adopted the 
classification of Gillespie et al. based on their location [42], This classification 
identifies the following subtypes of interstitial cells: Sub-urothelial interstitial 
cells; located directly below the urothelium [42]. These SU-ICs can be 
subdivided in Necklace SU-ICs, lying directly below the urothelium, Basal 
SU-ICs, lying below the necklace SU-ICs and Deep SU-ICs lying below the 
basal SU-ICs [42]. Between the SU-ICs and the detrusor muscle the Lamina 
Propria Interstitial Cells are located (LP-ICs) [42], In the detrusor muscle there 
are two types of ICs; cells lying around the muscle bundles, the Surface 
Muscle ICs (SM-ICs) and the cells lying in the muscle bundles, Intermuscular 
ICs (IM-ICs) [42], Both types of muscle ICs can be subdivided in inner muscle 
and outer muscle. At the end of the outer muscle the Muscle Coat ICs (MC-
ICs) are located [42]. 
Unknowns 
It has been known for over 30 years that prostaglandins (PGs), produced in both 
the urothelium and muscle layers, are released from the bladder in response to 
stretch [43-46]. It has been argued that the PGs play central roles not only in 
bladder physiology but also in the generation of bladder pathophysiology. This 
hypothesis is supported by the fact that infusion of PG into the bladder lumen 
gives rise to an increase in micturition frequency and the incidence of non-
voiding phasic contractions between voiding episodes [47-50], PG production in 
the bladder serves also other functions. Bachteeva et al reported that PGs play a 
role in the osmotic water permeability of the frog urinary bladder [51]. Both the 
details of the mechanisms underlying this action of PGs on voiding frequency 
and the location(s) where PGs are synthesized in the bladder were unknown until 
recently. Therefore a study into the localization of cyclo-oxygenase I (COX I), an 
enzyme which synthesises PGs, was indicated. We found the expression of COX 
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I predominantly within two general cell systems in the bladder wall: (i) cells 
within the basal and intermediate layers of the urothelium and (ii) within a 
population of small cells which are closely associated with a network of vimentin 
positive cells [4]. These vimentin positive cells presumably interstitial the ICs are 
present throughout the suburothelial space of the lamina propria and extend over 
the surface of the muscle bundles which make up the inner layers [4]. 
The urothelium responds to deformation in a complex manner by releasing not 
only PGs [47-50], but also adenosine trisphosphate (ATP) [52], nitric oxide (NO) 
[52-54], and acetylcholine (ACh) [20, 55]. The mechanisms generating these 
signals and the physiological systems which they target are poorly understood. It 
has been suggested that the release of these substances is an integral part of a 
sensory system assessing bladder volume and wall stress [56]. The current 
concept is that, like PGs, ATP, ACh and NO are released from the urothelium in 
response to stretch. These substances are then thought to act as transmitters and 
influence directly or indirectly the suburothelial afferent nerves that are involved 
in sensation. However, it is possible that there are other targets for these 
urothelially derived signals. 
Autonomous activity in the obstructed guinea pig bladder showed episodes of 
rapid phasic activity (bursts) [21]. The mechanism involved in controlling the 
frequency of the motor component of the motor/sensory system, the 'pacemaker', 
appears to become progressively 'supersensitive' to cholinergic stimulation with 
the development of pathology [21]. Altered nonmicturition activity might very 
well contribute to increased afferent output, which in turn contributes to the 
increased sensations of urge associated with bladder dysfunction. 
Aims of the project and long term objective 
The concept of the autonomous bladder is well founded and has its basis in a 
series of publications on the physiological properties and the microstructure of 
the guinea pig urinary bladder. Fine-tuning this concept to the clinical practice 
requires that a number of imported questions are resolved. For obvious reasons, 
many complex measurements and experiments cannot be performed on humans. 
Similarly, tissue samples from defined areas from the urinary bladder of well 
characterised patients and normal control subjects are almost impossible to 
obtain routinely. Therefore, in order to probe basic mechanisms and to study the 
detailed structure of the urethra and bladder, we are left with the choice of using 
experimental animals. Nevertheless, using this approach, complex questions 
concerning the bladder structure and function can be answered when keeping in 
mind the central thesis in our investigations, i.e. that structure must be related to 
function. 
Previous investigations in our group have clearly shown that in an animal model 
for the obstructed bladder, overactivity of bladder is accompanied by structural 
changes in the bladder wall [21], However, the contribution of each of the 
changes in the bladder wall that have been observed in relation to the 
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development of the overactivity remains an enigma. The following questions 
were the basis for the present investigations: 
1) It is known that ICs in the inner and outer muscle respond differently to NO. 
Axe there further subdivisions possible for ICs related to other transmitters that 
are known to be released in the bladder wall? 
2) What changes are there in the properties of the ICs in the obstructed bladder? 
3) Is there an influence of the operation on the urethra itself, which is necessary 
for the obstructed bladder model, on the structure and the functioning of the 
guinea pig bladder? 
4) Where are M3 receptors in view of the presumed role of these receptors in the 
overactive bladder syndrome, where are these receptors localized? 
Approach 
We chose the guinea pig as the experimental animal for our investigations. In 
previous investigations from our group we used mice, rats, and guinea pigs. 
However, as a model for the obstructed bladder syndrome, the guinea pig is the 
animal of choice. There are many similarities between the microstructure of the 
urinary bladder of the guinea pig and the human [31]. One very important aspect 
in this respect is the presence of intramural ganglia in the bladder wall of the 
guinea pig and the human. Intramural ganglia are involved in relaying afferent 
sensory information [16] and probably also in the pre-processing of this 
information [16]. We used in vitro incubated isolated guinea pig bladder which 
enabled us to perform pharmacological experiments in combination with 
immunocytochemistry. The latter technique was our main approach to the 
localization of nerves, receptors, and cellular components. Although 
immunocytochemistry can provide very precise information about the 
localization of specific cellular constituents, i.e. structural proteins or 
components of signal transduction cascades, it is also a technique which is ill-
famous for its artefacts and false positive results. This made it necessary to invest 
a considerable effort in the characterization of the specificity and applicability of 
a number of commercially available antibodies. Finally, there was always the 
self-inflicted requirement of concordance between structure and function. 
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Introduction 
Interstitial cells in the bladder are known for more than 10 years [1]. However 
the structural components of these cells form a continuing discussion. This 
review is an attempt to shed some light into this matter. We divided the 
interstitial cells on their location and identified the structural components of 
these cells. 
Smet et al were the first who described a cell type in the bladder, which 
responds to stimulation of NO with a rise in cGMP [1]. He named these cells 
interstitial cells (ICs) [1], These cells had long dendritic processes extending 
parallel to the smooth muscle fibres, and contained vimentin, an intermediate 
filament expressed by cells of mesenchymal origin [1, 2]. The ICs of the 
bladder have some cytological characteristics in common with the interstitial 
cells of Cajal (ICC) in the gut. Both ICs and ICC contain bundles of fine 
cytoplasmic filaments, dense bodies, linear arrays of subsurface vacuoles, and 
the presence of an interrupted basal lamina [3]. Like ICC, the ICs are vimentin 
positive and have long dendritic processes [4, 5]. The ICC in the gut play an 
important role in the control of autonomous activity of the gut. ICC have a 
distinct morphology; they have long processes and are connected with each 
other [5]. 
The gross structure of the bladder wall is well known. On the luminal side we 
find the urothelium, which is made up of several epithelial cells. The epithelial 
cells bordering on the luminal site are large flattened cells, and are named 
umbrella cells. Immediately adjacent to the urothelium lies the lamina propria, 
which consists of a dense layer of spindle shaped cells also called the 
suburothelial cell layer. In the part of the lamina propria which borders on the 
muscle these cells are distributed more sparsely. The lamina propria contacts 
the inner layer of two layers of criss-crossing muscle layers (figure 1). Although 
there is a clear difference between muscle cells and the cells of the lamina 
propria, these layers are intertwined at the bordering zone by the same spindle 
shaped cells which are often characterized by long processes [6], which appear 
to be interconnected [7], These cells have been tentatively identified as 
myofibroblasts [8], whereas others have termed these cells interstitial cells [1], 
Myofibroblasts are characterized by several features; they have a spindle-cell or 
stellate-cell morphology, a palely eosinophilic cytoplasm, and an abundant 
pericellular matrix [9], The immunophenotype of myofibroblasts is: vimentin 
positive, smooth-muscle actin positive, smooth-muscle myosin negative, non-
muscle myosin positive, virtually no desmin and fibronectin positive [9], 
Ultrastructurally the myofibroblast has a prominent rough endoplasmic 
reticulum, a golgi apparatus producing collagen secretion granules, peripheral 
myofilaments, fibronexus junctions and gap junctions [2, 9]. 
Morphological features of fibroblasts, myofibroblasts and interstitial cells are 
more or less the same [10]. Therefore, clear-cut criteria for distinguishing 
between fibroblasts, myofibroblast and interstitial cells are not available [10]. 
Komuro suggests that the majority of these cells, if not all, seem to belong to 
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the same population of cells, which are adapted to special functional needs in 
their own micro-environment that are peculiar to local, pathological, or 
experimental conditions [10]. 
In the literature the terms myofibroblast and interstitial cell have been used 
interchangeable. In this review we have adopted the name interstitial cell for all 
cells that are vimentin-positive. We will use the term myofibroblast only when 
discussing the explicit differences between these two cell types. 
Structural immunohistochemical markers used to identify interstitial cells. 
Most of the studies aiming at the identification and characterization of 
interstitial cells have been performed using antibodies against specific epitopes. 
In general, the specificity of antibodies is not always clear and often difficult to 
prove. There are many examples of monoclonal antibodies that are specific in 
Western blotting; however do not work at all in immunohistochemistry. The 
problems with polyclonal antisera are even bigger: multiple bands will be 
visible on Western blottings when the protein under study is a constituent in a 
tissue or cell homogenate. Insufficient blocking of protein degradation will 
result in epitopes at "incorrect" molecular weights. Unexpected interactions 
with related or even unrelated proteins have been reported in the literature [11]. 
Therefore, the question posed almost 25 years ago, is still valid: "Can 
specificity in immunocytochemistry ever be proven?" [11, 12]. Nevertheless, 
enzyme- and immunohistochemical methods are the available methods to 
characterize specific cells in complex tissues. We hold the view that using a 
number of antibodies in different combinations will result a reliable and 
reproducible characterisation of interstitial cells in the bladder of a number of 
species. Antibodies described in the literature to characterize interstitial cells of 
the bladder will now be discussed. One must realize however that 
immunohistochemical proof for one or another receptor does not equal function. 
Given the problem of histochemical specificity, concepts or hypothesis based on 
histochemical findings will have to be proven with functional experiments. 
Therefore western blotting or control staining on knock-out animals should be 
encouraged when immunohistochemical data are presented. In most of the 
immunohistochemical experiments no antibody controls studies have taken 
place. We mentioned wether antibody control studies did take place. 
The C-kit receptor, or also called KIT or CD 117, is a cytokine receptor 
expressed on the surface of haematopoietic stem cells, mast cells, melanocytes 
in the skin, and interstitial cells of Cajal (ICC) in the gut. This protein is a type 
3 transmembrane receptor for mast cell growth factor. C-kit is an important cell 
surface marker used to identify certain types of haematopoietic progenitors in 
the bone marrow. Literature on the expression of C-kit on interstitial cells of the 
bladder is inconsistent. Several authors found C-kit positive ICs in the bladder 
[2, 6, 13-16], but many other authors couldn't reproduce this. Pezzerone et al. 
identified C-kit positive interstitial cells in the ureter, but the ICs in the bladder 
were C-kit negative [17, 18]. This was consistent with the finding of several 
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other authors who also found C-kit negative ICs in the bladder [18, 19]. These 
cells were identified with a rise of cGMP after stimulation with NO, or by the 
use of vimentin [18, 19]. Davidson et al. identified a network of vimentin 
positive ICs below the urothelium, of which many but not all cells were C-kit 
positive [19]. 
Vimentin is a member of the intermediate filament family of proteins, which is 
a general marker for mesenchymal stem cells. Mesenchymal stem cells are 
multipotent stem cells that can differentiate into a variety of cell types. One of 
these cell types are fibroblasts. As described above both fibroblasts and ICs are 
stellate or spindle-shaped cells and both express vimentin. Thus differentiation 
between ICs and fibroblasts can be difficult, and caution should be taken 
interpretating results of vimentin positive cells. 
The CD34 molecule is a cluster of differentiation molecules present on certain 
cells within the human body. It is a cell surface glycoprotein and functions as a 
cell-cell adhesion factor. Cells expressing CD34 are found in the umbilical cord 
and bone marrow as haematopoietic cells, endothelial progenitor cells, 
endothelial cells of blood vessels, mast cells, a sub-population of dendritic cells. 
Rasmussen et al describes a subtype of ICs located between the muscle bundles 
in the bladder that show immunoreactivity for the CD34 molecule [20]. 
CD44 is a cell-surface glycoprotein involved in cell-cell interactions, cell 
adhesion and migration. It is a receptor for hyaluronic acid. CD44 participates 
in a wide variety of cellular functions including lymphocyte activation, 
recirculation and homing, haematopoiesis, and tumor metastasis. Transcripts for 
this gene undergo complex alternative splicing that results in many functionally 
distinct isoforms; however, the full-length nature of some of these variants has 
not been determined. Ozturk et al found that CD44 is expessed on cells in the 
interstitial space, possibly interstitial cells [21]. Te function of CD44 in these 
cells is not known. 
The number of structural markers to characterize interstitial cells is limited. The 
results are not unequivocal. Current literature does not provide any data that 
support the presence of interstitial cells of Cajal in the bladder. We conclude 
that the ICs in the bladder are best characterized by a combination of the 
presence of vimentin-immunoreactivity together with the morphological 
appearance of elongated cells somata showing a variable number of processes 
with variable length and branching patterns. 
Naming of Interstitial cells 
The terminology for ICs, proposed by Gillespie et al, based on their location has 
been used in this review [22]. Figure 2 shows an overview of this classification. 
ICs directly below the urothelium were named sub-urothelial ICs (SU-ICs), and 
these could be further subdivided in a) Basal SU-ICs: SU-ICs lying below the 
necklace cells (the deepest layer of urothelial cells), and b) Deep SU-ICs; SU-
ICs lying between the lamina propria and the Basal SU-ICs. ICs located in the 
lamina propria were named lamina propria ICs (LP-ICs). The ICs in the muscle 
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layers were divided in cells lying around the muscle bundles: surface muscle 
ICs (SM-ICs); and cells inside the muscle bundles: the inner muscle ICs (IM-
ICs). The ICs lying on the peripheral zone of the bladder muscle were named 
muscle coat ICs (MC-ICs). Based on this classification we have attempted to 
give an overview of the literature regarding the specific structural and 
functional features of these cells. 
Suburothelial Interstitial Cells 
SU-ICs are described as a distinctive zone directly below the urothelium [23-
25]. All layers consist of long spindle-shaped ceils that apparently form a 
network [2, 17, 19, 22, 23, 26, 27]. Depending upon the region, this zone varies 
from 2 cell layers in the dome up till 5 cell layers in the lateral wall, 
Ultrastructurally the SU-ICs contain bundles of fine cytoplasmic filaments, 
dense bodies, linear arrays of subsurface vacuoles, and an interrupted basal 
lamina, 
C-kit-IR on SU-ICs have been reported both positive [15, 16, 19, 26, 28] and 
negative [19, 28]. Using functional parameters a further subdivision can be 
made of the SU-ICs. Immediately below the urothelium there is a single layer of 
interstitial cells that are also immunoreactive for cGK-I [29]. These cells were 
termed necklace cells. As these cells have extended linking processes this also 
suggests a network. Although the necklace cells contain cGKI, they did show 
cGMP-IR in respond to NO [29]. There are several possibilities why no cGMP-
immunoreactivity was observed in the necklace cells. First, cGMP levels might 
be too low, due to high phosphodiesterase (PDE) activity, to be detected by the 
cGMP-antibody [22]. However, there are no data on PDE activity in these cells. 
Secondly, although the soluble guanylyl cyclase is present in these cells, it 
might be in an inhibited form [30]. 
The cells below the necklace cells stain intensely with cGMP after stimulation 
with NO [19, 22, 25, 29-32]. The specificity of the cGMP antibody is described 
in a seperate study [33]. The Deep SU-ICs are located below the layer of Basal 
SU-ICs. These cells do not show a prominent response to NO with a rise of 
cGMP, but do contain cGKI. This latter observation suggests that cGMP-
signalling plays a role in these cells [29, 30]. 
It has been demonstrated that the NOS enzyme is located in the SU-ICs [34]. 
This enzyme can be activated by acetylcholine and ATP. The urothelium 
releases signalling substances, like acetylcholine [35, 36], ATP [37], and 
prostaglandins [38-41]. Thus the acetylcholine and ATP derived from the 
urothelium could activate the SU-ICs. 
Both the M2 and M3 muscarinic acetylcholine receptors have been reported to 
be present on SU-ICs [42-45]. Two of these studies were performed by the 
authors. The specificity of the M3-antibody used in these studies were 
established by both western blots and immunohistochemistry of the antibody 
preincubated with the appropriate blocking peptide. The M3 immonoreactivity 
in the sub-urothelial interstitial cells indicates that these cells can be activated 
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by acetylcholine. However, the role of the muscarinic receptors in the SU-ICs is 
not clear. Although muscarinic receptors play an important role in the mediation 
of bladder contractions, it is not apparent that SU-ICs are involved in 
acetylcholine-controlled muscle contractions. However, SU-ICs also interact 
with unmyelinated axonal varicosities of cholinergic sensory nerves containing 
a mixture of clear and large dense-core vesicles, or clear vesicles alone [3, 15, 
46]. The identification of these vesicles indicates the release of acetylcholine 
alone (clear vesicles) or acetylcholine and ATP (dense-core vesicles) [3]. 
Purinoreceptors have been identified on the SU-ICs [23, 47]. The predominant 
purinoceptor is P2Y6, and there was weak expression of P2X3, P2Y2 and P2Y4 
[23, 47]. Activation of a P2Y receptor by ATP results in an intracellular Ca (2+) 
transient, which plays a role in the excitability of SU-ICs. This indicates that the 
purinoreceptors on the SU-ICs play a role in the excitability of the SU-ICs and 
thus have a possible role in the autonomous activity of the bladder. 
Additionally, the SU-ICs showed immunoreactivity for the vanilloid receptor-1 
[48]. Vanilloids are thought to block selectively C-fibres by desensitization, 
decreasing bladder activity, although the relationship between the vanilloid 
receptors on the SU-ICs and C-fibre desensitization is unclear. Further research 
is necessary in order to understand the role of the vanilloid receptor on the SU-
ICs 
Another feature of ICs is that they are inter-connected through connexin-43 
containing gap junctions [2, 16, 23, 27, 28, 42]. Sui et al used a well 
characterised anti-connexin-43 antibody [28], This antibody was characterised 
by immunofluorescence, Western blotting of connexin transfectants, and by 
immunogold electron microscopy [49]. The role of the connexin-43 positive 
SU-ICs is unknown but their coupling by gap junctions implies that they have 
the capacity to form a functional syncytium in the suburothelial space. E-
cadherins are located on SU-ICs on areas where SU-ICs come in close contact 
with each other [21, 50]. Cadherin-11 most probably plays an important role in 
the intercellular physical coupling of SU-ICs [50]. The specificity of the 
cadherin-11 antibody was established in this by internal and external controls; 
however a no knockout, blocking peptide or western blot studies were 
preformed. SU-ICs also stain for CD44; this cell-surface glycoprotein is also 
involved in cell-cell interactions [21]. CD44 participates in a wide variety of 
cellular functions including lymphocyte activation, recirculation and homing, 
haematopoiesis, and tumor metastasis. The function of CD44 on the SU-ICs is 
not known. 
Surface Muscle Interstitial Cells (SM-ICs) 
SM-ICs are described as cells located on the edge of smooth muscle bundles, 
containing lateral branches that run in parallel with the muscle bundles [2, 6, 17, 
19, 51, 52]. These lateral branches connect adjacent muscle bundles and also 
connect to the Muscle Coat Interstitial Cells (MC-ICs) [22]. A close association 
between enteric nerves and SM-ICs has been described [2, 6, 19]. 
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Ultrastructurally the SM-ICs contain nuclei with clumped peripheral 
heterochromatin and a dilated rough endoplasmic reticulum with a moderately 
electron dense amorphous content and prominent Golgi complexes [51]. 
A sub-population of the SM-ICs were C-kit positive [6, 15-17, 19, 20, 51, 53]. 
The specificity of the C-Kit antibody has been established using antiserum 
specificity control experiments [51], The outer muscle SM-ICs react to NO with 
a rise of cGMP [18, 22, 31, 54, 55], while this was not the case for the inner 
muscle SM-ICs. The specificity of the cGMP antibody used was established in a 
different study [33]. This indicates heterogeneity of these cells. A subset of SM-
ICs showed immunoreactivity to the vanilloid receptor 1 and nNOS [34, 48]. 
Also positive staining for CD34 has been reported [20]. These CD34 positive 
cells showed no C-Kit immunoreactivity [20]. 
Intramuscular Interstitial Cells (IM-ICs) 
IM-ICs are located throughout the smooth muscle bundles [51]. They have a 
stellate-like morphology [19, 22, 51] and are in close contact with cholinergic 
nerve fibres [55], Ultrastructurally the IM-ICs were comparable with the SM-
ICs as they had nuclei with clumped peripheral heterochromatin, a dilated rough 
endoplasmic reticulum with a moderately electron dense amorphous content, 
and prominent Golgi complexes [51]. 
As mentioned before, studies using C-kit as a marker reported contradictory 
results; C-kit immunoreactivity has been described in the IM-ICs [15, 20, 51, 
53], while other authors reported no C-kit immunoreactivity in these cells [18]. 
One study reported that a subset of IM-ICs stained for C-kit while another 
subset was C-kit negative [19]. The IM-ICs of the outer muscle also increase 
synthesis of cGMP when they are stimulated with NO, while the inner muscle 
M-ICs do not show a visible response in cGMP after NO stimulation [19, 22, 
54, 55]. The specificity of the cGMP antibody was established in a different 
study [33]. Surprisingly, immunohistochemical staining for choline 
acetyltransferase (ChAT) showed immunoreactivity in a subset of the IM-ICs 
[55]. Presently little data is available on other neurotransmitter receptors on this 
subtype of ICs. Stainings done with an antibody to CD34 showed positive 
staining in a subset of these cells [20]. 
Muscle Coat Interstitial Cells (MC-ICs) 
MC-ICs are located on the boundary of the outer muscle layer. Little is known 
in the literature of the MC-ICs. It has been reported that, in a number of species, 
these cells react to NO with a rise in cGMP [22], but also after incubation of 
tissue with atrial or brain natriuretic peptide, but not to C-type natriuretic 
peptide [30]. The specificity of the cGMP antibody was esablished in a different 
study [33]. 
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Iminunohistochemical markers used to characterize interstitial cells. 
Cyclic guanosine monophosphate (cGMP) is a cyclic nucleotide derived from 
guanosine triphosphate. cGMP acts is a second messenger molecule. Although 
cGMP is a small, water-soluble molecule, it can be visualized using 
immunohistochemistry as highly selective anti-cGMP antisera have been 
developed against formaldehyde-fixed cGMP (refs). Therefore, these antibodies 
can be used to locate the target structures for nitric oxide (NO) and natriuretic 
peptides (refs). There are three known cGMP binding proteins: cGMP 
dependent protein kinases (CKG), cGMP binding phosphodiesterases (PDEs), 
and cyclic nucleotide-gated ion channels [56]. 
cGMP-dependent protein kinases (CGK) are target molecules for cGMP. There 
are two different CKG genes that produce two isoforms of CGK i.e. CGK-I and 
CGK-II. These enzymes phosphorylate a number of biologically important 
targets and are implicated in the regulation of smooth muscle relaxation, platelet 
function, sperm metabolism, cell division, and nucleic acid synthesis. 
Antibodies against CGK-I and CGK-II have been used on bladder tissue (refs). 
These antibodies have been extensively characterized by biochemical means 
(refs). One obvious difference in the location of cGK-I and cGK-II is that CGK-
II has not been observed in the smooth muscle of blood vessels (refs). 
Nitric oxide synthase (NOS) is the enzyme that synthesizes NO from the 
terminal nitrogen atom of L-arginine in the presence of NADPH and 02. There 
are three different isoforms of NOS known. NOS-1 (originally called neuronal 
NOS: nNOS) is constitutively present and activated by calcium-calmodulin. 
NOS-2 is the inducible form of NOS, also called iNOS. iNOS is expressed in an 
active form as calmodulin is consitutively bound to the enzyme. iNOS has not 
been observed in the normal healthy bladder; however, it is expressed at high 
levels in the obstructed or inflamed bladder. NOS-3, or endothelial NOS 
(eNOS) is expressed in endothelial cells and needs to be activated by calcium-
calmodulin. There are a large number of antibodies available against the three 
isoforms of NOS. Also, antibodies have been developed which recognize in 
principle all NOS isoforms, so-called pan-NOS antibodies [34, 57]. 
Choline acetyltransferase (ChAT) is the enzyme that synthesizes acetylcholine. 
Antibodies to ChAT are well characterized, and performance of these antibodies 
in the bladder can be checked by performance against cholinergic innervation in 
the central nervous system (refs). In the bladder ChAT has been described to be 
present in the cholinergic fibres innervating the bladder muscle and occasional 
the urothelium, the ganglion cells. In addition, ChAT-immunoreactivity has 
been observed in umbrella cells lining the lumen of the bladder (refs), Instead of 
ChAT antibodies one can also use antibodies against the vesicular acetylcholine 
transporter. 
Muscarinic receptors are present in the bladder. Up to date the M2 and M3 
receptor have been described in this tissue. However, the location of the M3 
receptor is still controversial. This is in part caused by the lack of agreement on 
the selectivity, or specificity of the antibodies that are currently available. In our 
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own study have used a range of antibodies against the M3 receptor from 
different suppliers, and the results were sometimes widely different [44]. 
Nevertheless, the abeam Rabbit anti-M3 and the Santa Cruz Goat anti-M3 
antibodies give a reproducible labelling of the M3 receptor [44, 45]. Controls of 
the anti-M3 antibody used in these studies were performed by western blot and 
immunohistochemical studies of the antibody with the approprate blocking 
peptide [44]. 
P2Y receptors are a family of purinergic, G protein-coupled receptors, which 
are stimulated by ATP, ADP UTP, UDP and UDP-glucose. P2Y receptors are 
present in almost all human tissues where they exert various biological 
functions based on their G-protein coupling. 
The vanilloid receptor is a type of nerve receptor which is closely related to 
cannabinoid receptors [58]. Vanilloid receptors are activated by a ligand, which 
will communicate a sensation within the nervous system. In the bladder the 
vanilloid receptors subtype 1 (TRPY1) and 2 (TRPV2) is found [16]. This 
receptor is involved in the transmission and modulation of pain, as well as the 
integration of diverse painful stimuli [59, 60], The TRPV receptors in the 
bladder are thought to be involved in decreasing bladder activity by blocking C-
fibres by desensitization. 
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Immunohistochcmistry SU-ICs SM-ICs IM-ICs MC-ICs 
C-kit some + some + Some + 
Vimentin + + + + 
cGKI + 
! 
cGMP 
Necklace: -
Basal: + 
Deep: + 
Outer muscle: + 
Inner muscle: -
Outer muscle: + 
Inner muscle: -
+ 
Connexin 43 + + 
E-cadherin + 
CD44 + 
Alpha-SMA + -
ChAT Some + 
nNOS + some + 
P2X3, P2Y2, P2Y4 
P2Y6 
weakly+ 
M2 receptor + 
i 
M3 receptor + 
Vanilloid receptor-1 + some + 
Table 1. Immunohistochemical reactivity (ER) on the different types of ICs. Different 
immunohistochemical markers, seen in the interstitial cells of the bladder, are seen in the left 
collum. On the top row are the different types of interstitial cells; sub-rothelial interstitial cells 
(SU-ICs), surface muscle interstitial cells (SM-ICs), intra muscular interstitial cells (IM-ICs) and 
muscle coat interstitial cells (MC-ICs). + shows that that type of ICs shows immunoreactivity to 
the marker written on the left. - shows that that type of ICs do not show immunoreactivity to the 
marker written on the left side. cGMP-IR showed subtypes of interstitial cells; the SU-ICs can be 
devided into necklace SU-ICs, basal SU-ICs and deep SU-ICs; and the muscle interstitial cells 
can be divided into outer muscle interstitial cells and inner muscle interstitial cells. When there 
are no reports of a certain marker on a specific interstitial cell type the box is left blank. 
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Figure 1. C-Kit immunoreactivity (IR) in interstitial cells (ICs). Panel A shows a picture from 
a study by Davidson et al [19]. C-Kit IR is visible in sub-urothelial ICs (SU-ICs) and lamina 
propria ICs (LP-ICs). Panel B shows a picture from a study by Kubota et al [64]. C-kit IR is 
visible in SU-ICs (arrows). Panel C shows a picture from a study by McCloskey et al [6]. C-kit 
IR is visible in ICs in the muscle layer. Panel D shows a picture from a study by Biers et al [13], 
C-kit IR is visible in ICs in the muscle layer. Panel E shows a picture from a the same study as C 
[6]. C-kit IR is visible in ICs in the muscle layer. Panel F shows a picture from a study by 
Davidson et al [19]. C-kit IR is visible in ICs in the muscle layer. Panel G shows a picture from 
the same study as panel B [64]. C-kit IR is visible in surface muscle ICs (SM-ICs). 
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Figure 2. Vimentin immunoreactivity (IR) in interstitial cells (ICs). Panel A shows a picture 
from a study by de Jongh et al [65]. Vimentin positive sub-urothelial ICs (SU-ICs) are visible 
directly below the urothelium (green). Below this layer the vimentin positive lamina propria ICs 
(LP-ICs) are visible (green). COX I IR is visible in red. The basal urothelial layer shows strong 
COX I IR. A subset of the LP-ICs show IR for COX I. Panel B shows a picture from a study by 
Sui et al [47]. The SU-ICs and LP-ICs show IR for vimentin (red). Panel C shows a picture from 
a study by the authors [45]. Vimentin IR in the SU-ICs is visible in green. These cells also show 
IR for the M3 receptor (red). Panel D and E shows a picture from a study by Davidson et al [19]. 
Panel D shows vimentin IR in the LP-ICs (red). Panel E shows vimentin IR in ICs of the muscle 
(red). A subset of these cells also stains for C-Kit (jellow). Nuclei are visible in purple. Panel F 
shows a picture from the same study as A [65]. Vimentin IR is visible in surface muscle ICs (SM-
ICs, green). A subset of these cells also show IR for COX I (red). G shows a picture from a study 
by Smet et al, [1]. Vimentin IR is visible in ICs in the muscle bundles. 
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Figure 3. cGMP immunoreactivity (IR) in interstitial cells (ICs) in the bladder. Panel A 
shows a picture from a study by Gillespie et al [22]. cGMP IR is visible in green. ICs of the 
muscle coat (muscle coat ICs; MC-ICs) and of the outer muscle show cGMP IR, while the ICs of 
the inner muscle do not show this IR. Both the surface muscle ICs (SM-ICs) and the intra 
muscular ICs (IM-ICs) of the outer muscle show cGMP IR. The umbrella cells of the urothelium 
also show cGMP IR. Directly below the urothelium are cGMP positive ICs; the sub-urothelial ICs 
(SU-ICs). nNOS IR is visible in red. The basal urothelial layer stains intensely for nNOS. A 
subset of nerves in the lamina propria and muscle layers also show nNOS IR. Panel B shows a 
picture from a study by Smet et al [1]. Panel B shows cGMP IR in the umbrella cells of the 
urothelium and in cells directly below the urothelium; the SU-ICs. Panel C shows a picture from a 
study by de Vente et al. [30], cGMP IR is visible in a celllayer directly below the urothelium; the 
SU-ICs. Panel D shows a picture from the same study as panel B [1]. CGMP IR is visible in ICs in 
the muscle bundles (IM-ICs) of the outer muscle. Panel E shows a picture from a study by Lagou 
et al. [54]. The same cell types as in panel D are IR for cGMP (star). These cells lie in close 
relation with VAchT positive nerves (n). Panel F and G show pictures from a study by de Jongh et 
al [31]. Both panels show pictures from obstructed bladders. Panel F shows cGMP IR in an 
obstructed bladder. The SM-ICs show IR to cGMP. The number of SM-ICs is increased and these 
cells are clustered into nodes. Panel G shows a detail of the muscle coat (MC). There is an 
increase in the number of MC-ICs and all MC-ICs show IR with cGMP, 
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Figure 4. An overview of 
different antibody stainings 
on interstitial cells (ICs). 
Panel A shows a picture from 
a study by Kuijpers et al [50]. 
Immunoreactivity (IR) for 
Cadherin-11 is visible in the 
ICs. Panel B shows a picture 
from a study from the authors 
[45], IR for the M3 receptor is 
visible in red in vimentin 
positive ICs. Panel C shows a 
picture from a study by 
Gillespie et al [55]. IR for 
choline acety transferase is 
visible in ICs (red, arrow a). 
These cells lie in close relation 
with PGP 9.5 IR nerves (green, arrow b). Panel D shows a picture from a study by Ostef al [48]. 
The vanniloid receptor is visible on ICs (arrows). Panel E shows a picture from a study by 
Rasmussen et al [20]. The arrows point to CD34 IR ICs around the muscle bundles. Panel F 
shows a picture from a study by Ozturk et al [21], The arrows point to an area of interstitial cells 
that show IR for CD44. Panel G shows a picture from a study by de Jongh et al [32]. COX I IR is 
visible on ICs. Panel H shows a picture from a study by Sui et al [47]. P2Y6 IR is visible in ICs 
below the urothelium. The white line seperates the urothelium from the lamina propria. Panel I 
shows a picture of our own work. P2X7 IR is visible in ICs directly below the urothelium. 
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Figure 5. Summarizing a 
cartoon of changes in the 
bladder wall after bladder 
outlet obstruction. Panel A is 
a cartoon of the normal 
bladder wall. The urothelium 
consists of 3 layers. Directly 
below the urothelium the sub-
urothelial interstitial cells (SU-
ICs) are located. Below these 
cells lie the lamina propria 
interstitial cells (LP-ICs). 
Below the LP-ICs lie the 
muscle bundles. The surface 
muscle interstitial cells (SM-
ICs) are located around the 
muscle bundles, while the intra 
muscular interstitial cells (IM-ICs) are located inside the muscle bundles. The muscle coat consits 
of a thin layer of muscle coat interstitial cells (MC-ICs). Panel B shows a cartoon of the 
obstructed bladder. There is an increase in cells in the intermediate urothelium. No difference is 
noted in the number of SU-ICs, while the SM-ICs and MC-ICs increase dramatically. 
Furthermore there is a discrete increase in the LP-ICs and IM-ICs. 
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Figure 6. Ultra structural features of interstitial cells. Panel A shows a cartoon of an interstitial 
cell (myofibroblast) from a study by Eyden [9]. Abbreviations: AP, attachment plaque; c, 
collagen secretion granule; FD, focal density; FF} fibronectin fibril; FNXa fibronexus; G, Golgi 
apparatus; L, lamina; M, myofilament bundle; N, nucleus; RER, rough endoplasmic reticulum; 
SC, surface (plasrnalemmal) caveolae; SPL, subplasma-lemmal linear density (focal adhesion). 
Panel B and C show electronmicroscope pictures of a study by Drake et aL[51], Panel B shows a 
multipolar fibroblastic cell at the junction of 3 muscle fascicles (M). This cell shows typical 
cytoplasmic and nuclear appearances with numerous collagen fibrils ( Q and elastin bodies (E). 
Panel C shows a bipolar fibroblastic cell with flattened process (P) extending parallel to adjacent 
smooth muscle fascicle. 
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Figure 7. Spontaneous, and ATP-induced Ca2+ transients in suburothelial interstial ceils. 
Panel 1 and 2 show original panels from a study by Wu et al [62]. Panel 1 shows spontaneous 
currents in suburothelial interstitialcells (SU-ICs). Panel A shows current- and voltage-clamp 
recordings from an isolated cell using a Cs+-filled pipette. The first half of the record is under 
current-clamp; the second half shows ionic current recorded when voltage-clamped at -60mV. 
The dotted line shows the zero-current level. Panel B shows voltage dependence of spontaneous 
currents under voltage-clamp: holding potential was varied between -60 and 0 mV in this 
example in a series of steps. Spontaneous currents are arrowed. Panel C shows current-voltage 
relationship of spontaneous currents from seven cells. Mean ± S.D. of data; the straight line was 
fitted by least-squares analysis of the mean data. 
Panel 2 shows ATP-induced Ca2+ transients and spontaneous currents in SU-ICs. Panel A shows 
the effect of ATP in concentrations ranging from 0,1 to 100 uM, ATP was added during the 
periods indicated by the horizontal bars. Cell voltage-clamped at -60 mV with a Cs-K filled 
pipette. Panel B shows voltage dependence of Ca2+ transients and spontaneous currents induced 
by 100 ijM ATP. Membrane potential was varied between -60 and 0 mV. Panel C shows phase-
plane plot of the relationship between current and intrace. The recordings used to generate the 
plot are shown in the box; arrows indicate the direction of time. The horizontal black bar below 
the left limb of the plot shows the inherent noise in the traces used to generate the plot. Panel D 
shows the relationship between the change of membrane potential, Aem, and the initial value, 
Em, upon addition of 100 ATP. The straight line was calculated by least squares analyses. 
Data are from six separate cells are shown as indicated by different symbols. 
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Figure 8. Spontaneous and ATP-induced Ca2+ transients in surface muscle interstitial cells. 
Panel A and B show original panels from a study by Johnston et al [14], Panel Ai. Shows a 
preparation of a smooth muscle bundle loaded with fluo 4AM (green) and labeled with anti-c-Kit 
(red). The surface muscle interstitial cells (SM-ICs) are visible on the edge of the bundle 
(arrows). Panel A/7 shows a SM-ICs (arrowhead) on the left border of a smooth muscle bundle 
(arrow). Panel B shows the intensity time series from a smooth muscle cell (arrow in Aii) and 
SM-ICs (arrow head in Ail) showing the effect of 30 M carbachol. Carbachol increased the 
frequency of spontaneous transients in the smooth muscle cell and caused an additional increase 
in intracellular Ca2 in the interstitial cell followed by several oscillations. The reduction in 
baseline in the interstitial cell record is due to movement of the tissue. 
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Abstract 
Objective The aim of this paper was to identify and characterise possible 
structural specialisations in the wall of the lower urinary tract in the region of 
the bladder urethral junction (BUJ) with the specific objective of identifying 
regional variations in sensory nerve fibres and interstitial cells. 
Materials and methods The bladder base and urethra was removed from male 
guinea pigs killed by cervical dislocation (n=5). Tissue pieces were incubated in 
Kreb's solution at 36°C, gassed with 95% 0 2 and 5% C02. Tissues were then 
fixed in 4% paraformaldehyde and processed for immunohistochemistry. The 
non-specific marker vimentin and the general neuronal marker PGP 9.5 were 
used to identify interstitial cells and nerve fibres respectively. Specific antibody 
binding was visualised using the appropriate secondary antibodies. 
Results The wall of the lower urinary tract in the region immediately between 
the bladder base and the urethra, the BUJ, was found to differ in its cellular 
composition relative to the adjacent areas. PGP positive (PGP+) nerve fibres, 
presumptive afferent fibres, were seen to lie within the urothelium running 
between the epithelial cells. Two general nerve patterns were seen: branching 
fibres with no varicosities and complex fibres with varicosities. Fibre collaterals 
with varicosities were seen to exit the urothelium and occupy the space under 
the urothelium adjacent to the layer of sub-urothelial interstitial cells. Interstitial 
cells in the sub-urothelial layer, lamina propria and around the muscle bundles 
were identified using vimentin (vim+-ICs). In the base a small number of vim+ 
cells were also PGP+. In the region of the BUJ there was a decrease in the 
amount of smooth muscle. In this region, below the lamina propria, there was 
an area densely populated with vim+/PGP+ interstitial cells. Nerve fibres were 
seen to run between the cells in this region. 
Conclusion These structural specialisations with in the urothelium and deeper 
layers of the BUJ suggest that they might be associated with specific functions. 
The localised highly branched network of the putative afferent nerves suggests 
the presence of a local axonal reflexes involving possible crosstalk between the 
urothelium and sub-urothelial layer. The function of the specialised region of 
interstitial cells is not known and must await further information on the 
functional properties of this novel cell type. In summary these observations 
demonstrate further the cellular heterogeneity of the cells in the lower urinary 
tract and the complexity of the structures. It is one of the major current 
challenges in functional urology to understand the relationships between these 
novel structures and overall bladder and urethral function. 
Introduction 
Damage to the bladder neck is associated with increased voiding frequency, an 
increase in bladder excitability and major changes to the thickness of the 
bladder wall and its cellular constituents [1-7] Typically, these changes result 
from ligatures or restrictions applied to the urethra that are put in place to 
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reduce urine flow, an approach designed to mimic bladder outflow obstruction 
caused by conditions such as benign prostatic hyperplasia [1, 3], However, there 
are reports demonstrating that similar changes can occur in animals and humans 
where the bladder neck is damaged but not obstructed [8, 9]. Such observations 
suggest that obstruction and any resulting increase in voiding pressures cannot 
be the only factors responsible for triggering the changes. The possibility has 
therefore been put forward that the overall changes to bladder function and 
structure result from the damage to specific structures in the region of the 
bladder neck [8]. One suggestion that was put forward was that, during the 
surgical procedure, damage to the ganglia or the ganglionic network in the 
region of the bladder neck and proximal urethra might trigger changes resulting 
in bladder pathology. However, the possibility has to be considered that damage 
to other structures might also be involved. 
In order to explore these ideas further we must have a detailed overview of the 
structure of the lower urinary tract in the region of the bladder neck. We divided 
the region of the bladder neck in 3 areas; the base; the bladder urethral junction 
(BUJ) and the urethra. The area of the caudal anterior wall was defined as base. 
The BUJ was defined as the area below the bladder base and above the urethra. 
In this paper we have focused upon the intramural nerves and interstitial cells. 
The observations demonstrate regional variations in the wall structure with 
localised specialisations of innervation and interstitial cell types. These findings 
are discussed in terms of their possible physiological significance and potential 
link with the initiation of bladder pathology. 
Materials and Methods 
The Institutional Animal Care and Use Committee of Maastricht University 
approved the animal experiments in this study according to EC guidelines. 
Guinea pigs (5 males, weight range 480-525g) were killed by cervical 
dislocation. Urinary bladder including the proximal urethra was removed from 
each animal and placed in ice-cold Kreb's solution: NaCl, 121.ImM; KC1 
1.87mM; CaCl2 1.2mM; MgS04 1.15mM; NaHC03 25mM; KH2P04 1.17mM; 
glucose ll.OmM and gassed with 5% C02 and 95% 0 2 (pH 7.4). Each bladder 
was divided in two pieces, a ventral piece and a dorsal piece, and maintained in 
Kreb's solution containing ImM of the non-specific phosphodiesterase inhibitor 
isobutyl-methyl-xanthine (IBMX: Sigma-Aldrich) at 36°C for 30 minutes. 
Incubations were terminated by immersing bladder pieces in ice-cold fixative 
solution of 4% freshly prepared depolymerised paraformaldehyde for 120 min 
at 4°C. Then, tissues were fixed overnight at 4 °C in 0.1 M phosphate buffer 
with 10% sucrose and the next day the tissues were placed in at 0.1 M phosphate 
buffer with 20% sucrose at 4 °C and then washed overnight at 4 °C in 0.1 M 
phosphate buffer with 30% sucrose. The tissues were placed in Tissue-Tek 
O.C.T. compound to form a single block. This was then snap-frozen in 
isopentane cooled in liquid nitrogen. Cryostat sections (10 \im) were cut, such 
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that each section was perpendicular to the urothelial surface. Sections were then 
thawed on to chrome-alum-gelatin-coated slides and stored at -20°C until use. 
Immunohistochemistry Sections were dried for 60 min at RT followed by 
three washes with Tris-buffered saline (TBS; pH 7.6), and thereafter incubated 
overnight with primary antibodies at 4 °C. The mouse antibody against vimentin 
(Sigma-Aldrich) was diluted 1:5000. To visualize PGP9.5 we used rabbit anti-
PGP9.5 (1: 2000; Abd Serotec); the selectivity and an estimate of the detection 
limit of these antibodies have been described previously [10-14]. After 
overnight incubation with the primary antibodies diluted in TBS containing 
0,3% (v/v) Triton X-100 (TBS-T), sections were washed in TBS, TBS-T and 
TBS; each wash step lasted 15 min. Rabbit primary antibody was visualized 
using Alexa Fluor 488 donkey anti-rabbit IgG (H+L) conjugate (Molecular 
Probes), diluted 1: 100 in TBS-T. Mouse primary antibody was visualized with 
Alexa Fluor 594 donkey anti-mouse IgG conjugate (Molecular Probes), diluted 
1:100. Sections were incubated with the secondary antibodies for 90 min at RT 
in the dark. After washing with TBS-T, and TBS, sections were mounted with 
TBS-glycerol (80%). Typically, for each bladder the staining was done in 
duplicate and repeated at least 2 separate days. Observations were accumulated 
from the different slides and from the different bladders. 
Sections were analysed and photographed using an Olympus AX70 microscope 
using a x4, xlO, x20 and x40 (oil) objective. For the detection of Alexa 488 
fluorescence we used a narrow band-pass MNIBA-filter and for the detection of 
Alexa 594 we used a filter with a narrow excitation band, the U-M41007A filter 
(both filters are from Chroma Technologies). The microscope was equipped 
with a cooled CCD Olympus Digital video camera F-view. Images were stored 
digitally as 16 bits images by using the computer program cell-P® (Olympus, 
Germany). The number of grey values was reduced using a linear function into 
4095. Images were arranged with the program Adobe Photoshop 5.5 or 7.0.1 
(San Jose, CA, USA). 
Results 
General observations Figure 1 clarifies the regions investigated in this study 
and the major findings, Panels A, B and C show low power images of three 
different bladders of the region between the bladder base and the urethra: the 
bladder urethral junction (BUJ). Six regions have been identified (1-6): 1) 
urothelium of the BJU; 2) urothelium of the urethra; 3) suburothelial layer; 4) 
lamina propria; 5) urethral musculature; 6) BUJ transitional zone. The structural 
features of these regions will now be described in detail. These observations 
have been made in all sections of the bladders from 5 normal healthy guinea 
pigs (see Method sections). 
The differences between the urothelium of the BUJ and the urethra are 
illustrated in panels 1 and 2 of Fig. 1. A striking difference was observed in the 
innervation pattern of the urothelium: the BUJ urothelial layer is rather well 
innervated whereas no innervation was observed in the adjacent urothelium of 
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the urethra. In region 3, immediately below the urothelium, we observed 
vimentin positive (Vim+) interstitial cells: the sub-urothelial interstitial cells 
(SU-ICs; Fig. 1, panel 3). This layer is present in the BUJ as well in the urtheral 
region and in the bladder base. In region 4, the lamina propria of both regions 
we observed also Vim+ interstitial cells in addition to nerve fibres. Strikingly, 
we did not observed smooth muscle fibres in the BUJ, as opposed to the urethra 
(region 5). This is illustrated in panel 5 (Fig. 1). These muscle bundles are 
surrounded by Vim+ interstitial cells and have a clear innervation. Some of 
these Vim+ interstitial cells demonstrate colocalization with PGP9.5. A region 
which has not been described before is the transition zone between the bladder 
base and the urethra (Fig. 1, region 6): a region of the wall which is devoid of 
smooth muscle cells but which contains, in the region below the lamina propria, 
a dense area of Vim+ and PGP positive (PGP+) cells. These cells have the 
appearance of interstitial cells: nuclei are clearly visible and often several 
process can be observed. Based on this general structure and their location it is 
likely that these cells are not neurones and may therefore represent a type of 
interstitial cell that has not been described before (Vim+/PGP+) interstitial cells. 
Complex patterns of nerves running within the urothelial layer In the 
region between the bladder base and the urethra we observed that there was an 
unusual pattern of nerves running within the epithelial layer of the urothelium. 
Figure 2 A, B and C show respectively the urothelium of the bladder base, BUJ 
and urethra. The urothelium of the bladder base is sparsely innervated. Fibres, 
when present, were occasionally found within the urothelium but more often 
lying immediately below the epithelial layer (arrows Figure 2 A). There was a 
large number of fibres running between the epithelial cells of the urothelium of 
the BUJ (Fig. 2B). In complete contrast, no nerve fibres could be observed in 
the urothelium of the proximal urethra (Fig. 2C). Panels D, E and F show 
another three examples originating from different guinea pigs, of the dense 
innervation of the urothelium of the BUJ. In each panel fibres can be seen to 
exit the urothelium and enter the sub-urothelial layer. Panel E illustrates a 
particular feature where the fibres leaving the urothelium are shown to branch, 
often more than once, with each collateral having distinct varicosities. Fibres 
with varicosities are also observed within the urothelial layer. 
Interstitial ceils within the lamina propria and muscle layers Panel A in 
Figure 3 illustrates a low power image of the wall in the region of the proximal 
urethra. The region of the lamina propria and muscle layers are easily identified. 
Panels B and C show that the interstitial cells in the lamina propria are Vim+. 
PGP+ nerve fibres are seen to run between these interstitial cells. Panel C shows 
the presence of Vim+ interstitial cell on the surface of the muscle bundles and 
the presence of PGP1 nerve fibres within the bundles running between the 
fibres. Some of the Vim*" interstitial cells on the surface of the muscle bundles 
also stain for PGP9.5. Figure 4 picks up a further feature illustrating the Vim+ 
interstitial cells of the sub-urothelial layer (sub-urothelial interstitial cells (SU-
ICs). In the BUJ and urethra these cells form a layer 2-3 cells deep. These cells 
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are Vim+, In contrast, in the bladder base, Vim+ interstitial cells can be found 
which are also positive for PGP. This observation raises the possibility that the 
interstitial cells in this layer are heterogeneous with different types in the 
different region of the lower urinary tract. 
Specialisation of interstitial cells in the BUJ Figure 5 illustrates an unusual 
and distinctive feature of the wall in the region of the BUJ. As noted in Figure 1 
there are few muscle bundles lying immediately below the lamina propria. 
Instead, this region is occupied with a dense population of spindle shaped cells 
many cell layers thick. These cells have predominantly oval cell bodies and 
extend 2 or 3 short processes. All of the cells in this region are Vim+ and PGP+. 
These ceils do not have the characteristics of neurones. They appear to be a type 
of interstitial cell with an unusual immuno-profile. Such cells have not been 
described previously in the bladder or urethra. 
The features highlighted in the images above are brought together in Figure 6 
which shows, in cartoon form, the structures of the bladder base, bladder 
urethral junction and the urethra. The nature and possible physiological 
significance of these structures are discussed below. 
Discussion 
This paper describes two new general observations relating to the structure of 
the wall of the lower urinary tract in the region of the bladder base and urethra: 
the bladder urethral junction (BUJ). The findings point to specialisations in the 
structure and distribution of nerve fibres associated with the urothelium and 
interstitial cells deep in the wall. 
Interest in the structures of this region is increasing following the realisation 
that damage might contribute to changes resulting in general pathology, 
specifically overactive bladder [4, 6-8] Several structures are obvious 
candidates for such damage (nerve trunks, superficial and intra-mural ganglia 
and blood vessels). The present observations add to these possibilities 
identifying regions of sensory nerve and interstitial cell specialisations that may 
also contribute. 
It is well known that there are regional variations in the innervation of the LUT, 
particularly the afferent innervation, with a relatively sparse innervation of the 
dome and lateral wall and a denser innervation of the bladder base [15, 16]. The 
observations in this paper on the guinea pig bladder are in broad agreement with 
this concept. In the lateral wall of the guinea pig bladder it has been shown that 
nerves, presumably sensoiy nerves are found in the space immediately below 
the urothelium between the layers of sub-urothelial interstitial cells [17, 18]. 
Two different types of fibres were identified based on the expression of the 
enzyme responsible for synthesising acetylcholine (choline acetyl transferase 
(ChAT)) and calcetonin gene related peptide (CGRP). The majority of these 
fibres did not penetrate the urothelium but ran parallel to the basal membrane in 
the space between the urothelium and the sub-urothelial interstitial cells. ChAT 
and CGRP fibres were also found in this region of the bladder to make contact 
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with intramural ganglia suggesting the presence of local neural networks 
involving excitatory and inhibitory inputs [18, 19]. The pattern of nerve fibres 
found in this study in the bladder base is similar to that described above. 
However, in this study no attempt was made to identify different types of fibres. 
A clear difference was observed in the pattern of nerves found in the region 
lying between the base and the urethra. We have described this region as the 
bladder urethral junction (BUJ). Here there is a dense population of nerves 
which lie within the urothelium and which appears to send projections into the 
sub-urothelial layer. It would appear that there might be two distinct patterns of 
fibre: fibres with no varicosities and highly branched fibres with varicosities. 
This difference may reflect different fibre types but this differentiation awaits 
further study. It is not known whether these fibres are afferent or efferent. Given 
their location on the urothelium, a structure which is becoming more and more 
associated with sensory roles [20-22] it is possible they are afferent. However, 
the possibility cannot be excluded that some fibres may sub-serve an efferent 
role in modulating urothelial function in this region of the lower urinary tract. 
Some fibres are seen to exit the urothelium and branch in the sub-urothelial 
space. The functional significance of this specialisation is not obvious. It may 
be related to increasing the sensitivity of these fibres to a particular mode of 
stimulation (e.g. mechanical deformation). Alternatively it might represent 
regions where collateral fibres of the sensory nerves make contact with specific 
structures. Such a local reflex involving collaterals of sensory nerves is well 
recognised in the skin [23] and has been suggested to occur in the lateral wall of 
the bladder [18, 19]. Irrespective of the precise details of the function of these 
nerves fibres the fact that there is a clear specialisation in structure and 
distribution strongly suggests a high degree of specialisation in the function, 
possibly, sensory, in this region. 
In relation to this it is worth speculating about the origin of sensation in the 
bladder. It has been pointed out that sensations of bladder volume appear to be 
of different types [24]. In the early stages of bladder filling general sensations 
are felt in the general region of the bladder and lower abdomen. However, as 
the volume increases the sensations become more intense, sometimes described 
as urge sensations, and these now appear to come from lower down in the LUT 
in the region of the bladder neck and urethra [25, 26], The growing number of 
observations suggestion regional differences in the sensory innervation of the 
bladder wall may provide a structural correlation for these different sensations. 
Furthermore, it has been demonstrated by Barrington some 80 years ago that 
activation of sensory fibres from different regions of the LUT contributed to 
different reflexes (the 7 Barrington's reflexes, [27, 28]. The finding of different 
types of nerve fibre in the same region and different patterns of innervation in 
different regions might also provide structural correlates with Barrington's 
functional data. 
There is now a growing interest in structure, distribution and classification of 
cells in the lower urinary tract known collectively as interstitial cells. Interstitial 
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cells have been described in the ureter, bladder and urethra [29-33]. These cells 
are not a homogeneous population and there appear to be distinct populations in 
the different regions of the LUT. Indeed, even within the same region, there 
may be several distinct populations of interstitial cells associated with specific 
structures in the wall [5, 19, 34-36]. At present there is no single marker to 
identify interstitial cells. The majority can be identified by the expression of 
Vimentin [5, 34, 37], some express the receptor for stem cell factor (cKit) [38], 
others are responsive to nitric oxide showing an elevation in cGMP [19, 35] and 
others express specific patterns of receptors (e.g. the muscarinic receptor M3 
(unpublished data) [39], cyclo-oxygenase (COX I) [6] and prostaglandin 
receptors (S. Rahnama'i personal communication) [40] These cells are found in 
the normal bladder but it has been reported that there are major changes in the 
type and distribution of interstitial cells associated with bladder pathology. This 
suggests that they may play key roles in bladder physiology and pathology. In 
the mouse, it has been suggested that one population of interstitial cells may be 
associated with the modulation of motor activity in the bladder wall [30]. Here, 
the only ceils in the bladder wall which respond to exogenous nitric oxide with 
a rise in cGMP is a population of interstitial cells associated with the outer 
muscle layers. Since contractile activity in the whole isolated bladder is reduced 
by nitric oxide the conclusion has been drawn that these cells are involved in 
regulating activity in the smooth muscle. 
In the guinea pig bladder several distinct populations of interstitial cells have 
been described [6, 31, 34, 35]. These include a dense layer lying immediately 
below the urothelium (sub-urothelial interstitial cells (SU-ICs), cells in the 
lamina propria (lamina propria interstitial cells (LP-ICs), cells surrounding the 
muscle bundles (superficial muscle interstitial cells (SM-ICs) and cells within 
the muscle bundles (intramuscular interstitial cells (IN-ICs) [41]. Subsequent 
studies have shown that even within these broad populations of interstitial cell 
there may even be sub-populations with different characteristics. For example, 
the SM-ICs associated with the inner muscle layers express vimentin but do not 
respond to exogenous nitric oxide with a rise in cGMP. In contrast the SM-ICs 
associated with the outer muscle layer are vimentin positive but respond to 
nitric oxide with a rise in cGMP (R de Jongh personal communication) [19, 42]. 
Similarly, the SU-ICs are distinct from the LP-ICs in that the LP-ICs are 
associated with the expression of cyclo-oxygenase type I (COX I) while the SU-
ICs are not [6]. 
The present study adds to the complexity of the sub-types of interstitial cells 
found in the LUT: the description of a population of interstitial cells which are 
vimentin positive and which express PGP9.5 represents a new type. PGP9.5 is 
considered to be a non-specific but good marker for nerves. However there are 
reports that the epitope detected by PGP9.5 is also expressed on mesenchymal 
cells in the developing embryo [43, 44]. These mesenchymal cells represent a 
specific population of cells with a distinct function. The present observation that 
similar cells are found occasionally in the sub-urothelial layer of the bladder 
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base but predominantly in the interstitium of the BUJ, suggests a particular 
functional specialisation of these cells in this region. The nature of this function 
is not known. It may relate to the regulation of extra-cellular matrix or it may 
have more dynamic functional roles. Interstitial cells have been linked to 
possible sensory functions [45] while other interstitial cells are excitable and 
generate electrical activity and to communicate via gap junctions with the 
smooth muscle to influence contraction. Also some interstitial cells are thought 
to generate pacemaker activity and influence phasic activity in the bladder [6, 
41, 46]. It is possible that the specialised region of interstitial cells in the region 
of the BUJ might have sensory or pacemaker functions. In this region there is 
also a reduction in the amount of muscle in the wail. This is a surprising 
observation. It implies a specialisation but this cannot be associated with any 
sphincter function of the proximal urethra. One possibility is that this region is 
less rigid that adjacent regions with muscle and so more able amenable to 
distension. In conjunction with a possible increase in sensory innervation in this 
region it may be specialised to respond to distension with the generation of 
localised afferent nerve discharge. This could contribute to specific and 
localised sensation as described by Nathan [24] and above. 
The present observations add to the complexities of the lower urinary tract. The 
observation of such localised structural specialisations in nerve and interstitial 
cells must reflect specific functional specialisation. At present we can only 
speculate on the role of these structures. However, if we are to understand the 
detailed physiology of the LUT and the origins, nature and consequences of 
changes that give rise to bladder pathology we must identify and understand 
these complexities. This is the next series of challenges in functional urology. 
47 Chapter 2 
Figure 1. The structural components of the vessel wall in the region of the bladder urethral 
junction (BUJ). A, B and C show a low magnification picture of the BUJ of three different 
bladders stained with antibodies for the nerve marker PGP9.5 (green) and vimentin (red), a 
marker for interstitial cells (ICs). The BUJ is on the left and the urethra on the right. The numbers 
in the small panels correspond to the location of the panels on the right of panel C. The dotted 
lines show the location of the urothelium. The star shows the location of the prostatic duct. Panel 
1 shows PGP9.5 positive nerves in the urothelium of the BUJ, while the urothelium of the urethra 
is shown in panel 2. No PGP9.5 positive nerves are identified in this region. Panel 3 shows the 
vimentin positive ICs just below the urothelium; the sub-urothelium interstitial cells (SU-ICs). 
Panel 4 identifies the ICs in the lamina propria (LP-ICs). Note the close relation of these ICs with 
nerves. Panel 5 shows ICs between the muscle bundles of the urethra; surface muscle ICs (SM-
ICs). Note that some of these SM-ICs are PGP9.5 positive. Panel 6 shows an area in the BUJ 
containing a large amount of ICs (deep urothelial interstitial cells - DU-ICs). All these ICs are 
vimentin positive and PGP9.5 positive. Note the close relation between nerve fibres and the ICs. 
Calibration bars lOOum in A, B and C and 10 ^m in 1,2,3,4,5 and 6. 
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Figure 2. Differences in the 
distribution of nerves 
within the urothelium in 
the region of the bladder 
urethral junction (BUJ). All 
panels are stained with the 
nerve marker PGP9.5 (green) 
and the ICs marker vimentin 
(red). Panel A shows the 
urothelium and sub -
urothelium of the bladder 
neck. Sparse nerve 
innervation of the urothelium 
can be identified (arrows). 
Directly below the 
urothelium there is a layer of 
vimentin positive ICs. Note 
the PGP9.5 positive staining in the urothelium. Panel B shows the urothelium of the BUJ. There 
is a dense nerve innervation of the urothelium in this area. The arrow points to an urothelial nerve 
penetrating the sub urothelium. In this area there is no PGP9.5 staining of the urothelium. Panel C 
shows the urothelium and sub-urothelial layer of the urethra. No nerve innervation of the 
urothelium can be identified and only sparse nerve innervation of the sub-urothelial layer can be 
identified. Panel D, E and F show other examples of panel B; the urothelium of the BUJ. The 
arrows in panel D show urothelial nerves penetrating the sub-urothelium. Note the close relation 
of these nerves with the SU-ICs. The arrows in E also show urothelial nerves penetrating the 
urothelium and lying in close contact with SU-ICs. Note the varicosities on these nerves. Panel F 
shows varicosities of the urothelial nerves in the urothelium. The arrows point to urothelial nerves 
penetrating the sub-urothelium. Calibration bars 10pm in A, B, C, Da E and F. 
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Figure 3. Vimentin positive 
interstitial cells (ICs) in the 
lamina propria and muscle 
in the region of the urethra. 
Panel A shows an example of 
the lamina propria in the 
urethra. The area is stained 
with the nerve marker 
PGP9.5 (green) and vimentin 
a marker for ICs (red). 
PGP9.5 positive nerves lie in 
close contact with vimentin 
positive ICs (arrow). Note the 
absence of co-localisation 
between vimentin and 
PGP9.5 in the ICs (*). Panel 
B shows an example of the 
muscle in the urethra. Small 
nerves can be seen in the muscle bundles. Around the muscle bundles vimentin positive ICs can 
be seen; surface muscle interstitial cells(SM-ICs). Note that some of these SM-ICs stain for both 
vimentin and PGP9.5 (+). Calibration bars 20 |nm in A and B. 
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Figure 4. Vimentin positive cells in the sub-urothelial layer in the region of the bladder 
urethral junction (BUJ), the urethra and the bladder base. All panels are stained with the 
nerve marker PGP9.5 (green) and vimentin a marker for ICs. Panel A shows an example of the 
sub-urothelial layer of the BUJ. Vimentin positive sub-urothelial interstitial cells (SU-ICs, *) and 
PGP9.5 positive nerves (#) can be seen. Note the absence of PGP9.5 staining in the SU-ICs, Panel 
B shows an example of the sub-urothelial layer of the urethra. Vimentin positive SU-ICs can be 
seen (*). No co-localization between vimentin and PGP9.5 is identified in this area. Note the 
sparse innervation of PGP9.5 positive nerves. Panel C shows the sub-urothelial layer of the 
bladder base. In this area two types of SU-ICs can be identified; vimentin positive, PGP9.5 
negative SU-ICs (*) and vimentin positive, PGP9.5 positive SU-ICs (+). Calibration bars 10pm in 
A B and C. 
Figure 5. Vimentiii positive and PGP9.5 positive cells in the wall of the bladder urethral 
junction (BUJ). Panels A, B and C are stained with the nerve marker PGP9.5 (green) and 
vimentin (red), a marker for interstitial cells (ICs). A shows the area below the lamina propria in 
the BUJ (region 6 in Fig. 1). In this area lots of ICs can be found. All these ICs are vimentin 
positive and PGP9.5 positive. The boxes in panel A are shown in larger magnification in panel B 
and C. Note the co-localisation of vimentin and PGP9.5 in the ICs of this region and note the 
close relation of PGP9.5 positive nerves with these ICs. Calibration bars lO i^m in A, B and C. 
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Figure 6. Diagrammatic representation of the cellular components of the bladder wall in the 
region of the bladder base, the bladder urethral junction (BUJ) and the urethra. This 
cartoon shows a summary of the structural differences between the bladder base, the BUJ and the 
urethra, The urothelium of the bladder base contains some umbrella cells, while in the urothelium 
of the BUJ and the urethra no umbrella cells could be identified. The thickness of the urothelium 
is less in the urethra compared to the BUJ and bladder base. In the BUJ there is a dense nerve 
innervation in the urothelium, while in the bladder base only sparse nerve innervation can be seen 
and in the urethra there is an absence of nerve innervation in the urothelium. Some of the 
urothelial nerves in the BUJ have axons with varicosities, which might indicate the release of 
substances by these nerves. Some of the sub-urothelial interstitial cells (SU-ICs) of the bladder 
base also stain for the nerve marker PGP9.5, while this co-localisation is not found in the BUJ and 
urethra. In the BUJ there seems to be less SU-ICs. Some the urothelial nerves in the bladder base 
and BUJ penetrate the sub-urothelium. Some axons of the urothelial nerves in the BUJ that 
penetrate the urothelium have varicosities. The sub-urothelial axons of these nerves lie in close 
relation with the SU-ICs. Below the SU-ICs the lamina propria ICs and nerves are shown. There 
is no co-localisation of PGP9.5 and vimentin in this layer. Below the lamina propria in the bladder 
base and urethra the muscle can be seen. Small nerves lie in the muscle bundles while around the 
muscle bundles the surface muscle interstitial cells (SM-ICs) can be seen. Note that some of these 
SM-ICs are PGP9.5 positive. In the area between the BUJ and the urethra there is an absence of 
muscle bundles. This area contains a large amount of interstitial cells; deep urethral interstitial 
cells (DU-ICs). These DU-ICs show co-localisation of vimentin and PGP9.5 and lie in close 
relation with nerves. 
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Abstract 
Aim The aim of this study was to examine the expression of ubiquitin hydrolase 
(UBH), an enzyme which is part of the ubiquitin-proteasome system involved in 
the regulation of cell growth and differentiation, in order to gain insight into the 
cell types and processes underlying the tissue remodelling that occur following 
bladder neck damage. 
Methods Three groups of male guinea pigs were used: control (not operated, 
n=4), sham (n=5) and obstructed (n=6). Bladder outflow obstruction was 
achieved by implanting a silver ring around the urethra which was left in situ 
for 2-4 weeks. Sham operated animals underwent the same operative procedure 
but no ring was implanted. The bladders were removed and incubated in Krebs 
solution at 36°C, gassed with 95% 0 2 and 5% C02, Tissues were then fixed in 
4% depolymerised paraformaldehyde and processed for immunohistochemistry, 
We used antibodies raised against ubiquitin hydrolase (UBH)/protein gene 
product 9.5, cyclo-oxygenase type I and vimentin. Specific antibody binding 
was visualised using the appropriate secondary antibodies. 
Results Staining with an antibody to UBH revealed the presence of both 
sensory and motor nerves in control, sham and obstructed bladders. In the 
control bladders this was the predominant staining pattern. In the sham and 
obstructed bladders UBH staining revealed additional positive cell types: cells 
associated with the outermost layers of the urothelium (the umbrella cells), in 
the lamina propria (the lamina propria interstitial cells (LP-ICs), on the surface 
of the muscle bundles (surface muscle interstitial cells; SM-ICs) and on the 
serosal surface (muscle coat interstitial cells; MC-ICs). All interstitial cells 
stained with vimentin. The interstitial cells within the muscle bundles (intra-
muscular interstitial cells; IM-ICs) did not stain with UBH. The number and 
density of the UBH positive cells was greater in the obstructed compared to the 
sham suggesting a change in relation to the severity of damage to the bladder 
neck. 
Conclusion The expression of UBH implies the retargeting of proteins marked 
for degradation in the proteasome. Increased expression of UBH in the LP-ICs 
and SM-ICs demonstrates that these cells are active in the early and late stages 
of the tissue remodelling resulting from obstruction. These results demonstrate a 
further subset of interstitial cells which might be involved in the increased 
deposition of extracellular material and tissue remodelling. 
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Introduction 
There has been a great deal of interest in the heterogeneous population of cells 
in the bladder described as interstitial cells. They are found in all species 
examined so far (mouse [1, 2], rat [3], guinea pig [4-6] and human [4, 7, 8]) and 
are likely to be involved in numerous, varied key regulatory systems in the 
bladder. In the guinea pig bladder, cells described as interstitial cells are found 
below the urothelium, within the lamina propria, surrounding the muscle 
bundles, lying with the muscle bundles and on the outer coat of the bladder [4, 
5, 9-11]. Several criteria have been used to identify and distinguish these cells 
from each other and it is now accepted that there are different interstitial cell 
types. For example, one population of cells appear to express the stem cells 
factor receptor cKit [6]. The sub-urothelial interstitial cells SU-lCs) respond to 
nitric oxide (NO) with a rise in cGMP while those in the lamina propria do not 
[4, 5]. Also, the surface muscle interstitial cells (SM-ICs) associated with the 
inner muscle layers express cyclo-oxygenase I (COX I) while those in the outer 
muscle layers do not [11]. Despite a growing appreciation of the types and sub-
types of bladder interstitial cells we know very little about the functions they 
might sub-serve. For one sub-type, the SM-ICs, it has been suggested that they 
interact with the smooth muscle regulating excitability and contraction [2, 12]. 
However, the role of the other sub-types of interstitial cells remains an enigma. 
During bladder outflow obstruction there are many structural and functional 
changes in the bladder wall: the smooth muscle is more active and sensitive to 
acetylcholine [13-15], the urothelium thickens, the smooth muscles hypertrophy 
and there is a punctuate loss of the motor nerves. In addition there is an increase 
in number of muscle interstitial cells [16, 17] It has recently been suggested that 
these changes are triggered not by the obstruction per se but by the local 
damage that occurs to the bladder neck following surgery and which can be 
exacerbated by physical obstruction [15]. Such local damage results in global 
changes in the bladder wall. The mechanisms generating and coordinating the 
global changes from damage in a specific location are not known. 
The protein, protein gene product 9.5 (PGP 9.5), is a small protein (27kD) 
which was originally isolated from brain [18, 19], This molecule is now known 
to be a ubiquitin COOH-terminal hydrolase (UBH) and forms part of a complex 
ubiquitin-proteasome system. The binding of ubiquitin regulates and modulates 
protein function. The proteasome system is a non-lysosomal proteolytic 
pathway regulating degradation of proteins involved in cell growth, modulation 
of specific membrane receptors and rearrangement of cytoskeletal elements [20-
22]. UBH separates ubiquitin from its protein substrate affecting the targeting of 
the protein and thus functions also in a salvage pathway. 
It was originally thought that UBH was confined to neurones and neuro-
endocrine cells [19]. However, further studies have located UBH in a number of 
different cells types [23, 24]. UBH is no longer considered to be a specific 
marker for neurones. Rather, it is an indicator of cells undergoing major 
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changes in structure, differentiation and phenotype. It may also be involved in 
the regulation of the early stages of inflammation [25]. 
In studies of nerve distributions in obstructed bladder it was recognised that 
cells other than neurones were staining with UBH. This paper describes these 
non-neural cells, identifying them as a sub-set of bladder interstitial cells. 
Materials and Methods 
Three groups of male guinea pigs were used: control (not operated, n=4), sham 
(n=5) and obstructed (n=:6); Hartley strain guinea pigs, weighing between 266-
299 grams, were housed in a temperature and light (12h light/dark cycle) 
controlled room and allowed free access to food and water. The institutional 
animal care and use committee of Maastricht University approved all the animal 
experiments conducted in this study. All procedures were in line with the EC 
guidelines. 
Surgical procedure: The procedures used were similar to those reported 
previously [26], Briefly, in 6 animals a partial outflow obstruction was induced 
while 5 underwent sham operation. Animals were sedated with ketamine (40 
mg/kg) and xylazine (3 rng/kg) administered intraperitoneal^. Once sedation 
was achieved and the animals were prepared under sterile conditions, the 
bladder neck and urethra were exposed via a vertical midline abdominal 
incision. A silver jeweler's jump ring (1.8 mm internal diameter) was placed 
loosely around the proximal urethra. Bladder outlet obstruction occurred during 
subsequent growth of the animal. The analgesic medication flunixinum (5mg/kg 
s.c.) and the antibiotic gentamicin (5mg/kg i.m.) were administered once 
postoperatively. Sham surgery was performed in an identical manner, except for 
inserting the ring around the urethra. 
Four weeks after the operation, the weight gain in the contol group was 200 + 
65, in the sham operated animals it was 150 + 33 grams compared to the 
animals with a bladder outflow obstruction 100 ± 53 grams. 
After 4 weeks, the guinea pigs were killed by cervical dislocation. The urinary 
bladder was removed and placed in ice-cold Krebs solution containing 121.1 
mMNaCl, 1.87mMKCl, 1.2 mM CaC12, 1.15mMMgS04, 25mMNaHC03, 
1.17 mM KH2P04,11.0 mM glucose, bubbled with 5% C02 and 95% 02 (pH 
7.4). Each bladder was divided in two pieces, a ventral piece and a dorsal piece, 
and maintained in Kreb's solution containing ImM of the non-specific 
phosphodiesterase inhibitor isobutyl-methyl-xanthine (IBMX: Sigma-Aldrich) 
at 36°C for 30 minutes. Incubations were terminated by immersing bladder 
pieces in ice-cold fixative solution of 4% freshly prepared depolymerised 
paraformaldehyde for 120 min at 4°C. Then, tissues were washed at 4 °C in 
0.1M phosphate buffer containing 10% sucrose (24 h), 20% sucrose (24h) and 
30% sucrose (24h). The tissues from the lateral wall were then snap-frozen with 
CO, in Tissue-Tek O.C.T. compound to form a single block. Cryostat sections 
(10 |Lim) were cut, such that each section was perpendicular to the urothelial 
Ubiquitin hydrolase; evidence for tissue remodelling involving interstitial cells | 58 
surface. Sections were then thawed on to chrome-alumn-gelatin-coated slides 
and processed for immunohistochemistry. 
Immunohistochemistry : Sections were dried for 60 min at RT followed by three 
washes with Tris-buffered saline (TBS; pH 7.6), and thereafter incubated 
overnight with primary antibodies at 4 °C. The mouse antibody against vimentin 
(Sigma-Aldrich) was diluted 1:5000. To visualize UBH we used rabbit anti-
PGP9.5 (1: 2000; Abd Serotec); the selectivity and an estimate of the detection 
limit of these antibodies have been described previously [27-31]. After 
overnight incubation with the primary antibodies diluted in TBS containing 
0.3% (v/v) Triton X-100 (TBS-T), sections were washed in TBS, TBS-T and 
TBS; each wash step lasted 15 min. Rabbit primary antibody was visualized 
using Alexa Fluor 488 donkey anti-rabbit IgG (H+L) conjugate (Molecular 
Probes), diluted 1: 100 in TBS-T. Mouse primary antibody was visualized with 
Alexa Fluor 594 donkey anti-mouse IgG conjugate (Molecular Probes), diluted 
1:100. Sections were incubated with the secondary antibodies for 90 min at RT 
in the dark. After washing with TBS-T, and TBS, sections were mounted with 
TBS-glycerol (80%). Typically, for each bladder the staining was done in 
duplicate and repeated at least on 2 separate days. Only the lateral wall was 
studied and all observations were accumulated from the different slides and 
from the different bladders. 
Sections were analysed and photographed using an Olympus AX70 microscope 
using a x4, xlO, x20 and x40 (oil) objective. For the detection of Alexa 488 
fluorescence we used a narrow band-pass MNIBA-filter and for the detection of 
Alexa 594 we used a filter with a narrow excitation band, the U-M41007A filter 
(both filters are from Chroma Technologies). The microscope was equipped 
with a cooled CCD Olympus Digital video camera F-view. Images were stored 
digitally as 16 bits images by using the computer program cell-P® (Olympus, 
Germany). The number of grey values was reduced using a linear function into 
4095. Images were arranged with the program Adobe Photoshop 5.5 or 7.0.1 
(San Jose, CA, USA). 
Results 
The major findings of this study are: in sham operated and obstructed bladders 
there is an increase in the expression of UBH compared to the lateral wall of 
control bladders (Figure 1). In the control bladders UBH was located to both 
sensory and motor nerves. Occasionally, UBH was found in the umbrella cells 
of the urothelium. In the lateral wall of the sham and obstructed bladders 
several differences were observed. There was a distinct thickening of the 
urothelium (Figure 1 B and C) with a more pronounced expression of UBH. 
Also, UBH positive cells were found in the lamina propria and on the surface of 
the muscle bundles. These cells were more abundant in the obstructed compared 
to the sham bladders. In addition, there was a profound thickening of the outer 
coat (muscle coat) of the bladder in sham and obstructed animals. The majority 
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of these cells were UBH positive. The following section describes these basic 
observations in greater detail. 
In the lateral wall of the control bladder a few umbrella cells could be found 
which were strongly positive for UBH in the urothelium (Figure 2 A). Adjacent 
cells stained weakly or not at all. The cells lying immediately below the 
urothelium, the SU-ICs did not stain with UBH but were vimentin positive 
(Figure 2 A). In the lateral wall of the sham and obstructed bladders marked 
changes were noted in the urothelial layer. The number of cell layers forming 
the urothelium was in creased and the number of layers which were positive for 
UBH could be several layer thick (Figure 2 C). The vimentin positive SU-ICs 
layer was present in the sham and obstructed bladders but no UBH positive cells 
were detected (Figure 2 B and C). 
Close examination of the lateral wall of the sham operated and obstructed 
bladders revealed that the basal and intermediate cell layers of the urothelium 
do not stain for UBH (Figure 2 B and C). These cell layers express the enzyme 
COX I (Figure 3) suggesting that the different cell layers of the urothelium sub-
serve different functions, 
Vimentin-positive interstitial cells are present in the bulk of the lamina propria 
between the SU-ICs and the muscle layer: the lamina propria interstitial cells 
(LP-ICs). In the lateral wall of the control bladder these cells were UBH 
negative (Figure 4 A). In the lateral wall of the sham bladders cells two 
populations of vimentin positive cells were now observed. The majority were 
UBH negative while there is a small population of UBH positive cells (Figure 4 
B). In the lateral wall of the obstructed bladders the proportion of LP-ICs which 
were UBH positive was markedly increased (Figure 4 C). 
One sub-type of interstitial cell is located on the surface of the muscle bundles 
(SM-ICs). In the lateral wall of the control bladders these cells are vimentin 
positive and do not express UBH (Figure 5 A), while in the lateral wall of the 
sham bladders there are occasional UBH positive cells (Figure 5 B). In the 
lateral wall of the obstructed bladders there was an increased number of SM-ICs 
and the majority of these were UBH positive (Figure 5 C). Figure 6 shows 
further examples illustrating the increased expression of UBH in the lateral wall 
of the sham and obstructed bladders. Importantly, another striking observation 
in the obstructed bladders was the presence of the cell bodies of the UBH 
positive cells in small clumps or nodes (Figure 6 C). 
Within the muscle bundles there is a further population of interstitial cells 
(intra-muscular interstitial cells; IM-ICs). When these cells are examined in the 
lateral wall of the control, sham and obstructed bladders almost no cells express 
UBH (Figure 7). Interestingly, IM-ICs in the control, sham and obstructed 
bladders can be found which are in close proximity to UBH nerve fibres (Figure 
8). 
As shown in Figure 1 D, E and F the muscle coat becomes thicker in the lateral 
wall of the sham and obstructed bladders, with the obstructed bladder wall 
being thicker than that of sham-operated animals. This is illustated in more 
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detail in Figure 9. The muscle coat of the control bladders is only one cell layer 
thick. These cells show immunoreactivity for vimentin, identifying them as 
muscle coat interstitial cells (MC-ICs). These MC-ICs show no UBH-IR 
(Figure 9 A). In the sham operated and obstructed bladders the muscle coat 
MC-ICs are several cell layers thick (Figure 9 B and C), and the MC-ICs show 
immunoreactivity for both vimentin and UBH. 
Discussion 
The antibody to the protein PGP 9.5 has been used extensively as a non-specific 
marker of neurones and neuronal processes. In the guinea pig urinary bladder it 
is indeed an effective marker of nerve fibers and neuronal cells, i.e. ganglion 
cells. However, it has long been known that the protein PGP 9.5 is expressed in 
other cell types [24]. The realisation that PGP 9.5 was a member of a family of 
enzymes involved in protein de-ubiquitination (ubiquitin hydrolase; UBH) 
advanced our understanding of protein metabolism and management in cell 
function associated with proliferation and differentiation [21, 32], The processes 
of protein targeting and catabolism are highly regulated processes [33]. 
Ubiquitin is a small 76 amino acid protein which is covalently inked to proteins 
by specific proteins (El, E2 and E3) to alter their function [21, 32], Several 
ubiquitin molecules can be linked together to produce the appropriate effect. 
Removal of these bound ubiquitin molecules occurs by a family of de-
ubiquitination enzymes which alters the targeting of the proteins. The process of 
ubiquitination and de-ubiquitination enzymes in regulating protein function has 
been likened to the relationship between phosphatases and kinases [25, 34]. 
Thus, the up-regulation of UBH in LP-ICs and SM-ICs suggests that they have 
become more active. They appear to be one of the first cell types, apart from the 
urothelium (see below), to show activation following damage to the bladder 
neck. Thus, the appearance of UBH may be an early marker for the changes that 
occur in the bladder following bladder neck damage. De-ubiquitination has 
been linked to regulation of NO signalling via regulation of the beta-subunit of 
the guanylate cyclase [35] and to COX II activation [36]. Under these 
circumstances the regulation of ubiquitin binding and release is associated with 
early inflammation and its regulation [25]. cGMP and prostaglandins (PGs) are 
now recognised to be associated with bladder interstitial cells [4, 5, 9, 11]. 
Indeed, it may be that some of the bladder interstitial cells are involved in the 
initiation and regulation of the early stages of bladder inflammation following 
injury. It is now becoming clear from these observations that the LP-ICs and 
SM-ICs play a role in the changes in the bladder that follow injury. The present 
study supports previous observations that there are distinct sub-sets of 
interstitial cells in the bladder [5, 9,11]. 
As was argued previously, it does not appear to be the obstruction to bladder 
outflow per se that is the trigger for this pathological change [15]. Rather, as the 
same changes occur in the sham operated animals, this suggested that the 
pathological trigger is more related to damage of the bladder neck [15]. Once 
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the bladder neck is damaged the bladder undergoes major global changes: 
increased deposition of extracellular matrix, muscle hypertrophy, localised 
denervation and hypertrophy of the urothelium. It is not known how such global 
changes are triggered or coordinated. The present data are suggestive of a 
possible mechanism. The LP-ICs and SM-ICs constitute a network of interstitial 
cells extending through out the bladder. These cells appear to be particularly 
activated following bladder neck damage. It is possible that an initial local 
activation could be rapidly propagated throughout the network resulting in 
activation of the entire network. Activation might then trigger changes to the 
other cellular system in the bladder wall resulting in the observed global 
pathology. It has been demonstrated that there is a sub-population of LP-ICs and 
SM-ICs that express the enzyme COX I [11]. The local release of prostaglandin 
may be involved in this system of propagation and activation. 
Bladder neck damage is also associated with changes to autonomous activity in 
the isolated bladder [15]. The mechanisms generating this activity, controlling 
its pacemaker functions and facilitating its propagation through out the bladder 
are not known. It has been suggested that these functions involve interstitial 
cells. However the heterogeneity of the interstitial cell population makes it 
difficult to identify which sub-type underlies which function. In the mouse, t h e 
SM-ICs and M-ICs may be involved in the regulation of smooth muscle 
activity [2], The physiological role of the other sub-types of interstitial cel ls 
(SU-ICs, LP-ICs, and MC-ICs) remains an enigma. The present observations 
showing that the LP-ICs and SM-ICs react to bladder neck damage with an 
increased expression of UBH suggest at least one possible function for this sub -
set. The SM-ICs also show immunoreactivity for the muscarinic receptor M3 
(Grol et al. 2008 accepted BJU int.). This points out that the SM-ICs are able to 
react on cholinergic stimulation, thus these cells are part of the motor sensory 
system. 
Importantly, this study confirms that the SU-ICs and IM-ICs appear to be 
distinct populations. The SU-ICs express receptors to acetylcholine (muscarinic 
type 3, M3), PGs (EP Type 2) [37] and atrial naturetic peptide (ANP) [38]. T h e y 
also respond to NO with a rise in cGMP [4, 5]. Thus these cells appear to be 
able to integrate different signal inputs. The function of these cells remain 
unknown. The IM-ICs also appear to be different. Two populations have b e e n 
identified: those which express the enzyme choline acetyltransferase and a 
population which does not [39]. The function of this population is not k n o w n 
but it has been suggested that they are in close contact with nerve fibres and the 
smooth muscle suggesting that they may be involved in regulating m u s c l e 
activity [39-41]. 
We have demonstrated that the urothelium is dramatically changed following 
bladder neck damage. It would appear that it is the outer layers of t he 
urothelium, the umbrella cells, and the cells immediately below the u m b r e l l a 
cells which are activated and show an up-regulation of UBH. These cells are 
different form those in the basal and intermediate layers which do not s h o w 
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such changes, identifying again distinct sub-types of epithelial cells within the 
urothelium. Thus, there appears to be a high degree of complexity in the 
urothelium. The function and physiological systems that this complexity sub-
serves is not clear at present. However, the production of numerous signals (NO 
[42], adenosine trisphosphate (ATP) [43], acetylcholine [44, 45], and PGs [46]) 
suggests the potential for complex interactions and signalling in this region of 
the bladder [47]. One idea has been that the urothelium responds to increases in 
bladder volume by releasing NO, ATP and PG [47, 48]. These substances 
subsequently act upon sub-urothelial sensory nerves to influence bladder 
sensation [47, 49], The alterations to the urothelium structure following bladder 
neck damage may therefore have profound effects on the output of these signals 
and their physiological effects. This may be one component of mechanisms 
contributing to the increased sensation in patients with pathological bladder 
changes. 
The changes seen to the muscle coat with bladder neck damage are dramatic. 
Almost all of the cells in this system are activated to express UBH following 
severe bladder neck damage. In addition, these cells appear to undergo the 
highest degree of cell proliferation of any cell type in the pathological bladder. 
The function of this cell layer and the massive changes that are observed to 
occur remain unknown. They appear to be similar to the LP-ICs and SM-ICs in 
their expression of UBH but the high degree of proliferation might suggest that 
they have additional specific functions. Thus, they may form a further distinct 
sub-set of interstitial cells in the guinea pig bladder. 
The clear heterogeneity of interstitial cells in the bladder generates specific 
problems when attempting to study isolated interstitial cells. If it cannot be 
demonstrated which sub-type of interstitial cell is being studied then we must be 
cautious about extrapolating the data obtained to specific functions. Indeed, 
without knowing what type of cell is being studied it is impossible to make 
connections to the integrated physiology of the bladder and its pathology. 
In conclusion, the observations presented in this paper show what may be a 
novel sub-set of interstitial cells in the bladder wall of the guinea pig. The cells 
appear to form a network of activated and proliferating cells which extend 
throughout the bladder wall. More work is necessary to demonstrate the specific 
functions of these cells and whether they can alter underlying tissues and 
coordinate the global changes seen. 
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Figure 1. Structural 
differences in the guinea pig 
urinary bladder wall after 
bladder outlet obstruction. 
Ail panels are immunostained 
for the interstitial cell marker 
vimentin (vim, red) and 
ubiquitin hydrolase (UBH, 
green). Panel A shows an 
overview of the control 
bladder. Note the thin 
urothelium (u) and lamina 
propria (lp). The stars point to 
nerves in the lamina propria 
and muscle layers. Panel B 
shows an overview of the 
sham operated guinea pig 
bladder. Note the increase in 
thickness of the urothelium and lamina propria. A subset of the lamina propria interstitial cells 
(LP-ICs, #) shows immunoreactivity (IR) with UBH. The stars point to nerves in the muscle layer 
and lamina propria. Panel C shows an overview of the obstructed bladder. The urothelial cells 
become elongated. Note the further increase in thickncssof the urothelium and lamina propria. 
There is a further increase in the UBH-1R of the LP-ICs (//). The stars point to nerves in the 
muscle layer and lamina propria. Panels D, E and F show an overview of the muscle coat in the 
control (D), sham operated (E), and obstructed (F) bladder. In the control bladder (panel D) the 
muscle coat is one cell layer thick. These cells show IR for vimentin indicating that they are 
interstitial cells (muscle coat interstitial cells; MC-ICs). These MC-ICs are vimcntin-positive and 
UBH-negative (vim+/UBH-). In the sham operated bladder (E) there is an increase in the number 
of MC-ICs. A subset of the MC-ICs are vim+/UBH+. While in the obstructed bladder all MC-ICs 
show IR for both vimentin and UBH. Calibration bar in A is for A, B and C; size 50 jm 
Calibration bar in D is for D, E and F; size 20 (.tm. 
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Figure 2. Upregulation of 
ubiquitin hydrolase (UBH) 
in the urothelium after 
outlet obstruction of the 
guinea pig urinary bladder. 
Panels A, B and C are 
immunostained for the 
interstitial cell marker 
vimentin (vim, red) and the 
UBH (green). The panels 
below show the original 
images of vim and UBH Z 
immunoreactivity (UBH-IR). 
Panel A shows the 
urothelium and sub-
urothelium of a control 
bladder. Note that a subset of 
the umbrella cells show UBH-IR. Panel B shows the urothelium and sub-urothelium of the sham 
operated bladder. There is an increase in UBH-IR in the urothelial cells. Panel C shows the 
urothelium and sub-urothelium of the obstructed bladder. Not only is there a further increase in 
UBH-IR in the urothelial cells visible, they are also shaped more elongated. Calibration bar in A 
is for A, B and C, size 20 pm. 
7' 
UBH 
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Figure 3. Distribution of ubiquitin hydrolase (UBH) and COX I in the urothelium of an 
obstructed guinea pig urinary bladder. Panel A and B are immunostained for UBH (green) and 
COX 1 (red). Panel A points out that the COX I-immunoreactivity (COX I-IR) is located in the 
basal urothelial cells while the UBH-immunoreactivity is located in the umbrella cells. Panel B 
shows a detail of panel A. The panels below panel B are the original pictures of which panel B is 
constructed. Calibration bars 20 jam in A and 10 jam in B. 
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Figure 4. Upregulation of ubiquitin hydrolase (UBH) in lamina propria interstitial cells 
(LP-ICs) of the sham operated and obstructed guinea pig urinary bladder. Panels A, B and 
C are immunostained for UBH (green) and the interstitial cell marker vimentin (vim, red). The 
panels below show the original images of panel A, B and C. Panel A shows in detail the LP-ICs 
(*) of the control bladder. These cells do not show UBH-immunoreactivity (UBH-IR), while the 
LP-ICs of the sham operated bladder do show UBH-IR (panel B, #). Panel C shows the LP-ICs of 
the obstructed bladder. Note the upregulation of UBH in these cells and the increase in number of 
the LP-ICs. Calibration bar in A is for A, B and C; size 10 pm. 
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Figure 5. Upregulation of surface muscle interstitial cells (SM-ICs) and ubiquitin hydrolase-
immunoreactivity (UBH-IR) in the sham operated and obstructed guinea pig urinary 
bladder. Panels A, B and C are all stained for ubiquitin hydrolase (UBH, green) and the 
interstitial cell marker vimentin (vim, red). The panels below show the original images of panels 
A , B and C. In the control bladder SM-ICs can be seen around the muscle bundles (panel A, *). 
T h e s e cells do not show UBH-IR, In the sham operated bladder there is an increase in number of 
the SM-ICs (panel B). Two types of SM-ICs can be identified; vim+/UBH- SM-ICs (*) and 
vim+/UBH+ SM-ICs (#). In the obstructed bladder there is a further increase in the number of 
SM-ICs (panel C). The two types of SM-ICs can also be seen here; vim+/UBH- SM-ICs (*) and 
vim+/UBH+ SM-ICs (#). Calibration bar in A is for A, B and C; size 10 jam. 
control obstructed 
Figure 6. Upregulation of surface muscle interstitial cells (SM-ICs) and ubiquitin hydrolase 
immunoreactivity (UBH-IR) in the sham operated and obstructed guinea pig urinary 
bladder. Panels A, B and C are immunostained for ubiquitin hydrolase (UBH, green) and the 
interstitial cell marker vimentin (vim, red). The panels below show the original images of which 
panels A, B and C are constructed. In the control bladder there are SM-ICs visible around the 
muscle bundles A, *). These cells are vim+/UBH-. Panel B shows the sham operated bladder. 
Note the increase in number of SM-ICs. A subset of these cells shows UBH-IR (#). Panel C shows 
a detail of the obstructed bladder. Note the further increase in number of SM-ICs and upregulation 
of UBH-IR. Calibration bar in A is for A, B and C, size 10 pm. 
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Figure 7. Intra-muscular interstitial cells (IM-ICs) do not change after outlet obstruction of 
the guinea pig urinary bladder. Panels A, B and C are all immunostained for ubiquitin 
hydrolase (UBH, green) and the interstitial cell marker vimentin (vim, red). The panels below 
show the original images of panels A, B and C. Panel A shows IM-ICs of a control bladder (*). 
Note that there is no UBH-ER. Panel B shows IM-ICs in the sham operated bladder (*). These 
cells are also UBH-. Panel Cshows IM-ICs in the obstructed bladder (*). No UBH-IR can be seen 
here. Calibration bar in A is for A, B and C, size 10 j-im 
Figure 8. Intra-muscular interstitial cells (IM-ICs) are in close proximity with nerves. Panel 
A, B and C are stained with the interstitial cell marker vimentin (vim, red) and the enzyme 
ubiquitin hydrolase (UBH, green) which is located in nerve fibres. The panels below B and C 
show the original images of which panel B and C are constructed. Panel A shows an IM-ICs, 
fibres of IM-ICs and nerve fibres. Panel B and C show in more detail that the fibres of the IM-ICs 
(*) are in close proximity with nerve fibres (#). Calibration bars 10 jam in A, 5 jim in B and C. 
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Figure 9. Upregulation of ubiquitin hydrolase immuno re activity (UBH-IR) in the muscle 
coat interstitial cells (MC-ICs) of the sham operated and obstructed bladder. Panel A, B and 
C are all stained with the interstitial cell marker vimentin (vim, red) and ubiquitin hydrolase 
(UBH, green). The panels below show the original pictures of which panel A, B and C are 
constructed. Panel A shows the muscle coat of the control bladder. The MC-ICs (*) do not show 
any UBH-IR. Panel B shows the muscle coat of the sham operated bladder. There are now two 
types of MC-ICs; vim+/UBH- MC-ICs (*) and vim+/UBH+ MC-ICs (#). Note the increase in 
number of interstitial cells. Panel C shows a detail of the muscle coat of the obstructed bladder. 
All MC-ICs show UBH-IR. Note the further increase in number of MC-ICs. Calibration bar in A 
is for A, B and C, size 10 pm. 
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Chapter 5 
The localisation of cyclo-oxygenase immuno-reactivity 
(COX I-IR) to the urothelium and to interstitial cells in 
the bladder wall 
R de Jongh, S Grol, GA van Koeveringe, PEV van Kerrebroeck, J de Vente 
and JI Gillespie 
J Cell Mol Med, 2008 
76 | Chapters 
Summary 
Localised phasic contractions in the bladder wall (autonomous activity) have 
been hypothesized to be an integral part of a motor/sensory system contributing 
to bladder sensation. The sites responsible for generating this activity, the 
mechanisms involved in its propagation and modulation remain unknown. This 
phasic motor activity is modulated by exogenous prostaglandins. Therefore, 
analysis of the sites of prostaglandin production and action within the bladder 
wall may shed light on the mechanisms of generation and modulation of this 
phasic activity. In this paper we report the localization of immuno-reactivity 
indicative of the expression of cyclo-oxygenase enzyme type I (COX I-IR.) 
within the bladder wall Basically, three types of COX I-IR cell were identified: 
epithelial cells in the basal and intermediate layers of the urothelium, complex 
vimentin-positive and COX I-IR cells in the lamina propria and vimentin-
negative COX I-IR cells in the lamina propria and on the surface of the inner 
muscle bundles. These vimentin-negative/COX I-IR cells appear to be in close 
apposition to a continuous network of vimentin-positive cells which extends 
from the lamina propria into the inner muscle layers and subsequently into t h e 
outer muscle layers. However, the interstitial cells in this region might form a 
distinctly different sub-type. Firstly, the interstitial cells in this region differ 
from those in the inner layer by their responsiveness to NO with a rise i n 
cGMP. Two subtypes have been identified: cells on the surface of the muscle 
bundles and within the muscle bundles. Secondly, COX I-IR cells are n o t 
associated with the interstitial ceils in the outer layers. The physiological 
significance for these apparent differences in the interstitial cell network is n o t 
clear. However, such differences are likely to reflect differences in t h e 
processes involved in their activation, modulation and control. 
Introduction 
Prostaglandins (PGs) are found in virtually all tissues where they exert a w i d e 
variety of functions including modulating smooth muscle activity, haemostasis 
and cytoprotection [1]. It has been known for nearly half a century that, in t h e 
bladder, PGs are released into the general circulation by the bladder in response 
to distension [2]. It has been established that the bladder PGs originate in b o t h 
the urothelial and muscle layers [2-5]. The precise role of this endogenous PG i s 
not known but it is well documented that exogenous PGs alters bladder activity 
both in vivo and in vitro influencing voiding and smooth muscle contractility. 
This occurs in different species: human [6-9], rat [10-12], guinea pig [13-1 5 ] , 
rabbit [16-19] and monkey [20,21]. The underlying mechanisms which involve 
the PGs to alter voiding patterns and induce smooth muscle contraction are n o t 
known. Regarding PG induced changes in voiding frequency it was envisaged 
that they might act directly on the afferent nerves to modulate firing and s o 
trigger micturition at lower bladder volumes [22-24]. With regard to a d i r e c t 
action on the muscle it was pointed out that they can be co-released w i t h 
acetylcholine at efferent nerve endings and so directly contribute to m u s c l e 
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excitation [20,21]. Alternatively, they might act indirectly on pre-synaptic 
motor terminals to affect the release of excitatory transmitters [11,12]. It was 
considered they might also inhibit acetylcholine esterase [9] or enhance 
myogenic bladder activity [6,22]. In other organs, PG production in fibroblasts 
resulted in a decrease in collagen production [25]. It has also been reported that 
prostaglandin production by fibroblasts plays a role in tumor necrosis [26]. In 
the intestine Powell et all found that interstitial cells in the subepithelial space 
of the intestine are important in the organogenesis of the intestine [27], and 
secretion of prostaglandins by these interstitial cells is an important factor of 
this mechanism [27]. Therefore, it must be taken into consideration that, next to 
effects on contractility, PGs might have additional functions in the bladder, e.g. 
a role in cell proliferation [25]. 
Recently, a concept was proposed which attempts to integrate the effects of PG 
on the sensory elements of bladder control with its motor actions. Using the 
isolated bladder it was reported that exogenous PGs modulate the autonomous 
activity [28]. It has been argued previously that autonomous activity is part of a 
motor/sensory system operating within the bladder wall whereby localised 
contractions of the bladder wall stimulate firing in afferent nerves contributing 
to sensation [29,30]. PG induced modulation of the autonomous activity would 
thus increase bladder sensation and so modify voiding activity [28]. 
The origin of autonomous activity and how it is modulated by PGs is unknown. 
It has been hypothesized that it is generated within and distributed by a network 
of specialised cells in the bladder wall: interstitial cells [30,31]. The precise 
identification and definition of what is an interstitial cell in the bladder is, at 
present under discussion. The initial description of interstitial cells was based 
on their ability to show a rise in cGMP in response to nitric oxide donors 
[31,32]. Different sub-types of cGMP+ interstitial cell have been identified lying 
principally in the sub-urothelial layer and in the outer muscle layer [31]. 
Finally, the stem cell factor receptor cKit, which identifies interstitial cells in 
the gut, has been reported to mark cells in the bladder [33]. However, this cKit 
staining is proving difficult to reproduce. Direct evidence for the physiological 
role of interstitial cells is, so far, limited and comes from experiments which 
show that nitric oxide (NO), which generates a rise in cGMP in the interstitial 
cells, also abolishes autonomous activity [34]. 
Since exogenous PG modulates autonomous activity [28] further insights into 
the origin of this activity and possible links to interstitial cells may be got from 
a detailed understanding of where PGs are synthesised and where they act in the 
bladder. PGs are synthesised by the two distinct enzymes: cyclo-oxygenase type 
I (COX I) and cyclo-oxygenase type II (COX II). COX I is associated with cell 
somata in the urothelium and with a network of cells running over the muscle 
bundles [28]. A detailed description of the different cell types expressing COX-
I is not yet available. Therefore, the present experiments were done to 
characterise the cells expressing COX I in the normal bladder and to determine 
the relationship between these cells to the networks of interstitial cells. The 
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distribution and characteristics of COX II expression in the bladder is the 
subject of a separate paper [28], 
Materials and Methods 
Guinea pigs (7 male, weight 270-350 g) were killed by stunning and 
exsanguinations. The urinary bladder was removed and placed in ice-cold 
Kreb's solution containing 121.1 mMNaCl, 1.87mMKCl, 1.2mMCaCl2, 1.15 
mM MgS04, 25 mM NaHC03, 1.17 inM KH2P04, 11.0 mM glucose, bubbled 
with 5% C02 and 95% 02. The bladder wall was cut into 3 or 4 sections from 
the base to the dome. The procedures for isolation, stimulation with the NO 
donor diethylamine-NONOate (DEANOl Sigma-ALdrich), and detection of 
cGMP-immunoreactivity were as described previously [28,31]. Preparation of 
the cryostat sections and imrnunocytochemical procedures were as described 
before [28,31]. Specificity studies on the sheep or rabbit anti-formaldehyde-
fixed-cGMP antisera have been published before [31] and preabsorbtion studies 
to ascertain the specificity of the COX I antiserum have been published before 
also [28]. Primary antibodies used were goat polyclonal antibody to COX I 
(1:2000; Santa Cruz Biotech, Santa Cruz, Ca, USA), rabbit anti-nNOS 
antiserum (1:3000, Diasorin), mouse anti-vimentin antiserum (1:5000; 
Sigma/Aldrich). Secondary antibodies were Alexa Fluor 488 donkey anti-sheep 
IgG (H+L) and donkey anti-mouse conjugate (Molecular Probes, 1:100); Alexa 
Fluor 594 donkey anti-rabbit IgG conjugate (Molecular probes, 1:100); CY3 
donkey anti-goat IgG conjugate (Jackson Immunoresearch, Newmarket, UK; 
1:800). Sections were analyzed using an Olympus AX70 fluorescence 
microscope, equipped with a narrow band-pass MNIBA-filter for the detection 
of Alexa 488, and for detection of CY3 and Alexa 594 we used a filter with a 
narrow excitation band, the U-M41007A filter (both from Chroma 
Technologies, Rockingham, Vt, USA). The microscope was equipped with a 
cooled charge-coupled device, the Olympus digital video camera F-view. 
Images were stored digitally as 16 bits images by using the computer program 
CellAP (Soft Imaging Systems, Olympus, Germany). The number of grey values 
was reduced by using a linear function to 4095. Color images were produced by 
combination of the original grey values photographs using the Cell-P program. 
Images were arranged using the program Adobe Photoshop 7.0.1 (San Jose, Ca, 
USA) without further processing. 
Results 
The key basic observations regarding the distribution of COX I-IR in the 
bladder wall are illustrated in Figure 1. All animals showed the same results. 
Panel A shows a low power section of the entire bladder wall. COX I-IR cells 
are seen within the urothelium and also associated with a network of cells which 
extends from the lamina propria into the inner muscle layers. Note that there are 
fewer COX I-IR cells associated with the outer muscle layers. These 
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observations are illustrated in greater detail in panels 1 and 2 which show the 
sub-urothelial region (1) and outer muscle layer (2) at higher magnification. 
COX I-IR is therefore associated with two distinct structures; the urothelium 
and a network of cells in the lamina propria and around the muscle. The patter 
of distribution of these network cells bears a strong resemblance to the 
distribution of vimentin positive (vim+) cells in the muscle layers bladder wall 
but not the distribution of NO-responsive cGMP+ interstitial cells (Figures 1 B 
and C). Note that the cGMP+ interstitial cells are found in the outer muscle 
layers where there is considerably less COX I-IR. These observations on COX 
I-IR in the urothelium and associated with the networks of interstitial cells are 
described in more detail below. 
COX I-IR in the urothelium and sub-urothelial layer 
Figure 2 A illustrates a section showing the urothelium and sub-urothelial 
region, double stained for COX I (red) and cGMP (green). Figure 2 B shows a 
similar section but from a different bladder illustrating the combined colour 
image (top) and the component COX I (middle) and cGMP (lower) images. As 
reported previously, the umbrella cells lying on the surface of the urothelium 
and the sub-urothelial interstitial cell layer closes to the urothelium are sensitive 
to exogenous NO and demonstrate a rise in cGMP (cGMP*), It is also clear that 
COX I-IR is associated with intense staining in the intermediate and basal 
layers of the urothelium (buc) and weekly in cells in the lamina propria (lamina 
propria interstitial cells (LP-ICs). Figure 2 B shows, in greater detail that, in this 
region of the bladder wall, the majority of the sub-urothelial cGMP+ interstitial 
cells do not have COX I-IR. 
The cells of the basal layer of the urothelium express neuronal nitric oxide 
synthase (nNOS) [31]. The relationship between these cells and those with 
COX I-IR is shown in Figure 3. In this experiment the sections were double 
stained with nNOS (green) and COX I (red). The nNOS positive (nNOS+) cells 
are easily seen in the basal layer. These cells are also COX I-IR (showing 
green/yellow in the combined sections). Note that in the intermediate urothelial 
layer the cells are COX I-IR but not nNOS* (Figure 3 B). Thus, there are two 
types of COX I-IR cell in the urothelium: basal COX I-IR/nNOS+ and 
intermediate COX I-IR/nNOS". 
The layer of densely packed cells lying immediately below the urothelium, the 
sub-urothelial interstitial cells (SU-ICs) are responsive to NO with an elevation 
in cGMP [31], Figure 4 illustrates a section double labelled to show these 
cGMP+ cells (green) and the vimentin4* cells (red). cGMP+ umbrella cells are 
seen on the surface of the urothelium but there were no vim+ cells in any cell 
type within the urothelium. In contrast the cells immediately below the 
urothelium, the SU-ICs, were vim+ and cGMP+. Vimentin staining revealed a 
network of intracellular fibres while the cGMP staining was most intense within 
the cell bodies (Figure 4 B). Processes of these cells were seen to contain vim+ 
fibres but these structures were often not strongly cGMP* indicating that there 
are intracellular gradients of cGMP. Vim+ cells were seen in the layer of the 
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lamina propria between the SU-IC layer and the muscle layer (Figure 4 A). 
These cells did not demonstrate a cGMP signal and can be described as lamina 
propria interstitial cells (LP-ICs). Thus, there appear to be different types of 
interstitial cell within the lamina propria: a dense region of cGMP7vim+ and 
sparse cGMPVvim* cells. 
An additional feature of the the COX I/vimentin double staining becomes 
apparent when studying in detail the diffuse network of vim1 cells in the region 
of the lamina propria immediately below the SU-ICs and above the muscle 
layer (Figure 5). These cells appear to form a distinct network of inter-
connecting cells contiguous with the SU-ICs layer and with vim+ cells within 
the muscle layer (see below). In this section no COX I-IR cells are visible 
within the SU-ICs layer. But, COX I-IR is seen within the cell bodies of the 
vim+LP-ICs (Figure 5 B). 
Regions of the lateral wall, particularly towards the bladder base, could be 
found in which the density of LP-ICs was high (Figures 6 and 7). In these 
regions two different cell types were readily identified based on the expression 
of vimentin and COX I-IR. Figure 6A shows such a region at higher 
magnification. Small bipolar cells with round cell bodies which were COX I-IR 
but did not stain strongly for vimentin (*) (Figure 6B) and larger complex cells 
with multiple processes which showed COX I-IR and a diffuse network of 
vimentin fibres ((f) and Figure 6 C) are now visible. 
The network of vim"1" fibres was observed to continue from the lamina propria 
into the inner smooth muscle layer where they run primarily on the surface of 
the muscle bundles (Figure 7). Here, the vim+ cells appear on the surface of the 
muscle bundles and so can be described as surface muscle interstitial cell (SM-
ICs). Within this network cell bodies were apparent which were COX I-IR but 
that did not stain strongly for vimentin. Examples of such cells are shown in 
Figure 7 B and 7 C. At the junction of the lamina propria and inner smooth 
muscle cell layer small clusters of COX I-IR cell bodies were often observed 
(Figure 8). The cell bodies in these clusters did not stain strongly for vimentin 
but were in close proximity to vimentin positive cell processes (Figure 8 B and 
C), These collections of cell bodies which have the appearance of nodes were 
also apparent, although fewer in number and with fewer cells, laying between 
the muscle bundles of the inner muscle layer (see Figure 7A). 
Outer muscle layers 
The network of vim4' SM-ICs was observed to extend into the outer muscle 
layers of the bladder wall (Figures 1 and 9). However, in this outer region there 
are few cell bodies which are COX I-IR. This points out that there must be 
different types of SM-ICs associated with the inner and outer muscle layers. 
This is supported in Figure 10 which shows sections double labelled for cGMP 
(green) and vimentin (red). As has been reported previously the SM-ICs of the 
outer muscle layers respond to NO with a rise in cGMP [31]. The cells bodies 
of these outer SM-ICs are clearly seen but these are not COX I-IR. In contrast, 
there are few cGMP+ cells in the inner muscle layers (see also Figure 1). NO-
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responsive cells producing cGMP are also found within the muscle bundles of 
the outer muscle layer: intramuscular interstitial cells (IM-ICs). Figure 10 
illustrates that these IM-ICs are also vim+. 
Thus, these data support the idea that there are different sub-types of interstitial 
cell associated with the lamina propria and inter-muscular spaces in the guinea 
pig bladder. The different cell types which have been identified and described 
above, based on the staining for cGMP, vimentin, COX I and nNOS, are 
summarised in Table 1. 
Discussion 
It has been known for over 30 years that PGs are released from the bladder in 
response to stretch, the PGs coming from both the urothelium and muscle layers 
[19,24,35,36]. Sprem et al found that intravesically administrated ketoprofen, a 
non-selective COX inhibitor, reduced detrusor instability [37]. Based on these 
findings it has been argued that the PGs play central roles not only in bladder 
physiology but also in the generation of bladder pathophysiology [2-5,38-40], 
this led to the trial of cyclo-oxygenase inhibitors for the treatment of bladder 
over activity [37,41]. One indication as to the possible role of PGs has come 
from experiments involving the infusion of PG into the bladder lumen. When 
this is done it gives rise to an increase in micturition frequency and the 
incidence of non-voiding phasic contractions between voiding episodes [42,43]. 
Prostaglandin production in the bladder serves also other functions, Bachteeva 
et al reported that PGs play a role in the osmotic water permeability of the frog 
urinary bladder [44]. Several subtypes of prostaglandin receptors have been 
found in the bladder. It has been reported that the urothelium contains both the 
prostaglandin receptor subtype E2 (EP2), which plays a role in osmoregulation 
[45], as well as the EP1 receptor, which plays a role in the micturation reflex 
[46]. Schröder et al reported that the EP1 receptor has a role in the 
development of detrusor overactivity caused by PGE2 and outlet obstruction 
[47]. The details of the mechanisms underlying this action of PGs on voiding 
frequency are not known. 
Several possible mechanisms have been put forward. One idea is that the PGs 
have a direct effect on bladder afferent nerve fibres [48], By increasing afferent 
nerve activity this would result in a more frequent activation of the micturition 
reflex. It is well documented that PGs cause a sensitisation of cutaneous 
nociceptors [49]. This might also occur in the bladder. Support for the idea 
comes indirectly from experiments in which the bladder was treated with 
capsaicin to remove the afferent contribution of C fibres. After functionally 
removing the C fibres the PG induced increase in micturition frequency of 
micturition was reduced [40]. A different mechanism involving an indirect 
action of PGs on afferent nerves has recently been proposed. It is known that 
small localised contractions occur in the bladder wall of many species. This 
complex activity is hypothesized to be the motor component of a motor/sensory 
system involved in the generation of afferent firing and bladder sensation 
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[29,31]. Using the isolated guinea pig bladder is has been shown that PGs 
increase the frequency of this phasic motor activity [28]. Thus, the increased 
phasic motor activity could result in an increase in afferent discharges and in so 
doing influence the point at which voiding is triggered [28]. 
As discussed above PGs are synthesised within the lamina propria and muscle 
layers. The present observations extend this broad observation and demonstrate 
specifically that the expression of COX I-IR predominates within two general 
cell systems in the bladder wall: (i) cells within the basal and intermediate 
layers of the urothelium and (ii) within a population of small cells which are 
closely associated with a network of vimentin positive cells. These vimentin 
positive cells are present throughout the sub-urothelial space of the lamina 
propria and extend over the surface of the muscle bundles which make up the 
inner layers. It is interesting and important to note that no COX I-IR was seen 
within the muscles indicating that, in the guinea pig, it is not the smooth muscle 
that is producing PG but the cells associated with the vimentin network. 
These observations raise intriguing questions regarding the mechanisms of 
action of PGs in the guinea pig bladder. One hypothesis might be that the COX 
I in the basal urothelial cell layers which is activated by bladder distension. The 
PGs produced here could diffuse the relatively short distance to the sub-
urothelial space in which sensory afferent nerve fibres are found. Thus, this 
arrangement would represent the site where there is a PG induced direct 
modulation of afferent nerves. However, the abundance of COX I-IR in the 
urothelium of the lateral wall and the relative paucity of afferent nerves 
indicates that this is not the only role for PGs produced by the urothelium in the 
lateral walk 
The present data also show that the COX I-IR cells in the base of the urothelium 
also express nNOS. Like PG, NO is known to be produced by the urothelium in 
response to stretch [50]. It is also known, on other cell systems, that PG 
production is influenced by NO and, conversely, that NO production is 
influenced by PGs [51,52]. Other signals also originate in the urothelium in 
response to stretch. Specifically ATP has been shown to be released [53] and 
one of its actions is to influence afferent nerve firing [54]. Also, there are 
reports that acetylcholine is released from the urothelium [55]. Thus, we 
conclude there is a complex and inter-related release of signalling substances 
from the urothelium in response to mechanical deformation. 
To add to this complexity, the cell layer immediately below the urothelium, the 
sub-urothelial interstitial cell (SU-IC) layer can be a possible location for 
further integration of urothelial derived signals. These SU-ICs, in the guinea pig 
and human, respond to both exogenous and endogenous NO demonstrating a 
rise in cGMP [30,32]. These cells are also immuno-reactive for antibodies to the 
type 3 muscarinic receptor (M3) (unpublished observation), purinergic receptor 
[56] and the type 2 prostaglandin receptor (EP2) (unpublished observation). 
Thus, the integrated output of PG, NO, ATP and cholinergic stimuli from the 
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urothelium can be further integrated and modulated on the SU-ICs. The specific 
function of the SU-ICs cells is, at present, not known. 
Indeed, there is indirect support for such a possible integration on the sub-
urothelial cells. The SU-ICs are in close relation with the network of interstitial 
cells of the lamina propria and on the surface of the inner muscles. The 
autonomous bladder hypothesis suggests that, based on the observations of 
Lagou et al. [34] that the muscle interstitial cells are involved in the activation 
and co-ordination of complex phasic activity (autonomous activity) within the 
smooth muscle [57] and it is this activity that is the motor component of the 
motor sensory system [30]. The amplitude and frequency of the autonomous 
activity is increased by cholinergic agonists [58,59] and ATP [60]. If this type 
of activity is generated within an interstitial cells network this points out that 
there are M3/ATP activated pacemakers linked to a distributed network [59], 
It has also been shown that bladder distension alters autonomous activity: an 
increase in bladder volume increases autonomous activity while a decrease in 
bladder volume inhibits it [61]. The complex scheme outlined above might 
provide an explanation for these volume related events. Mechanical 
deformation of the urothelium in the lateral wall triggers complex cascade of 
interacting signals within the urothelial epithelium resulting in the release of 
signals into the sub-urothelial space. There, these urothelial signals are further 
integrated on the SU-ICs. Activity in the SU-ICs is then distributed to the 
muscle via the vimentin positive interstitial cell network resulting in the 
excitatory and inhibitory effects on the phasic activity (see Figure 11). 
Prostaglandin synthesis has been associated with the smooth muscle [24]. The 
precise cell types and their location have not been considered in detail, it was 
simply assumed that it originated in smooth muscle cells. The present 
observations put forward a new idea that, at least in the guinea pig, it is the 
COX I-IR cells associated with the network of vimentin positive interstitial cells 
on the surface of the muscle bundles which are responsible for synthesising PG 
in this layer. As already discussed one of the possible roles of this network of 
muscle interstitial cells is to generate and distribute signals leading to phasic 
contractions in the bladder wall [34,57,62]. Thus the micro-anatomical 
arrangement of cells in the muscle layer appears to involve COX I-IR (PG 
producing) cells contacting vimentin interstitial cells in close apposition to 
smooth muscle. Functionally, it can be hypothesized that this arrangement 
involves a PG regulation of activity in the vimentin network and consequently 
an input to the muscle. The actions of PG on the muscle would thus be indirect 
being interceded by the network of interstitial cells (see Figure 11). 
The present observations also demonstrate a difference in the interstitial cells in 
the outer and inner muscle layers of the bladder wall, specifically the reduction 
in number of COX I-IR cells in the outer layers. Differences have been noted 
before [31,34]. However, the functional roles for these apparently different 
types of muscle interstitial cell are not known. What is clear is that the network 
of interstitial cells is complex and may sub-serve several different functions. 
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In conclusion, it is now quite clear that there are several complex signalling 
systems operating within the bladder wall In addition, it is clear that these 
signals act within cells systems that interactions between the urothelium, 
interstitial cells, muscle, sensory fibres and intra-mural ganglia. It is a major 
challenge for the future to unravel this complexity not only in relation to the 
physiology and pharmacology of the bladder but also in relation to the origins 
and treatment of bladder pathology. 
Figure 1. The localisation of COX I immunoreactivity, vimentin+ cells, and NO-responsive 
cGMP+ cells in the guinea pig bladder. A, B and C show respectively images stained with 
antibodies to COX I, vimentin and cGMP. In each panel two regions are identified (1 and 2) 
located in the outer and inner regions of the bladder wall. For A-C these identified regions are 
shown at greater magnification in the adjacent panels. A illustrates COX I-IR. More COX I-IR 
cells areare seen in the inner regions of the bladder. In B vimentin+ cells are seen in both the outer 
an inner layers. In C the presence of cGMP+ ceils is clearly seen. No cGMP cells are seen 
associated with the inner muscle layer but the umbrella cells and sub-urothelial cells are cGMP-h 
Calibrations bars: 150 jim in A and 40 jam in B. 
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Figure 2. cGMP and COX I 
immunoreactivity (IR) 
associated with the 
urothelium in the guinea pig 
bladder. Panel A shows an 
image of the urothelium of the 
lateral wail stained for COX I 
(red) and cGMP (green). The 
preparation was stimulated 
with a NO donor to elevate 
cGMP levels in responsive 
cells prior to fixation. The 
umbrella cells on the surface 
of the urothelium (umb) and 
cells in the sub-urothelial 
space, the sub-urothelial 
interstitial cells (SU-ICs) are 
cGMP*. The basal urothelial 
cells (buc) are stained 
intensely with the COX I antibody. In addition, COX I-IR cells are also found in the lamina 
propria interstitial cells (LP-ICs). B illustrates a section from a different bladder processed and 
stained in the same way as section A. The upper panel shows the combined colour image. The 
middle and lower panels show COX I-IR and cGMP-IR respectively. These two panels illustrate 
that the cGMP f SU-ICs are negative for COX I-IR. They also show that the COX I-IR cells in the 
buc are separated from the COX I-IR LP-ICs. Calibration bars 50 (am in A and 30 jam in B. 
Figure 3. The identification 
of cells expressing neuronal 
nitric oxide synthase (nNOS) 
and COX I 
immunoreactivity (IR) in the 
urothelial layer of the guinea 
pig bladder. Sections were 
co stained with antibodies to 
nNOS (green) and COX I 
(red). A shows an example of 
the staining pattern associated 
with the urothelium. nNOS+ 
cells (#) are seen to be located 
within a single layer in the 
basal urothelium (buc). These 
cells also demonstrate COX I-
IR. Note that the COX I-IR 
extends into further cell layers 
within the urothelium (f). B 
shows a further example from 
a different bladder. The combined image and the individually stained images are shown, The 
location of nNOS to a single layer in the basal urothelium is clearly seen while the more diffuse 
location of the COX I-IR is apparent. Calibration bars: 30 pm in A and B 
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Figure 4. The location of 
vimentin* structures in the 
urothelium and sub-
urothelial space. Sections 
were double labelled with 
antibodies to show cGMP 
(green) and vimentin (red). 
Panel A shows a section from 
the lateral wall of the bladder 
illustrating the urothelium and 
sub-urothelial space. The 
umbrella cells (umb) and sub-
urothelial interstitial cells 
(SU-ICs) are cGMP+. No 
vimentin4" structures are seen 
within the urothelium. Vimentin* structures are seen in the sub-urothelial space. Intense staining is 
seen associated with the cells immediately below the urothelium while structures laying deeper 
within the lamina propria are vimentin"4* but more defuse. B and C illustrates examples of the cells 
in the sub-urothelial layer at higher magnification, showing the combined colour image (upper 
panel: cGMP-green, vimentin-red), the cGMP image alone (middle panel) and vimentin image 
alone (lower panel). The cGMPf sub-urothelial interstitial cells can readily be identified (*). 
Vimentin staining is associated with the cell bodies of these cells being highly concentrated 
around the cell nuclei (#). C illustrates a further feature. Vimentin+ but cGMP" fibres are seen (# in 
C). Calibration bars 80 jam in A and 20 jum in B and C. 
within the lamina propria (LP-ICs). Structures positive for vimentin and with COX I-IR are seen 
within this layer. B shows a section of the image in A at higher magnification. The panel on the 
left shows the doubled labelled image (vimentin-green, COX I-red), the middle panel shows the 
vimentin image and the right panel shows the COX-I image. The basal urothelial layer (1), sub-
urothelial layer (2) are identified. The staining pattern of the vimentin* cells in the lp is highly 
suggestive for a network of vimentin* structures (4). In addition there appear to be COX I-IR cells 
(3).These cells are spindle shaped and are weakly positive for vimentin. They appear to lay on or 
between the vimentin* structures. Calibration bars 40 jam in A and 20 fim in B. 
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Figure 6. Differentiation of COX I-IR and vimentin* structures in the lamina propria. A 
shows a region of the lateral wall. The sections were stained with antibodies to COX I (red) and 
vimentin (green). A shows a region of the lamina propria immediately below the urothelium. The 
COX I-IR of the urothelium (uro) and spindle cells in the lamina propria are seen (*) (see also 
Figure 5). Also, cell processes expressing vimentin are visible. Large irregular cells are also seen 
which are COX I-IR and which have an extensive diffuse network of vimentin fibres (f) . B and C 
show selected areas of the image in A with the individual images of COX I (middle panel) and 
vimentin (lower panel). In B the COX I-IR cells are seen to have little or no vimentin staining. 
The edges of the COX I-IR cells are indicated by the arrows and (c). Vimentin"1" fibres are 
indicated (v). C illustrates the larger cells with the diffuse vimentin*1" network in the lamina 
propria. Calibration bars 20 |am in A, B and C* 
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Figure 7. A network of vimentin* processes around the muscle bundles of the inner muscle 
layer. Sections were double stained for COX I (red) and vimentin (green). A shows a low power 
image. The COX I-IR cells in the urothelium (uro) and lamina propria (LP-ICs) are seen. The 
vimentin* fibres of the sub-urothelial cell layer (SU-ICs) and within the cell network in the lamina 
propria are also apparent. Muscle bundles in the inner muscle layer are shown (m). A shows a 
network of vimentin4" fibres which are associated with the muscle bundles Collections of COX I-
IR cells are seen between the muscle bundles (n). These structures are described as 'nodes'. B and 
C show examples of the COX I-IR cells and their relationship to the vimentin+ fibres. B and C 
showing combined colour image (upper panel: vimentin-green, COX I-red), the COX I image 
alone (middle panel) and the vimentin image alone (lower panel). The COX I-IR cells (1) are 
weakly vimentin4" and are associated with the vimentin* processes (2) of other cells. Calibration 
bars 240 jam in A and 10 jam in B and C. 
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Figure 8. Nodes associated with the interstitial cells within the lamina propria and inner 
muscle layer. Sections were double stained with antibodies COX I (red) and vimentin (green). A 
shows a region of the lamina propria. Collections of COX I immonoreactivity (IR) structures 
(nodes) are seen associated with collections of vimentin* fibres. B and C show selected areas of 
the image in A with the associated individual images to COX I (middle panel) and vimentin 
(lower panel). The COX I-IR structures are identified by the arrows. Little of no vimentin staining 
is associated with these COX I-IR structures. Calibration bars 50 {im in A and 30 jluh in B and C. 
Figure 9. The distribution of COX I immunoreactivity (IR) and cGMP* cells in the outer 
muscle layers. A shows an image double labelled with antibodies to cGMP (green) and COX I 
(red). cGMP* cells are seen in the outer muscle layer (oml) while there are no cells associated 
with the inner muscle layer (iml). cGMP* cells (*) and COX MR cells (#) are identified. B and C 
show regions of the image in A of the outer and inner layers respectively at higher magnification, 
showing the combined colour image (upper panel: cGMP-green, COX I-red), the cGMP image 
alone (middle panel) and COX I image alone (lower panel). In B cGMP* cells are clearly seen (*) 
while COX I-IR cells are scarce (#). The COX I-IR cells do not show any cGMP staining. C 
shows the network of COX I-IR cells in the iml and the absence of cGMP staining. Calibration 
bars 120 |im in A and 40 jim in B and C. 
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Figure 10. Identification of interstitial cells in the muscle layers of the bladder. The sections 
are double labelled with antibodies to cGMP (green) and vimentin (red). A shows a low power 
image identifying the outer (oml) and inner muscle layers (iml). The network of cGMP+ ICs 
associated with the outer layer and the network of vimentin* cells in the inner (*) and outer layers 
are readily seen. The different types if cGMP*ICs are indicated by the arrows: muscle coat 
interstitial cells (MC-ICs), surface muscle interstitial cells (SM-ICs) and intra- muscular 
interstitial cells (IM-ICs), B, C and D illustrate regions of the image in A at higher magnification 
and showing combined colour image (left panel: cGMP-green, vimentin-red), the cGMP image 
alone (middle panel) and vimentin image alone (left panel), B shows primarily the SM-ICs. All 
cGMP* structure are also vimentin*. C and D focus on the IM-ICs. cGMP* cells are seen to extend 
long fine processes. The cell bodies and initial parts of the cell processes are also vimentin 
positive. D illustrates that there is a variation on the intensity of cGMP and vimentin staining. All 
IM-ICs express vimentin. However, there are vimentin* cells which are strongly cGMP* (1) while 
others have little cGMP immunostaining (2 and 3). Calibration bars, 100 jim in A, 40 \xm in B and 
20 pm in C and D. 
umbrella cells 
Intermediate urofheMum 
basal urothelium 
EP, P * M, 
sub-urothelial Interstitial cells 
:Ik v " • 'cj •  i . 'I - }m\ 
lamina propria IC network 
Inner muscle IC network 
Figure 11. Summary diagram illustrating the arrangement of cells found in the wall of the 
guinea pig bladder. The urothelium releases NO, PG, ATP and acetylcholine in response to 
stretch. The production of NO and PG in the urothelium may be interrelated. The substances 
released may act on afferent nerves but may also act upon the sub-urothelial interstitial cells. This 
network is in direct contact with a network of vimentin positive interstitial cells which run in the 
sub-urothelial space of the lamina propria and extend over the surface of the inner muscle bundles. 
The mechanisms connecting cells in this network is not known but may be via gap junctions 
(black squares). COX I-IR cells (satellite cells) are associated with the vimentin* interstitial cell 
network where they may influence the activity of the network. 
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Abstract 
Aims The aim of this study was to identify the cells expressing the M3 
muscarinic receptor sub-type in the lamina propria of the bladder. 
Materials and Methods The bladders from 5 normal guinea pigs were isolated 
and fixed in 4% paraformaldehyde. Tissues sections (10 jam) were then cut and 
stained with antibodies to the type 3 muscarinic receptor (M3), the interstitial 
cell marker vimentin and the non specific nerve marker PGP 9.5. The 
specificity of the antibody to the M3 receptor was established using the 
complementary blocking peptide and western blot analysis of HEK cells 
transfected to express the M3 receptor protein. 
Results The M3 antibody pre-incubated with its blocking peptide did not show 
any immunohistochemical staining. Investigating this antibody using HEK cells 
transfected to express the M3 receptor protein and control HEK cells showed a 
single band in the transfected cells and no band in the control cells, M3 receptor 
immuno-reactivity (M3-IR) was detected primarily on a dense network of 
vimentin positive (vim+) cells lying immediately below the urothelium: the sub-
urothelial interstitial cells (SU-ICs). The M3-IR was punctuate and appeared to 
be located on the cell surface. The diffuse cell network of cells in the remaining 
regions of the lamina propria did not show M3-IR. Few nerve fibres were 
associated with the M3-IR SU-ICs. The M3-IR SU-ICs were most numerous and 
prominent in the lateral wall. The number of M3-IR/vim+ cells diminished 
towards the bladder base and were absent in the bladder urethral j unction. In the 
base and urethral junction vim+ cells were observed which were not M3-IR, A 
population of umbrella cells in the lateral wall also showed weak punctuate M3-
IR. 
Conclusions Using a well characterised M3 antibody these observations 
demonstrate for the first time that the type 3 muscarinic receptor in the lamina 
propria is located specifically on the sub-urothelial interstitial cells. The 
physiological role of a these cells is not known and consequently the 
significance of what appears to be a cholinergic signalling system is unclear. 
Previously published data has shown that these cells respond to nitric oxide and 
atrial naturetic peptide with a rise in cGMP and possibly prostaglandin. All of 
these observations, taken together, suggest that the SU-ICs receive multiple 
inputs and that they must be part of a complex signalling system in this region 
of the bladder wall 
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Introduction 
The importance of cholinergic muscarinic receptors during bladder stimulation 
was recognised over 100 years ago [1]. It has long been recognised that the M3 
receptors are responsible for activating the detrusor [2]. This has been elegantly 
demonstrated using M3 knockout mice where cholinergic activation of the 
bladder is drastically affected although the animals still appear to void normally 
[3,4]. 
One of the major clinical conditions associated with bladder dysfunction is a 
sensation of urgency during filling and an increased frequency of voiding. It 
was originally thought that these symptoms were associated with bladder 
contractions during the filling phase. Given the importance of M3 receptors in 
the activation of bladder contractions M3 specific anticholinergic drugs were 
developed to treat the urological symptoms. Clinically, these drugs are effective 
in reducing symptoms of urgency and frequency. However, it has become 
apparent that, at therapeutic doses, these drugs do not affect either the non-
voiding contractions or the voiding contractions [5-7], Thus, these drugs must 
also act on other systems in the bladder. This has led to the suggestion that the 
anticholinergic drugs act upon sensory mechanisms operating during the filling 
phase. The search is now on to find these mechanisms. Current thinking has 
suggested roles for cholinergic mechanisms associated with the urothelium, 
afferent nerves and the motor/sensory system [8-10]. 
Molecular studies have shown that the all 5 muscarinic receptors are expressed 
in the mouse [11] and human bladder [12, 13]. However, it is generally 
accepted that only M2 and M3receptors are involved in the bladder smooth 
muscle contraction [14]. The relative amounts of M2 or M3 receptors in the 
muscle and urothelial layers of several species, like rat, mouse, and the human, 
are the not the same [11, 12, 15-18], and the M2 receptor being present in 
greater amounts than the M3 receptor [16, 19]. In order to unravel the different 
cholinergic elements in the normal and pathological bladder it is essential to 
know where the muscarinic receptors are located. The most obvious approach 
would be to use immunohistochemistry. However, the absence of specific and 
reliable antibodies has limited this way forward. Recent studies on the location 
of M2 and M3 receptors on the human bladder demonstrated their presence 
either only on smooth muscle cells [20] or on both interstitial cells in the lamina 
propria and muscle [21]. Another study demonstrated a weak immunostaining 
of the human urothelium for the M2 receptor and a strong M3 immunostaining in 
this tissue, whereas the real time PCR showed no difference in expression [12]. 
Unfortunately, in these studies the specificities of the antibodies used was not 
thoroughly investigated. The aim of the present study was to investigate the 
localization of the M3 receptor in the normal guinea pig bladder and in the 
bladder of animals with a previous inflicted obstruction. A main concern of this 
study was the characterization of a number of M3 antibodies, all marketed as 
specific reagents for this receptor subtype. Although it has been argued that the 
specificity of antibodies can never be proved [22, 23], we have performed 
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several tests on these antibodies. We transfected HEK cells with a rodent M3 
receptor as a model system. In addition, we studied all antibodies by Western 
blotting and, where possible, with preaborbtion experiments. The antibody 
which passed all these tests were applied to sections of the guinea pig urinary 
bladder in order to localize the M3 receptor in this tissue. 
Materials and Methods 
Guinea pigs (5 male, weight range 270-300g) were killed by cervical 
dislocation. All procedures were carried out in accordance with guidelines of the 
University of Maastricht and were in line with the EC guidelines. 
Urinary bladder including the proximal urethra was removed from each animal 
and placed in ice-cold Kreb's solution: NaCl mM, 121.1 mM; KC1 1.87 mM; 
CaCl21.2 mM; MgS041.15 mM; NaHC03 25 mM; KH2P04 1.17 mM; glucose 
11.0 mM and bubbled with 5% C02 and 95% 0 2 (pH 7.4). Each bladder was 
divided in two into pieces, a ventral piece and a dorsal piece, and maintained in 
Kreb's solution containing 1 mM of the non-specific phosphodiesterase 
inhibitor isobutyl-methyl-xanthine (IBMX: Sigma-Aldrich) at 36°C for 30 
minutes. Incubations were terminated by immersing bladder pieces in ice-cold 
fixative solution of 4% freshly prepared depolymerised paraformaldehyde for 
120 min at 4°C. Then, tissues were fixed overnight at 4 °C in 0.1 M phosphate 
buffer with 10% sucrose and the next day the tissues were placed in at 0,1 M 
phosphate buffer with 20% sucrose at 4 °C and then washed overnight at 4 °C 
in 0.1 M phosphate buffer with 30% sucrose. The tissues were placed in Tissue-
Tek O.C.T. compound to form a single block. This was then snap-frozen in 
isopentane cooled in liquid nitrogen. Cryostat sections (10 \xm) were cut, such 
that each section was perpendicular to the urothelial surface. Sections were then 
thawed on to chrome-alumn-gelatin-coated slides and processed for 
immunocytochemistry. 
Immunohistochemistry 
Sections were dried for 60 min at RT followed by three washes with Tris-
buffered saline (TBS; pH 7.6), and thereafter incubated overnight with primary 
antibodies at 4 °C. To visualize PGP9.5 we used rabbit anti-PGP9.5 (1: 2000; 
Abd Serotec); the selectivity and an estimate of the detection limit of these 
antibodies have been described previously [24-26]. The mouse antibody against 
vimentin (Sigma-Aldrich) was diluted 1:5000. The goat antibody against the M3 
receptor (Santa Cruz) was diluted 1:300. Pre-absorption of the anti-M3 antibody 
(1:300) was done by incubating the antibody with or without 10 |ig/ml of the 
peptide against which the antibody was raised. Thereafter the antibody solution 
or antibody plus peptide solution was applied to the sections. 
After overnight incubation with the primary antibodies diluted in TBS 
containing 0.3% (v/v) Triton X-100 (TBS-T), sections were washed in TBS, 
TBS-T and TBS; each wash step lasted 15 min. Rabbit primary antibody was 
visualized using Alexa Fluor 488 donkey anti-rabbit IgG (H+L) conjugate 
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(Molecular Probes), diluted 1 : 100 in TBS-T. Mouse primary antibodies were 
visualized with Alexa Fluor 488 donkey anti-mouse IgG conjugate (Molecular 
Probes), diluted 1:100. Goat primaiy antibodies were visualized with Alexa 
Fluor 594 donkey anti-goat IgG conjugate (Molecular Probes). Sections were 
incubated with the secondary antibodies for 60 min at room temperature in the 
dark. After washing with TBS-T, and TBS, sections were mounted with TBS-
glycerol. 
In total 5 bladders were used in the study. Typically, for each bladder and for 
each antibody combination staining was done in duplicate and repeated on at 
least 2 separate days. Observations were accumulated from the different slides 
and from the different bladders. 
Sections were analysed and photographed using an Olympus AX70 microscope 
using a x4, xlO, x20 and x40 objective. For the detection of Alexa 488 
fluorescence we used a narrow band-pass MNIBA-filter and for the detection of 
Alexa 594 we used a filter with a narrow excitation band, the U-M41007A filter 
(both filters are from Chroma Technologies). The microscope was equipped 
with a cooled CCD Olympus Digital video camera F-view. Images were stored 
digitally as 16 bits images by using the computer program analySIS® Vers.3.0. 
(Soft Imaging System, Münster, Germany). The number of grey values was 
reduced using a linear function into 4095. Images were arranged with the 
program Adobe Photoshop 5.5 or 7.0.1 (San Jose, CA, USA). 
Western blots of transfected M3 cells 
HEK-293 cells were grown with Dulbecco's modified Eagle's medium, 
supplemented with 2 mM L-glutamine, 10% (v/v) fetal bovine serum and 
penicillin (100 U/ml)/streptomycin sulfate (0.1 mg/ml), at 37 °C in a humidified 
5% C02 environment. Transfections were performed for 15h using ProFection 
Mammalian Transfection System-Calcium Phosphate (Promega, USA), 
following manufacturer's recommendations with the ORF Clone of Homo 
sapiens cholinergic receptor, muscarinic 3 (CHRM3, OriGene, USA). 
To obtain cell extracts, growing cultures were rinsed with ice-cold phosphate 
buffered-saline (PBS) and homogenized on ice bed with 25 mM Tris-HCl pH 
7.5, 150 mM NaCl, 0.5% Triton X-100, 1 mM phenylmethylsulphonyl fluoride 
(PMSF) and 10 |ig/ml leupeptin. Mixtures were cleared by centrifugation at 500 
x g for 10 min, protein concentration determined and stored at -70 °C. Protein 
measurements were done using Bovine Albumin Serum dilutions (4 mg/ml, 2 
mg/ml, 1 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml, 0.0625 mg/ml 0 mg/ml) 
with the Biorad protein measurement device (Bio-Rad Laboratories, Inc., 
Hertfordshire, CA, USA) according to the manufacturer's instructions. 
Western blot analysis were performed under reducing conditions following 
standard procedures and using the Odyssey infrafed imaging system (Li-cor 
Biosciences, USA). Primary antibodies used for western blotting were: goat 
anti- M3 antibody (Santa-Cruz, SC7474) used in a dilution of 1:500, and mouse 
anti-rabbit GAPDH (RDI, 5G4-6C5) used in a dilution of 1: 3.000.000. 13063). 
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Secondary antibodies used were: Donkey anti-Goat IRDey 800 (Odyssey, 926-
32214), and Donkey anti-mouse IRDye 700 (Rockland, 610-730-124) both in a 
dilution of 1:10.000. 
Results 
Characterisation of the M3 antibody 
In order to find an M3 antibody suitable for immunohistochemical studies we 
studied several M3 antibodies. Figure 1 illustrates the characterization of an 
antibody (Ab) to the muscarinic type 3 receptor used in this study (Santa Cruz-
goat Ab). Panel A shows a section of guinea pig bladder stained with this 
antibody. The image shows that a strong immuno-fluorescence signal is 
restricted to cells lying immediately below the urothelium and that there is faint 
staining in some of the umbrella cells. Staining was also seen associated with 
the smooth muscle (not shown). One approach to assess whether this staining is 
specific is to interfere with the reactive site of the antibody by pre-incubation 
with the peptide to which it was raised. Panel B shows that all of the staining is 
removed with the pre-absorbed antibody. This is one indication that the Ab 
binding is specific for the epitope to which the Ab was raised. A second 
approach was to demonstrate that the antibody reacts specifically with the M3 
receptor by Western blot studies. This was done using Western blot 
examination of homogenates from cells which do not express the M3 receptor 
(control cells) and from cells which were transfected with DNA encoding for 
the M3 receptor (transfected cells, see above). Panel C shows a western blot 
demonstrating that the antibody detects a protein band of approximately 100 
kD, the correct molecular weight for the M3 receptor. This band is only found in 
the transfected cells. Therefore, based on these criteria we have an antibody 
which can be reliably used to explore the distribution of M3 receptors in the 
guinea pig bladder 
Location of the M3 antibody 
Muscarinic type 3 receptors were found to be located on the dense population of 
sub-urothelial interstitial cells (SU-ICs) which lie immediately below the 
urothelium (Figure 2). These cells express vimentin, identifying them as of 
mesenchymal origin. The diffuse network of vimentin positive cells which lie 
within the bulk of the lamina propria (lamina propria interstitial cells (LP-ICs) 
did not express M3 receptors indicating at least two distinct types of interstitial 
cell in the lamina propria. The staining associated with the SU-ICs appeared to 
be concentrated in the cell bodies and is particularly intense in the region of the 
nucleus. However, staining was also clearly associated with cell processes 
(Figure 2B and C). It is noteworthy that the staining appears to be punctuate 
with intense aggregations of fluorescence appearing through out the cells. 
Figure 1 A shows that there are a small number of the umbrella cells which 
stain weekly with the M3 antibody (+). This is again illustrated in Figure 3. Here 
also there appears to be a punctuate distribution of M3 receptors. Not all 
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umbrella cells stain with the M3 antibody indicating a possible heterogeneity 
within these epithelial cells. 
Regional differences in distribution of the M3 antibody 
An interesting observation was that the interstitial cells expressing the M3 
receptors were more prominent in the lateral wall compared to the bladder base 
and in the urethra (Figure 4). In the lateral wall the SU-ICs layer could be up to 
5-8 cells deep with the vast majority of the cells expressing the M3 receptor. 
Towards the bladder base this layer thinned and was only 1-3 cells deep and 
was completely absent in the region of the bladder urethral junction (Figure 4 B 
and A respectively). Comparing panels B and C it is also apparent that the 
number of clusters of M3 receptors appears to be higher in the cells of the lateral 
wall compared tot the base. This differential expression might suggest a 
localized regulation of receptor expression. Close examination of these different 
regions revealed the presence of SU-ICs (vimentin positive) that did not express 
M3 receptors (M3 negative). Few such cells were seen in the lateral wall while 
they were more abundant at the base (Figure 5). In the bladder urethral junction 
vimentin positive cells were found in a sub-urothelial layer but these cells did 
not demonstrate M3 receptors. 
It was also noted that the M3 positive SU-ICs were not directly associated with 
nerve fibres. Nerves were seen to run within the M3 positive SU-ICs layer but 
the density was low. However, in the region of the bladder/urethral junction 
where there are numerous nerve fibres the M3 positive SU-ICs were absent. 
Discussion 
In the present study we used antibodies which detect the M3 type muscarinic 
receptors in the guinea pig urinary bladder wall. It can never be ruled out 
completely that the antibody exhibits some non-specific binding [22, 23] and 
also that it might also recognise other muscarinic receptor iso-forms. By 
transfecting HEK cells with the M3 receptor and the demonstration that this 
receptor is actually present using the two antibodies, in combination with the 
demonstration of M3 receptor reactivity in Western blots of whole guinea pig 
bladder homogenates, and in addition the complete absence of immunostaining 
in the tissue after preabsorbtion of the antibodies with the respective peptides, 
we have met the criteria necessary to characterise polyclonal antibodies. 
However, as antibodies are affinity reagents there will always be room for 
discussion, as there are no pharmacological/physiological model systems 
available to test the M3 antibodies as e.g. have been used characterizing the 
cGMP antibody [27]. However, there is a concordance between our 
immunohistochemical results and the physiological data already available and 
presented during the introduction of this paper lending additional support to our 
viewpoint that using these antibodies it is indeed possible to visualize the M3 
receptor. Therefore, this discussion is presented on the basis that the antibody 
identifies cells expressing muscarinic receptors. 
Chapter 4 
The urothelium has been shown to release PG [28-31], ATP [32], NO [32-34] 
and ACH [11, 35] primarily in response to stretch. This release is thought to be 
the initial step involved in a system involved in detecting bladder volume. As 
the bladder fills the urothelium is stretched and substances are released which 
results in the activation and modulation of afferent nerves. There is 
experimental evidence demonstrating the modulation of afferent nerve firing by 
ATP [36] and indirect evidence for the involvement of NO [37] and ACh [38] 
in the modulation of the afferent limb of the micturition reflex. PG, ATP, ACh 
and NO appear to be released through out the bladder, in the lateral wall and 
dome. In these regions the density of afferent nerves is low. Therefore, is seems 
likely that substances released in these regions sub-serve functions other than 
direct neuro-activation or neuro-modulation. 
The possibility has been considered that there are more indirect involvement of 
substances released from the urothelium and afferent nerves [6, 39]. For 
example, it has been suggested that there are specialized cells in the lamina 
propria, myofibroblasts, which lie close proximity to afferent nerve fibres [40]. 
Cells purported to be these myofibroblasts respond to ATP [41]. This has led to 
the idea that the myofibroblasts contract in response to ATP so distorting and 
activating the adjacent afferent nerves. Although an interesting concept there is 
no direct experimental evidence for the operation of such an arrangement in the 
bladder wall. Based on the original description of myofibroblasts in the lamina 
propria is seems unlikely that these distributed cells are those described as SU-
ICs. It is more likely that the myofibroblasts lie within the regions of LP-ICs. A 
further aspect, suggesting that myofibroblasts and SU-ICs are different, is that 
the SU-ICs layer in the lateral wall is poorly innervated with sensory fibres 
(Figure 6) [42]. 
The absence of nerves associated with the SU-ICs layer further suggests that 
these ceils do not have an efferent supply and so are not under the influence of 
any significant neural control. If the M3 receptors are functional and activated 
by ACh then a key question is the source of the ACh. It has been shown that 
ACh is released from the urothelium in response to stretch [43]. Therefore, this 
is a potential source. The data from these human studies suggests that the outer 
cells of the urothelium that express the enzyme choline acetyltransferase 
(ChAT) and are thus responsible for the synthesis of ACh. A similar 
observation, locating ChAT to the umbrella cells has been made of the guinea 
pig urothelium (de Vente and Gillespie, unpublished observations). Thus, the 
likely elements of this signalling system involve the release of ACh from the 
urothelium and the activation of the underlying sub-urothelial cells. 
The network of vimentin positive SU-ICs extends from the bladder base, over 
the lateral wall and into the dome. The co-expression with the M3 receptor is 
primarily located in the lateral wall where the cell layer is several cells thick. 
This region must therefore represent the region of the bladder where this 
mechanism is most active and most relevant. Towards the bladder urethral 
junction this system disappears, the expression of the M3 receptor declines and 
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the proportion cells which are only vimentin positive is increased. The M3 
mechanism is therefore absent in the region of the bladder urethral junction. 
The cells which lie in the sub-urothelium of the bladder were first described by 
Smet [44] as a population of cells that responded to exogenous nitric oxide with 
a rise in cGMP. The physiological role of these cells and the significance of this 
responsiveness was not considered. Subsequent work has confirmed the 
sensitivity of this cell layer to NO and shown that they lie in close proximity to 
cells in the basal urothelium which express neuronal nitric oxide synthase, the 
enzyme responsible for generating NO [45]. This suggested that there is a 
transfer of signals between the urothelium and SU-ICs. 
It has been shown that, in the guinea pig, the basal and intermediate cells of the 
urothelium express the cyclo-oxygenase enzyme COX I [46]. Therefore, these 
cells are likely to be responsible for the generation of prostaglandin from the 
urothelium. The cellular target for this prostaglandin is not known but there is 
preliminary data suggesting that the SU-ICs express the type 2 prostaglandin 
receptor (EP2) [47]. In other tissues the EP2 receptor is linked to adenylate-
cyclase and, when activated, generates a rise in intracellular cAMP. Thus, a 
second urothelial derived signal, prostaglandin, has the potential to interact with 
the SU-ICs and to generate a second cascade of intracellular signals. 
The present data shows that these SU-ICs also express type 3 muscarinic 
receptors suggesting that they can respond to ACh. M3 receptors belong to the 
sub-set of muscarinic receptors that couple to G proteins and when activated 
result in a rise in diacylglycerol and inositol-trisphosphase (IP3). The IP3 
generated then initiating the release of intracellular calcium. This series of 
events may occur within the SU-ICs. 
It would thus appear that the SU-ICs receive multiple inputs via the urothelial 
derived signals. These signals are likely to be involved in activating or 
modulating different pathways within the SU-ICs. These systems may act 
synergistically to produce or modulate a specific response. Alternatively, they 
may be antagonistic and, depending upon their level, integrate to produce a 
specific response. The SU-ICs may therefore be a point of integration of 
signals derived from the urothelium. The signals generated by the urothelium 
and the receptors and pathways they may act upon associated with the SU-ICs 
are illustrated in the cartoon in Figure 7. The output of the SU-ICs and the 
physiological system that they might control or regulate are not known. 
It has been known for many years that the urothelial cell layer of the bladder 
expresses type 2 and type 3 muscarinic receptors with amount of M2 being 
greater than M3. This conclusion is based upon studies of the relative expression 
of the appropriate mRNA and from studies of radio-ligand binding [18, 48]. The 
techniques used cannot identify the specific cell types expressing these 
receptors and the question of the location of these receptors has remained open 
for some considerable time. Although the present observations do not yield any 
information on the location of the M2 receptors they do point to the SU-ICs as 
the location of the M3. 
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In conclusion, the characterization of an antibody which is specific for the M3 
sub-type of the muscarinic receptor has pointed to a novel signalling system in 
the bladder wall. The suggestion that the SIJ-ICs represent a cell type which can 
integrate the plethora of urothelial signals is an additional novel concept. These 
ideas now pose intriguing questions regarding the generation and modulation of 
the urothelial signals, how these signals interact and influence SU-ICs and 
finally what systems are activated following SU-IC activation. Overall, the 
major driving question must be to discover the physiological system that these 
processes underpin. 
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Figure 1. Specificity of the M3-antibody. Panel A shows M3-hnmunoreactivity (M3-IR) in a 
layer directly below the urothelium. Panel B shows the same M3-antibody pre-incubated with its 
blocking peptide. The M3-IR in cells directly below the urothelium and in urothelial cells has 
disappeared. Panel C shows a western blot of HEK cells with and without transfection with the 
M3-receptor. The first lane shows the control HEK cells stained with our M3 antibody and 
GAPDH, The M3 antibody does not show any staining in the non-transfected cells (lane 1), while 
there is a clear band at the height of 95kD in the M3-transfected cells (lane 2). GAPDH shows the 
same amount of protein in both lanes. 
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Figure 2. M3-immunoreactivity (M3-IR) in sub-urothelial interstitial cells. All panels are 
stained for vimentin (vim, green) and M3 (red). Panel A shows a low power image of the 
urothelium (uro), sub-urothelium and lamina propria (lp). The sub-urothelial interstitial cells (SU-
ICs) show immuno-reactivity for both vim and M3. Panel B and C show in more detail the SU-
ICs. The M3-IR on these cells is punctuated and located on both the cellbody and their processes 
(*). Calibration bars SOjim in A, 20pm in B and lO i^m in C. 
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Figure 3. M3 immun ore activity (M3-IR) in the urothelium. Panel A and B are stained for the 
M3 receptor (red) and the interstitial cell marker vimentin (green). The panels on the right of panel 
B show the original pictures of which panel B is constructed. Panel C is stained for the M3 
receptor. Panel A illustrates the M3-IR in the sub-urothelial interstitial cells (SU-ICs) and in the 
umbrella cells (*). Panel B shows at high magnification a detail of panel A. The M3-IR appears to 
be punctuate in both the umbrella cells and the SU-ICs. Panel C shows in further detail the 
punctuate M3-IR in the umbrella cells of a different bladder. Calibration bars 50 jam in A and 10 
j^ m in B and C. 
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Figure 4. Distribution of M3-immunoreaetivity (M3-IR) on sub-urothelial interstitial cells 
(SU-ICs) in different regions of the bladder. Panel A, B and C are all stained for the M3 
receptor (red) and the interstitial cell marker vimentin (green). The panels below A, B and C show 
the original pictures of which panels A, B and C are constructed. Panel A shows a section of the 
urethra (U). No SU-ICs were located in this area. Panel B shows a section of the transition zone of 
the base/lateral wall (B/LW). Here there are SU-ICs visible. There appear to be two subsets of 
SU-ICs, vim+ / M r SU-ICs (#) and vim+ / M3+ SU-ICs (*). In the lateral wall (panel C, LW) the 
SU-IC layer appears to be thicker and here almost all SU-ICs show M3-IR (*). Calibration bar in 
A is for A, B and C; size 10 
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Figure 5. Differences in M3-immunoreactivity (M3-IR) in sub-urothelial interstitial cells (SU-
ICs). Panel A, B and C are all stained for the M3 receptor (red) and the interstitial cell marker vimentin 
(green). The panels below show the original images of panel A, B and C. Panel A shows a SU-ICs (#) 
of the base (B). This cell shows no M3-IR. Panel B shows SU-ICs of the transition zone base/lateral 
wall (B/LW). In this area there appears to be two types of interstitial cells; vim+/ M3+ cells (*) and 
vim+/ M3- cells (#), while in the lateral wall (panel C, LW) there is only one type of su-ics: vim+/M3+ 
su-ics (*). Calibration bar in A is for A, B and C; size 10 \nm. 
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Figure 6. M3-immun ore active 
(M3-IR) sub-urothelial 
interstitial cells (SU-ICs) in 
relation to the distribution of 
nerves. Panel A, B and C are all 
stained for the M3 receptor (M3, 
red) and the non-specific 
neuronal marker PGP9.5 (PGP, 
green). The panels below show 
the original images of panel A, 
B and C. In the urethra (U) 
there are no M r I R SU-ICs, 
while there is a dense network 
of nerves (panel A). In the base 
(B) there are M3-IR SU-ICs, but 
only a sparse distribution of 
nerves (panel B). In the lateral 
the number of M3-IR SU-ICs is increased, while there is no difference in the 
t ion of nerves. Thus, it can be concluded that there is no relation between the distribution 
e s and the distribution of M3-IR SU-ICs. Calibration bar in A is for A, B and C; size 10 
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7. Cartoon illustrating the output of urothelial signals and possible interactions of 
ignals on the sub-urothelial interstitial cells in the guinea pig bladder. The output of 
^thelium including prostaglandin (PG), nitric oxide (NO), acetylcholine (ACh) and 
i n e trisphosphate (ATT) are all well documented [11, 28-35]. The present data demonstrate 
-sence of M3 receptors on the SU-ICs. EP2 receptors have been demonstrated immuno-
^mically and atrial naturetic peptide (ANP) receptors inferred from the actions of 
-ous ANP [47,49]. NO and ANP induce a rise in cGMP. Based on published data activation 
generates a rise in cAMP via adenylate cyclise (AC) and activation of M3 causes a rise in 
pillar Ca2+ from intracellular stores and diacylglycerol (DAG). The physiological system 
inned by these signalling elements on the SU-ICs has yet to be identified. 
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Abstract 
Type M3 muscarinic receptors are central to bladder function. There is growing 
awareness that M3 receptors are located not only on the smooth muscle but also 
associated with other cell types and mechanisms. The aim of this study was to 
identify the cellular location of M3 receptors in bladders from normal guinea 
pigs and guinea pigs with surgically induced bladder neck damage. In the sham-
operated bladder M3 like immuno-reactivity (M3-IR) was associated with 
nerves: a sub-population of nerves in the lamina propria, a sub-population of 
nerves within the muscle bundles and the intra-mural ganglia. M3-IR was also 
associated with vimentin positive interstitial cells. Different types of cell were 
identified: sub-urothelial cells (SU-ICs), cells in the lamina propria (LP-ICs) 
and cells associated with the muscle either on the surface (SM-ICs) or within 
the bundles (IM-ICs). In bladders with previous damage to the bladder neck 
there was a hypertrophy of the wall accompanied by a loss of intramural nerves 
and ganglia. The SU-ICs appeared little changed but LP-ICs were more 
abundant, the cells having long bifurcating processes. There was an increase in 
SM-ICs and IM-ICs. Between the muscle bundles the cell bodies of these cells 
appeared in clusters forming 'nodes'. Thus, there is a major remodelling of the 
bladder wall following damage to the bladder neck. The loss of nerve and the 
up-regulation of interstitial cells expressing M3-IR may underlie major 
functional changes. The hypothesis is put forward that the augmentation of the 
interstitial cell network modifies the non-voiding phasic activity and increases 
motor/sensory output resulting in sensations of urgency. Furthermore, it is 
argued that the cholinergic receptors associated with this interstitial cell 
network are a therapeutic target for anticholinergic drugs. 
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Introduction 
The importance of cholinergic muscarinic receptors during bladder stimulation 
was recognised over 100 years ago (Langley 1895). We now know that, based 
on analyses of total mRNA, all five receptor subtypes (M^ M2, M3, M4 and M5) 
are found in both in the urothelial and muscle layers (Siglia et al 2002; Tyagi et 
al. 2006; Ruggieri and Braverman 2006). Ligand binding receptor assays 
suggest that the most abundant forms are M2 and M3 with M2 being present in 
greater amounts than M3 (Mansfield et al. 2005; Ruggieri and Braverman 
2006). It has long been recognised that the M3 receptors are responsible for 
activating the detrusor (Chess-Williams 2002). This has been elegantly 
demonstrated using M3 knockout mice where cholinergic activation of the 
bladder is drastically affected although the animals still appear to void normally 
(Matsui et al. 2000; Matsui et al. 2002). At present the precise role of the M2 
receptor sub-type in the bladder is controversial. 
One of the major clinical conditions associated with bladder dysfunction is a 
sensation of urgency during filling and an increased frequency of voiding. It 
was originally thought that these symptoms were associated with bladder 
contractions during the filling phase. Given the importance of M3 receptors in 
the activation of bladder contractions M3 specific anticholinergic drugs were 
developed to treat the urological symptoms. Clinically, these drugs are effective 
in reducing symptoms of urgency and frequency. However, it has become 
apparent that, at therapeutic doses, these drugs do not affect either the non-
voiding contractions or the voiding contraction (Andersson and Yoshida 2003; 
Andersson and Arner 2004; Finney et al. 2006). Thus, these drugs must also act 
on other systems in the bladder. This has led to the suggestion that the 
anticholinergic drugs act upon sensory mechanisms operating during the filling 
phase. The search is now on to find these mechanisms. Current thinking has 
suggested roles for cholinergic mechanisms associated with the urothelium, 
afferent nerves and the motor/sensory system (see de Groat 2004; Fry et al. 
2004; Gillespie 2005). 
In order to unravel the different cholinergic elements in the normal and 
pathological bladder it is essential to know where the muscarinic receptors are 
located. Remarkably, there are few published studies which have succeeded in 
addressing this question. Molecular studies have suggested differences in the 
relative amounts of M3 and M2 receptors in the muscle and urothelial layers 
(Ruggieri and Baverman 2006) and also in different regions of the bladder 
(Sigala et al 2002). Such approaches do not allow the location of receptors to 
specific cell types. As a result functional interpretations of these molecular 
approaches have focused on the major cell types in the bladder: the urothelium 
and muscle. However, other cell types which may be in low abundance may 
have cholinergic inputs that may be central to bladder function. 
The most obvious approach would be to use immunohistochemistry. However, 
the absence of specific and reliable antibodies has limited this way forward. 
One recent study on human bladder located M2 and M3 receptors to interstitial 
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cells in the lamina propria and muscle (Mukerji et al 2006). Unfortunately, this 
work did not demonstrate the specificity of the antibodies and the observations 
must be regarded with caution. In this study we present immunohistochemical 
data using an antibody which appears to be specific for the M3 receptor based 
on its molecular characterisation using western blot analysis (Santa Cruz 
laboratories (Ab SC-7474); (Espanol and Sales 2004; Rimmaudo et al 2005) 
and the use of its blocking peptide. However, we can never be absolutely certain 
of the specificity of this or any other antibody. Hence we describe the staining 
and M3 immuno-reactivity (M3-IR). With this caution the M3-IR appears to be 
located on different cell types in the bladder wall: muscle, interstitial cells, 
ganglia and nerves. Also, there appear to be differences in the pattern of M3-IR 
in bladders of sham operated animals and animals with previous surgical 
damage to the bladder neck. These observations are discussed in terms of 
normal bladder function and in association with the changes seen in the 
pathological bladder. 
Materials and Methods 
The studies were performed in 14 male guinea pigs (Hartley strain) weighing 
between 266-299 grams. The guinea pigs were housed in a temperature-and 
light - (12h light/dark cycle) controlled room and allowed free access to food 
and water. The institutional animal care and use committee of Maastricht 
University approved all the animal experiments conducted in this study. All 
procedures were in line with the NIH guidelines. 
Surgical procedure: The procedures used were similar to those reported 
previously (Mostwin et al. 1991). Briefly, in 8 animals a partial outflow 
obstruction was induced while 6 underwent sham operation. The protocol based 
on this guinea pig model for gradual urethral obstruction was used as described 
by (Mostwin et al. 1991). Animals were sedated with ketamine (40 mg/kg) and 
xylazine (3 mg/kg) administered intraperitoneal^. Once sedation was achieved 
and the animals were prepared under sterile conditions, the bladder neck and 
urethra were exposed via a vertical midline abdominal incision. A silver 
jeweler's jump ring (1.8 mm internal diameter) was placed loosely around the 
proximal urethra. Bladder outlet obstruction occurred during subsequent growth 
of the animal. The analgesic medication flunixinum (5mg/kg s.c.) and the 
antibiotic gentamicin (5mg/kg i.m.) were administered once postoperatively. 
Sham surgery was performed in an identical manner, except for inserting the 
ring around the urethra. 
Four weeks after the operation, the weight gain in the sham operated animals 
was 190 + 52 grams compared to the animals with a bladder outflow 
obstruction 112 ± 56 grams. The bladder weights of sham operated and 
obstructed animals were 400 ± 73 mg and 1568 + 500 mg respectively. 
The bladders of these animals were used to study NO-mediated cGMP synthesis 
as described (De Jong et al CTR 330:147-60 2007). The present study was 
done on sections from these animals. After 4 weeks, the guinea pigs were killed 
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by cervical dislocation. The urinary bladder was removed from each animal and 
placed in ice-cold Kreb's solution containing 121.1 mM NaCI, 1.87 mM KC1, 
1.2mMCaC12, 1.15mMMgS04, 25 mMNaHC035 1.17 mM KH2P04, 11.0 
mM glucose, bubbled with 5% C02 and 95% 02 (pH 7.4). The procedures for 
isolation, stimulation with nitric oxide (NO) and detection of cGMP were as 
described previously (Gillespie et al. 2004). The lateral wall bladder was 
dissected into sections (approximately 20 mm2), each of which was maintained 
in 2 ml Krebs' solution containing 1 mM of the non-specific phosphodiesterase 
inhibitor isobutyl-methyl-xanthine (EBMX: Sigma-Aldrich) at 36°C for 30 min. 
Tissues were either stimulated with 100 |jM of the NO donor diethylamine-
NONOate (DEANO; Sigma-Aldrich) or left in control medium containing only 
IBMX. The NO donor was prepared immediately before use, added directly to 
the bathing solution and incubated with the tissue for 10 min. Incubations were 
terminated by immersing bladder pieces in ice-cold fixative solution of 4% 
freshly prepared depolymerised paraformaldehyde for 120 min at 4°C. Then, 
tissues were washed at 4 °C in 0.1M phosphate buffer containing 10% sucrose 
(24 h), 20% sucrose (24h) and 30% sucrose (24h). The tissues from the lateral 
wall were then snap-frozen with C02 in Tissue-Tek O.C.T. compound to form a 
single block. Cryostat sections (10 |um) were cut, such that each section was 
perpendicular to the urothelial surface. Sections were then thawed on to 
chrome-alumn-gelatin-coated slides and processed for immunohistochemistry. 
Sections were dried for 20 min at RT followed by three washes with Tris-
buffered saline (TBS; pH 7.6), and thereafter incubated overnight with primary 
antibodies at 4 °C. 
Primary antibodies were diluted in TBS containing 0.3% (v/v) Triton X-100 
(TBS-T), sections were washed in TBS, TBS-T and TBS; each wash step lasted 
10 min. The antibodies used here: rabbit anti-PGP-antibody (Biogenesis) 
diluted 1:1000; goat anti- M3 antibody (Santa-Cruz, C-20) used in a dilution of 
1:300; rabbit anti-ChAT-antibody (Chemicon) used 1:100; mouse anti-
vimentin- antibody (Chemicon) used 1:100 and CGRP (Chemicon) used 1:200. 
The goat primary antibodies were visualized using donkey anti-goat-CY3 
conjugate IgG (Jackson) diluted 1:100 in TBS-T, Rabbit primary antibodies 
were visualized with Alexa Fluor 594 donkey anti-rabbit IgG conjugate 
(Molecular Probes), diluted 1:100. Sections were incubated with the secondary 
antibodies for 60 min at RT in the dark. After washing with TBS-T, and TBS, 
sections were mounted with TBS-glycerol. 
Pre-absorption of the anti- M3 antibody (1:300) was done by incubating the 
antibody with or without 10 |ag/ml of the peptide (SC7474P, Santa Cruz) 
against which the antibody was raised overnight at 4°C. Thereafter the antibody 
solution or antibody plus peptide was applied to the sections. Pre-absorption of 
the antibody with the peptide abolished antibody binding indicative of a high 
degree of antibody specificity. Information available in the antibody data sheets 
from Santa Cruz indicates that, using western blot analysis, this M3 antibody 
recognises the 75kD M3 receptor protein (Espanol and Sales 2004; Rimmaudo 
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et al 2005) and that this specific protein binding is also removed by pre-
incubation of the antibody with the blocking peptide. Thus, it is possible to 
conclude that this antibody is capable of recognising specifically the type 3 
muscarinic receptor. However, there is always uncertainty with respect to such 
specificity. For this reason we have described the results as determining M3 
receptor immuno-reactivity rather than a categorical statement that we are 
seeing the M3 receptors. 
Typically, for each bladder and for each antibody combination staining was 
done in duplicate and repeated on at least 2 separate days. Observations were 
accumulated from the different slides and from the different bladders. 
Sections were analysed and photographed using an Olympus AX70 microscope. 
For the detection of Alexa 488 fluorescence we used a narrow band-pass 
MNDBA-filter and for the detection of Alexa 594 we used a filter with a narrow 
excitation band, the U-M41007A filter (both filters are from Chroma 
Technologies). The microscope was equipped with a cooled CCD Olympus 
Digital video camera F-view. Images were stored digitally as 16 bits images by 
using the computer program CellAF (Soft Imaging System, Münster, Germany). 
The number of grey values was reduced using a linear function into 4095. 
Images were arranged with the program Adobe Photoshop 5.5 or 7.0.1 (San 
Jose, CA, USA) without further processing unless indicated otherwise. 
Results 
Antibody specificity and muscarinic receptor type 3 immunoreactivity 
Immuno-reactivity to the M3 antibody is seen in cells in the immediate sub-
urothelial cell layer, the sub-urothelial interstitial cell layer (SU-ICs), lamina 
propria and inner muscle (see figure 1A). Pre-incubation of the antibody with 
the peptide against which the antibody was raised abolished staining (see figure 
lc). Thus, the antibody is able to detect structures with M3-IR. 
Bladders from sham operated control animals 
The structures within the lamina propria expressing M3-IR are shown in Figures 
2-4. In Figure 2 panels A and D show low power images of sections double 
stained for vimentin (green) and M3-IR (red). Cells in the sub-urothelial layer 
are densely packed and stain intensely for vimentin. Vimentin positive cells are 
also found in the lamina propria but here the cells are sparse. The panels B, C, 
and E show that M3-IR is located immediately below the urothelium in the sub-
urothelial interstitial cells. A comparison of panels B and C shows that the 
number of M3-IR cells can vary in different regions of the sub-urothelial layer. 
Panel E illustrates the sub-urothelial interstitial cells. F shows a region of this 
image at higher magnification illustrating the observation that the M3-IR is 
located in the region of the interstitial cell bodies. However, M3-IR is also 
located in the sub-urothelial cell processes although here the intensity of the 
staining is week (Figure 3). 
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Nerves, presumably sensory nerves, are found in the sub-urothelial space. 
Examination of sections double stained for the non-specific neuronal marker 
PGP 9.5 and the M3 antibody suggest that there is one population of nerves 
which express M3-IR and a second population which does not (Figure 4 A and 
B). In the muscle layers M3~IR is associated with the smooth muscle (Figure 4 
C) but it can also be located to nerve fibres identifiable by PGP 9.5 co-staining 
((+) Figure 4 D and E). Interestingly, as in the lamina propria, there is a sub-
population of PGP 9.5 fibres which do demonstrate M3-IR ((f) Figure 4 D and 
E). Thus, there appear to be different types of nerves in both the lamina propria 
and muscle layers. 
Ganglia are found in the sub-urothelial layer where they form an 
interconnecting network. Previous studies have shown that the cell bodies of the 
neurones forming these ganglia receive inputs from two sets of fibres: fibres 
that stain positively for the enzyme synthesising acetylcholine, choline acetyl-
transferase (ChAT) and fibres containing calcitonin gene related peptide 
(CGRP) (See Figure 5 A, B and C). Figure 5 D shows that M3-ER can be 
detected on the ganglionic nerve cell bodies. The staining is highly punctate 
suggesting possible receptor clustering. Therefore, it seems likely that the 
ChAT fibres are releasing acetylcholine which activates the ganglion cells via 
M3 receptor mediated mechanisms. 
Vimentin positive cells are also found in the lamina propria where they form a 
loose network (see Figure 6 A and 7 A). Some of these lamina propria 
interstitial cells are M3-IR. It is also apparent in Figures 6 B and 7 A that 
vimentin positive cells can be found on the surface of the inner and outer 
muscle bundles. Here too M3-IR can be seen. In addition, in 3 of 7 sham 
operated control bladders studied these M3-IR cells were seen to be in close 
apposition lying between muscle bundles in structures which can be described 
as 'nodes' (Figure 6 D-F). 
Bladders from animals with damage to the bladder neck 
Bladders from animals with damage to the bladder neck were larger indicative 
of bladder wall hypertrophy. This is exemplified by examining the wall 
thickness of a normal bladder (Figure 7 A) with that of an operated bladder 
(Figure 7 B): 6 mm compared to 12 mm. There are also major differences in the 
number and distribution of vimentin positive cells. In obstructed bladders there 
is an increased density of vimentin fibres in the lamina propria and surrounding 
the muscle bundles, particularly the outer muscle bundles. In addition, there 
appears to be an increase in the M3-IR in the lamina propria and outer muscle 
layer (Figure 7 B). These observations are elaborated in Figures 8 and 9. 
In the bladders from obstructed animals the sub-urothelial interstitial cells 
persist and remain strongly M3-IR. Little difference was noted in this cell layer 
in comparison to control bladders. However, there was a higher density of 
vimentin positive interstitial cells within the wall region between the sub-
urothelial interstitial cells and the inner muscle layer. These cells are shown in 
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Figure 8 A and D. Figure 8 C shows a region of the section in Figure 8 B at 
higher magnification. These diffuse lamina propria interstitial cells are M3-IR 
and appear to extend complex bifurcating processes. This network of lamina 
propria interstitial cells appears to be continuous with vimentin positive cells 
which run over the surface of the muscle bundles and within the muscle bundles 
(Figure 8 D). Examples of nodes are also shown in Figure 8 E and F. 
As noted in Figure 7 B there is a high density of vimentin positive structures in 
the outer muscle layers of the OB-bladders. Further examples of this are shown 
in Figure 9. Cell bodies of these vimentin positive cells can be found in groups 
or 'nodes'. These nodes are found in close apposition of several muscle 
bundles. The cell bodies of these interstitial cell nodes are associated with M3-
IR. Vimentin positive cells are also apparent within the muscle bundles. 
Regions of the bladder wall can be found where trabeculae are seen with a high 
density of vimentin positive cells. Such trabeculae are often found in close 
apposition to others with few vimentin positive structures (see Figure 9 E-G). 
The intra-muscular vimentin positive cells can be seen to send processes to and 
be in contact with the vimentin positive structures lying on the surface of the 
trabeculae. In addition, these intra-muscular vimentin positive cells are M3-IR 
(see Figure 9 F and G) 
Discussion 
In the present study we used an antibody which appears to detect M3 type 
muscarinic receptors in the bladder wall. It has to be emphasised that the 
possibilities remain that the antibody exhibits some non-specific binding and 
also that it might also recognise other muscarinic receptor iso-fonns. For these 
reasons the structures recognised by the antibody are described as having 
muscarinic receptor type 3 like immuno-reactivity (M3-IR). This discussion is 
presented on the basis that the antibody identifies cells expressing muscarinic 
receptors. The reliability of this assumption may be increased since there are 
functional data to suggest the presence of muscarinic receptors on different cell 
types in the bladder wall. 
It must also be pointed out that the present data are derived from guinea pig 
bladder. Morphologically the guinea pig bladder has many similarities with the 
human bladder (Dixon et al 1983; Gabella 1990; Smet et al 1996a; Smet et al 
1996b; Zhou and Ling 1998). In addition, pathologies such as that produced by 
partial outflow obstruction are similar to that seen in man (Mostwin et al 1991). 
Thus, the model has value in unravelling the complications of the human 
situation. 
In the normal bladder M3-IR can be identified on different structures. M3-IR is 
associated with the smooth muscle cells and this may represent the muscarinic 
receptors that are known to play a central role in the cholinergic 
parasympathetic post-ganglionic activation of the detrusor involved in the 
voiding contraction. The presence of M3-IR on nerve fibres, ganglionic cell 
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bodies and interstitial cells suggests roles for muscarinic receptors in addition to 
the control of the voiding contraction. 
There appears to be M3-ER associated with a population of nerves fibres in the 
sub-urothelial space and in the muscle layer. Specific physiological roles for 
these potentially different nerve types have yet to be determined. At least two 
types of sub-urothelial sensory fibres have been identified in the guinea pig 
bladder: one type expressing ChAT and the other cgrp, substance P and the 200 
kD neurofilament protein (Gillespie et al. 2006). It has been suggested that 
these fibres send collaterals to the sub-urothelial ganglionic network 
contributing to local reflexes in the bladder wall. It is possible that one or other 
of these nerve sub-types expresses M3-IR. The presence of nerves expressing 
muscarinic receptors points to a possible regulation of their firing by cholinergic 
stimuli. Muscarinic receptors have been suggested to be present on pre-synaptic 
nerve endings in the bladder (Kim et al. 2005). Mi receptors are thought to be 
facilitatory while M2 and M4 inhibitory (Somogyi and de Groat 1999). A role for 
M3 receptors has not been demonstrated. Physiologically, the source of 
acetylcholine which might activate these nerves is not known. It may come 
from the cholinergic nerves themselves: a form of auto-excitation or inhibition. 
Alternatively, the acetylcholine may originate from the other structures such as 
the urothelium. It has been shown that, upon stretch, the urothelium of the 
human bladder releases acetylcholine (Yoshida et ah 2004). Thus, as with 
urothelial stretch induced ATP and NO release, acetylcholine released in this 
way may exert a modulatory role influencing afferent nerve activity. 
M3-IR and the presence of ChAT fibres associated with the intra-mural ganglia 
suggest that the ganglionic network has a presumably sensory cholinergic input. 
The precise role these ganglia play in the bladder is not known but it has been 
speculated that they are involved in local reflexes and that they are the site of 
integration of excitatory and inhibitory inputs (Lagou et al. 2005; Gillespie et 
al. 2006). The presence of different nerve types has also been noted in the 
muscle layers. Here, there are fewer insights into the possible physiological 
relevance of the different types of nerve but they may also be involved in the 
local reflexes alluded to above (Gillespie et al. 2006). 
Perhaps the most unexpected observation in the normal bladder was the 
presence of M3-ER. associated with sub-urothelial interstitial cells and surface 
muscle interstitial cells. A brief note of this has appeared previously (Gillespie 
et aL 2003). The functional role of the sub-urothelial interstitial cells is not 
known. These cells are responsive to NO and demonstrate an NO dependent rise 
in cGMP. The basal layer of the urothelium expresses neuronal nitric oxide 
synthase and so can produce NO (Gillespie et al. 2005). Also, endogenous NO 
has been shown to activate the sub-urothelial interstitial cells (Gillespie et al. 
2006c). Thus, the sub-urothelial interstitial cells are clearly able to respond to 
urothelial derived signals. The presence of muscarinic receptors suggests other 
possible mechanisms leading to the activation of these cells. 
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In the normal bladder there is a network of vimentin positive cells that 
surrounds the muscle bundles in the inner and outer muscle layers (Brading and 
McCloskey 2005; Drake et al 2006). There may be different types of cells 
associated with the outer and inner muscle bundles. In the outer muscle layer 
these cells respond to NO with a rise in cGMP (Gillespie et al 2004; Gillespie 
et al. 2006b) a situation also seen in the mouse (Lagou et aL 2006). The 
presence of M3-IR on this network of cells suggests the possibility of a 
cholinergic regulation of their function. Experiments using the guinea pig 
isolated whole bladder preparation have demonstrated cholinergic mechanisms 
involved in the activation of phasic contractile activity. The properties of this 
phasic activity are consistent with the hypothesis of a cholinergic driven 
pacemaker mechanism affecting the frequency of the activity and a cholinergic 
dependent component involved in the distribution of the activity and the 
augmentation of its amplitude (Gillespie et al 2004; Finney et al. 2007). The 
observations presented here provide circumstantial support for the concept that 
the interstitial cell network associated with the muscle layers are involved in the 
generation of phasic activity. The M3-IR on the interstitial cells may represent 
either the pacemaker element or the regulation of the distributive element. 
Phasic activity occurs in the normal bladder in vivo: non-micturition activity. 
Such activity has been suggested to play a central role in a motor/sensory 
system involved in the generation and regulation of bladder afferent nerve 
activity and sensation (Starling 1905; Gillespie 2005a). Evidence is thus 
accumulating in vitro to link cholinergic driven interstitial cells with phasic 
activity and in vivo to link phasic activity with the generation of sensation. 
Thus, interstitial cells may have key role to play in sensory mechanisms in the 
bladder. 
In the present study, bladders from animals which had previous surgical damage 
to the bladder neck show distinct differences compared to control. The finding 
that there is loss of nerve fibres from the muscle have been reported previously 
(Charlton et aL 1999; Drake et al 2000). This denervation must have profound 
effects on the properties and control of the bladder wall. Exactly what these 
changes in function are is not known. It is also apparent from this study that 
there are changes in the number and distribution of vimentin positive M3-ER 
interstitial cells. There appears to be little change to the network of sub-
urothelial interstitial cells but the amount of interstitial cells distributed in the 
lamina propria and within the muscle layers seems to increase. In addition there 
also seems to be an increase in the interstitial cells sham operated bladders. 
These cells have M3-IR and may therefore be regulated by cholinergic 
mechanisms. A recent study has examined the number and distribution of 
cGMP identified interstitial cells in bladders from animals with previous 
damage to the bladder neck (de Jongh et al 2007). In this work, nodes of cGMP 
positive cells were also described associated with the outer muscle bundles. It 
was also shown that, despite denervation of the muscle, nerve profiles were 
associated with these nodes. Thus, it is possible that the nodes are innervated 
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and that this might be a means of activating the cholinergic receptors on their 
surface resulting in regulation of the interstitial cell network. 
Summaries of the major observations on vimentin positive and M3-IR cells in 
both sham operated and obstructed bladders is shown in Figure 10 A and B. In 
the sham operated bladder there is a growing awareness that the physiological 
processes in the bladder wall rely on complex interactions between different 
systems and cell types. Each of these systems (urothelium and urothelial 
modulation of afferent nerves, the sub-urothelial system, the ganglionic network 
and the network of interstitial cells) has the possibility to interact. The present 
observations also demonstrated the possibility that within each system there 
may be a role for muscarinic receptors, specifically M3. The dramatic changes 
in these systems induced by bladder neck damage and the alterations to the 
functional properties of the bladder suggest links between specific structures 
and altered function. It has recently been shown that the isolated bladders from 
animals with previous damage to the bladder neck demonstrate large phasic 
contractions and that the bladders appear to have an increased sensitivity to 
applied cholinergic stimuli (de Jongh et al. 2007b). The loss of intra-mural 
ganglia and the altered number and distribution of M3-IR muscle interstitial 
cells may be linked to these functional changes. It has been speculated that one 
of the pathologies of the bladder could arise following damage to the bladder 
neck, the loss of intramural nerves and the up-regulation of the system of 
interstitial cells. Since the interstitial cell network may be involved in the 
generation of phasic activity and the modulation of sensation its potential role in 
the sensation of urgency and frequency are obvious. The present observations 
add to this concept by suggesting the possibility that the interstitial cell network 
may be regulated by cholinergic mechanisms. This increased activity could 
contribute to increased motor/sensory activity. The cholinergic component of 
this modulated sensory system being up-regulated by the pathology and, 
possibly, one of the therapeutic targets for the anticholinergic drugs. 
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Figure 1. Localisation of M3 
antibody binding within the lamina 
propria of the guinea pig bladder. 
A shows a section of the luminal 
surface of the bladder wall. The 
urothelium (uro), lamina propria (lp) 
and the inner muscle (im) layer are 
identified. Cells showing M3 
immuno-reactivity {M3-IR), are seen 
in the layer immediately below the 
urothelium in the layer of cells 
described as sub-urothelial interstitial 
cells (SU-ICs). Staining, although 
weaker, is seen associated with the 
muscle bundles of the inner layer. B 
and C are adjacent sections from the 
same bladder. B was exposed to the 
M3 antibody while C was exposed to the same antibody dilution but pre-incubated with the 
peptide to which the antibody was raised. The images were captured using the same gain on the 
low light level digital camera. The inset in C shows an enhanced image of C to show the content 
of the section. The absence of staining in C strongly suggests that the M3-IR is likely to be the M3 
receptor. Calibration bars: 80 jam in A and 110 pm in B and C. 
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Figure 2. Co-localisation of M3-
immunoreactivity (IR) with 
vimentin in the sub-urothelium 
and lamina propria. The colour 
panels show a sections double 
labelled with antibodies to M3 (red) 
and vimentin (green). In A the 
lumen, urothelium, sub-urothelial 
layer and the inner muscle layer are 
identified. B and C show regions of 
the image in A but with the 
individual images of the vimentin 
staining and the M3-IR. The layer 
of sub-urothelial interstitial cells is 
strongly positive for vimentin. M3-
IR is also seen within this layer 
located within the vimentin positive 
cells. Comparison of B and C 
shows that there are variations in 
the density of the M3-IR staining in 
nearby regions of the bladder wall: 
there appears to be less M3-IR in B 
compared to C. Note that there is 
little M3-IR within the lamina 
propria. D shows a section of the 
urothelium from a different bladder. 
E and F show regions of D at higher 
magnification with the individual M3 and vimentin images. E point out that all of the sub-
urothelial interstitial cells are M3-IR. F shows, at higher magnification, that most of the M3-IR 
appears to be located in the central cell body of the SU-ICs. Calibration bars: 120 [xm in A and D, 
75 nm in B, C, and E and 15 jam and F. 
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Figure 3. Co-localisation of M3 immunoreactivity (IR) with vimentin in the processes of sub-
urothelial interstitial cells. A shows a section double labelled with antibodies to M3 (red) and 
vimentin (green). The lumen, urothelium, sub-urothelial layer and lamina propria are identified. 
Note the presence of cells in the lamina propria which have M3-IR, The region highlighted by the 
square is shown in B along with the separate images of M3-IR and vimentin. The arrows identify 
weekly staining M3-IR associated with the processes of the sub-urothelial interstitial cells. 
Calibration bars: 50 pm in A and 25 \xm in B. 
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Figure 4. Illustration of M3 iramunoreactivity (IR) and nerves in the lamina propria and 
muscle. The colour panels show sections stained with antibodies to M3 (red) and the non-specific 
nerve marker PGP9.5 (green). A and B show the colour images with the composite images for 
M3-IR and PGP9.5 shown on the right. A shows nerve fibres in the lamina propria as determined 
by PGP9.5 staining (far right hand panel). The fibres marked (*) are also M3-ER. However the 
fibre marked (#) is not M3-IR. B shows images from a different bladder illustrating a nerve fibre 
which is M3-IR. In C the section is taken from the outer muscle layer. Nerve fibres are easily 
recognised (*) and M3-IR is associated with the smooth muscle cells (#). D and E illustrate 
regions of the image in D with the accompanying M3-IR and PGP9.5 images. In the colour panels 
nerve fibres are easily recognised. Examination of the images showing M3-IR reveals that there 
are nerve fibres which are M3-IR (+) while there are fibres which are not (J). Thus there appear to 
be two different types of nerve fibre M3-IR positive (M3-IR+) and M 3 - IR negative (M3-IR~). 
Calibration bars: 120|iin in A and B, 40}im in C and 50pm in D and E. 
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Figure 5. Intra-mural ganglion with possible cholinergic and peptidergic inputs. A shows a 
section containing an intra-mural ganglion. The section is stained with an antibody to the enzyme 
choline acetyl-transferase (ChAT, red) and neuro-filament protein (NF) (green). Nerve cell bodies 
can be seen and ChAT positive terminals are apparent on the cell bodies. B and C show regions of 
the image in A with the accompanying ChAT and NF images. In B the ChAT positive terminals 
are readily seen (*) in addition to ChAT positive fibres with varicosities (#). D shows an 
intramural ganglion stained with antibodies to the non-specific neuronal marker PGP 9.5 (green) 
and the M3 receptor (red). E illustrates the same ganglion but with the individual images for PGP 
9.5 and M3-IR. The punctuate localisation of M3-IR is clearly seen. F illustrates a ganglion from a 
different bladder where the punctuate distribution of M3-IR is also apparent. Calibration bars: 
40|im in A, 30|um in B and C and 40jj.m in D, E and F. 
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Figure 7. Full thickness sections of a 
sham operated bladder and a bladder 
with previous surgical intervention to 
restrict the bladder neck (note the 
difference in scaling). In each of the 
colour panels vimentin is shown green 
and M3-IR red. A shows the sham 
operated bladder and B the bladder with 
previous damage to the bladder neck. 
The individual images of M3-IR and 
vimentin are also shown. The lumen, 
serosa, urothelium (uro), sub-urothelial 
interstitial cells (SU-ICs) and lamina 
propria (lp) are indicated by arrows. In 
the bladder neck operated animals the 
inner muscle layer (iml). and outer 
muscle layer (oml) are also shown, 
Discrete M3-IR is seen in the lamina propria and the outer muscle layers. Calibration bar: 100pm 
in A and llOjam inB 
lumen 
* uro 
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' ' sy 
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iml 
Figure 8. M3-immunoreactivity (IR) 
and vimentin positive cells in the sub-
urothelial layer, lamina propria and 
muscle layers in bladders from 
obstructed animals. The coloured 
sections illustrate the double labelling 
with vimentin (green) and the antibody 
to the M3 receptor (red). In A the lumen, 
urothelium (uro), the sub-urothelial cell 
layer, lamina propria and inner muscle 
layer (iml) are marked. M3-IR is seen in 
structures within the sub-urothelial cell 
layer and in the lamina propria. B shows 
a region of the lamina propria from a 
different bladder. The upper panel 
shows the combined stained image and 
the lower panels the individual images. 
A loose layer of vimentin positive cells 
is seen in the lamina propria. C shows a 
region of the images in B but at higher 
magnification. Vimentin positive/M3-IR 
cells are seen. These cells have a 
distinctive morphology: a round cell 
body with long ramifying processes. D 
shows a network of vimentin positive 
cells lying over the surface of muscle 
bundles in the mid muscle layer. M3-IR 
is seen associated with the cell bodies 
of these structures, Vimentin and M3-IR is also seen in structures within the muscle bundles. E 
and F show regions of the image in A at higher magnification along with the accompanying 
images of vimentin and M3-IR. The localisation of the M3-IR to the cell bodies of the vimentin 
positive structures is clear. + and # show M3-IR and vim+ structures respectively. Calibration 
bars: 90|.im in A and D, 50 jam in B and E, 20 ^m in C and 15 pm in F. 
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Figure 9. 'Nodes' of vimentin positive and M3-immonoreactive (IR) cells in the outer muscle 
layers of an obstructed guinea pig bladder. Panels A, B and E show examples of sections 
doubled stained with vimentin (green) and the M3 antibody (red). Bundles of vimentin positive 
fibres are seen to run between the muscle bundles.The cell bodies of these structures appear to be 
collected together to form nodes. Structures associated with the cell bodies of these nodes are M3-
IR. Note the presence of vimentin positive and M3-IR in structures within the muscle bundles. C} 
D, F and G show regions of these images at higher magnification along with the associated 
individual images of the vimentin and M3-IR. The localisation of the M3-IR to the region of the 
nucleus and cell body of these cells is readily seen. Panel E illustrates the presence of two 
categories of muscle bundle: those with numerous intra-muscular interstitial cells (+) and those 
with few intestinal cells (#). F and G show examples of the intra-muscular interstitial cells which 
are M3-IR. Calibration bars: 80fxm in A, B and E and 15 \im in C, D and F. 
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Figure 10. Schematic diagrams illustrating the observations made on the localisation of M3-
JR to cells and structures in the wall of normal bladders and bladders with previous surgical 
intervention to restrict the bladder neck. A shows the normal bladder. M3-IR is located within 
sub-urothelial interstitial cells, cells in the lamina propria, nerves in the lamina propria, on the 
intra-mural ganglia, on superficial muscle interstitial cells in the inner muscle layer, on interstitial 
cells of the outer muscle layer, on small nodes and on a population of nerves in the muscle 
bundles. B shows the situation in the obstructed bladder (OB). M3~IR is located to the same cell 
types as in the control bladders but there are be differences in the number and distribution of these 
cells. In the OB bladders there seem to be more M3-IR cells dispersed within the lamina propria. 
M3-IR positive superficial muscle interstitial cells appear to be more abundant particularly in the 
outer region. There are also prominent nodes of M3-IR positive cells. Muscle bundles are found 
which have a high incidence of intra-muscular M3-IR positive cells while others have few such 
cells. 
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Disregulation of the control mechanism of the urinary bladder presents a 
considerable clinical problem. Therefore, it receives a great deal of attention 
from both clinicians and basic scientists. Because experiments in humans raise 
legal, moral and ethical dilemmas, such studies are inherently limited. Therefore 
in the last century, experimental work on human bladder function has focused 
primarily on in vivo cystometric investigations and structural studies of biopsy 
material. However, it is impossible to acquire a significant amount of bladder 
tissue from healthy normal subjects for investigating the cellular structure and 
the locations of different receptors in the bladder. Thus, basic science has 
resorted to the use of animal models to gain insights into the principles 
governing integrated control of the lower urinary tract and its cellular 
components. 
The guinea pig bladder shows significant structural similarities with the human 
bladder and obstructed guinea pig bladders show similar cystometric changes as 
patients suffering from the overactive bladder syndrome [1]. Hence, this is a 
good model to study changes in bladder structure after outflow obstruction. 
Bladder outflow obstruction results in many structural and functional changes in 
the bladder wall: the smooth muscle is more active and more sensitive to 
acetylcholine, the urothelium thickens, there is hypertrophy of the smooth 
muscles and a punctuate loss of the motor nerves [2, 3], It has recently been 
suggested that these changes are triggered not by the obstruction per se but by 
the local damage that occurs to the bladder neck following surgery, which can 
be exacerbated by physical obstruction [4]. Such local damage results in global 
changes in the bladder wall. 
We investigated the regional differences in sensory innervation and 
suburothelial interstitial cells (ICs) in the bladder neck and urethra (chapter 3). 
For a long time it has been known that obstruction to the bladder neck was 
associated with an increase in voiding frequency, an increase in bladder 
excitability and an increase in bladderwall thickness [5]. Experimentally, 
similar changes result from ligatures applied to the urethra that are put in place 
to reduce urine flow, an approach designed to mimic bladder outflow 
obstruction caused by conditions such as benign prostatic hyperplasia [3]. 
However, there are reports demonstrating that similar changes can occur in 
animals and humans where the bladder neck is only damaged and not obstructed 
[4]. In order to explore what structures could be damaged in the bladder neck 
we must have a detailed overview of the structure of the lower urinary tract in 
the region of the bladder neck. In this region, sensory nerves penetrate the 
urothelium and there is a dense area with ICs» The observation of an area 
densely populated with ICs in the bladder urethral junction (BUJ) adds to the 
complexity of ICs found in the lower urinary tract (LUT). ICs have been linked 
to sensory functions while other ICs are excitable and generate electrical 
activity and communicate via gap junctions with the smooth muscle to influence 
contraction [6]. Also some ICs are thought to generate pacemaker activity and 
influence phasic activity in the bladder [7]. There is a possibility that the 
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specialised cluster of ICs in the region of the BUJ might have sensory or 
pacemaker functions. In this region a reduction in the amount of muscle in the 
bladder wall is observed. It could be that this region is less rigid then adjacent 
regions with muscle and thus more compliant to distension. The ICs together 
with the sensory innervation in this region may be specialised to respond to 
distension with the generation of localised afferent nerve discharge. This could 
contribute to a specific and localised sensation. 
Prostaglandins (PGs) are produced in both the urothelial and muscle layers of 
the urinary bladder in response to bladder distension [8]. PGs alter bladder 
activity by influencing voiding and smooth muscle contractility [9]. Regarding 
the changes in voiding frequency it has been hypothesized that PGs might act 
directly on the afferent nerves to modulate firing and so trigger micturition at 
lower bladder volumes [10]. With regard to a direct action on the muscle, it was 
pointed out that they could be co-released with acetylcholine at efferent nerve 
endings and so directly contribute to muscle excitation [11]. Alternatively, they 
might act indirectly on pre-synaptic motor terminals to affect the release of 
excitatory transmitters [12]. It has also been considered that PGs might inhibit 
acetylcholine-esterase or enhance myogenic bladder activity [13]. 
Using the isolated bladder model it was reported that exogenous PGs can 
modulate the autonomous activity [7]. The action of PGs could play a role in the 
motor component of a motor/sensory system involved in the generation of 
afferent firing and bladder sensation [14]. Thus, increased phasic motor activity 
would result in an increase in afferent discharges and, subsequently influence 
the point at which voiding is triggered. To further understand the function of 
PGs in the modulation of autonomous activity, it is essential to know where 
PGs are synthesized and where the receptors for PGs are located. PGs are 
synthesised by the two distinct enzymes: cyclo-oxygenase type I (COX I) and 
cyclo-oxygenase type II (COX II) [7]. COX I is constitutively expressed in the 
urinary bladder [7]. COX II expression has also been observed in the normal 
bladder, however the expression of this enzyme is strongly increased during 
inflammation of the bladder [15]. In this study we demonstrate that COX I-DR. 
predominates within two general cell systems in the bladder wall: (i) cells 
within the basal and intermediate layers of the urothelium and (ii) within a 
population of ICs. These ICs are present throughout the sub-urothelial space of 
the lamina propria and extend over the surface of the muscle bundles, which 
make up the inner layers. It is interesting and important to note that no COX I-
IR was seen within the muscle bundles indicating that, ICs in the guinea pig and 
not the smooth muscle cells are producing PGs. These observations raise 
intriguing questions regarding the mechanisms of action of PGs in the guinea 
pig bladder. One hypothesis might be that COX I in the basal urothelial cell 
layers is activated by bladder distension. The PGs produced here could diffuse 
over a relatively short distance to the sub-urothelial space in which sensory 
afferent nerve fibres are found.With this arrangement it would be explained 
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how PGs might modulate afferent nerves. However, the abundance of COX I-IR 
in the urothelium of the lateral wall and the relative paucity of afferent nerves 
indicates that this can not be the only role for PGs produced by the urothelium 
in the lateral wall. 
The cells in the basal urothelium express both COX I and neuronal nitric oxide 
synthase (nNOS). Like PGs, nitric oxide (NO) is produced by the urothelium in 
response to stretch [16]. It is known in other cell systems, that PG production is 
influenced by NO and, conversely, that NO production is influenced by PGs 
[17]. Other signals also originate in the urothelium in response to stretch [18]. 
Specifically adenosine triphosphate (ATP) has been shown to be released and 
one of its actions is to influence afferent nerve firing [18]. There are also reports 
that acetylcholine is released from the urothelium [19]. Adding to this 
complexity, the ICs immediately below the urothelium, the sub-urothelial 
interstitial cells (SU-ICs) can be a possible location for further integration of 
urothelial derived signals. In the guinea pig and human these SU-ICs respond to 
both exogenous and endogenous NO with an increased synthesis of cyclic 
guanosine monophosphate (cGMP). There is evidence that these cells also 
express type 3 muscarinic receptor (M3), purinergic receptor (P2Y6) and the 
type 2 prostaglandin receptor (EP2). Thus, the integrated output of PG, NO, 
ATP and cholinergic stimuli from the urothelium can further be integrated and 
modulated on the SU-ICs. The SU-ICs are in close relation with the network of 
ICs of the lamina propria continuing on the surface of the inner muscles 
bundles. 
The complex scheme makes it possible to outline a mechanism to explain 
volume related events. Mechanical deformation of the urothelium in the lateral 
wall triggers complex cascade of interacting signals within the urothelial 
epithelium resulting in the release of signals into the sub-urothelial space. 
There, these urothelial signals are further integrated on the SU-ICs. Activity in 
the SU-ICs is then distributed to the muscle via the IC network resulting in the 
excitatory and inhibitory effects on the phasic activity. 
Prostaglandin synthesis has been associated with the smooth muscle [20]. Since 
the surface muscle ICs (SM-ICs) show COX I-IR, these cells are responsible for 
synthesising PG in the muscle layer. The SM-ICs form a network on the surface 
of the muscle bundles. The possible role of this network is to generate and 
distribute signals leading to phasic contractions in the bladder wall. PGs may be 
involved in the generation and distribution of these signals. 
Surprisingly, we found occsional UBH-IR in all types of interstitial cells of the 
normal bladder. The binding of ubiquitin to a protein targets a protein 
intracellularly for protein degradation [21]. UBH separates ubiquitin from its 
protein substrate affecting the fate of ubiquitinylated proteins, which results in 
the prevention of protein degradation [22]. UBH is therefore involved in the 
regulation of protein trafficking, and thus an indicator of cells undergoing major 
changes in structure, differentiation and phenotype. 
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We found occasional UBH-IR in all types of interstitial cells the normal 
bladder. The interstitium of the bladder urethral junction contained a dense 
population UBH-IR interstitial cells. This subtype of ICs must serve a specific 
function, however the nature of this function is not known. It may relate to the 
regulation of extra-cellular matrix or have a more dynamic functional role. In 
the lateral wall of both sham operated and obstructed guinea pig bladders we 
found an up-regulation of UBH in urothelial cells and a subset of ICs. These 
cells are one of the first cell types to show activation following damage to the 
bladder neck. These UBH positive ICs are located in the lamina propria (lamina 
propria interstitial cells; LP-ICs), on the surface of the muscle bundles (surface 
muscle interstitial cells; SM-ICs) and in the muscle coat (muscle coat interstitial 
cells; MC-ICs). 
The LP-ICs and SM-ICs constitute a network of ICs extending throughout the 
bladder. These cells appear to be particularly activated following bladder neck 
damage. It is possible that an initial local activation could be rapidly propagated 
throughout the entire network resulting in activation of the entire network. 
Activation might then trigger changes to the other cellular system in the bladder 
wall resulting in the observed global pathology. It has been demonstrated that 
there is a sub-population of LP-ICs and SM-ICs that express the enzyme COX I 
and thus are able to produce prostaglandin [23]. The local release of 
prostaglandin may be involved in this system of propagation and activation, 
since the interstitial cells that show COX I-IR are upregulated following bladder 
outlet obstruction [15]. 
In conclusion, distribution of UBH in the obstructed bladder identifies a novel 
sub-set of ICs. These cells appear to form a network of activated and 
proliferating cells which extend through out the bladder wall. 
When we started this thesis, the localisation of the M3 receptor in the guinea pig 
bladder was not known. It has been demonstrated that M3 knockout mice have a 
drastically changed bladder activation, but still appear to void normally [24]. It has 
been known for a long time that activation of the M3 receptor results in activation 
of the detrusor [25]. For this reason it was assumed that the M3 receptors were 
located on the detrusor muscle and that this was the site of action of the M3 specific 
antagonists used in clinical practice [26]. Given the importance of M3 receptors in 
the activation of bladder contractions, the concept arose that the cause of the OAB 
syndrome had to be in the bladder muscle. This resulted in the concept that the M3 
receptors play a role in the autonomous contractions [27]. Clinically, M3 specific 
antagonists are effective in reducing symptoms of urgency and frequency [28]. 
However, it has become apparent that, at therapeutic doses, these drugs do not 
affect either the non-voiding contractions nor the voiding contractions [29]. Thus, 
possibly the site of action of the M3 specific anticholinergic drugs is not on the 
detrusor. For understanding the working mechanism of M3 antagonists it is 
essential to identify the cell systems on which the M3 receptors are located. It has 
been hypothesised that substances released from the urothelium act on the LP-ICs, 
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whom in turn respond by a contraction and so distorting and activating the adjacent 
afferent nerves [30]. However we found that not the LP-ICs show M3-IR, but the 
SU-ICs (Chapter 6). This sub-urotheiial layer is poorly innervated with sensory 
fibres, thus our observations suggest that acetylcholine (ACh) derived from the 
urothelium may have an effect on the SU-ICs, in addition to a possible activation 
of sensory/afferent fibres in the sub-urothelium. 
Antibodies are used in order to identify specific structural features. The use of 
antibodies has several disadvantages. For example the structure of specific 
peptides which an antibody is raised against may be slightly different in 
different spiecies. A small structural difference in a peptide in the area where 
the antibody was raised against may result in the lack of specific staining. Thus 
when an antiby shows specific immunoreactivity in one spiecies it may not 
work in different spiecies. Next to this difficulty there is the fact that there are 
differences in the stucture of the bladder wall between spiecies. Some celltypes 
which show specific immunoreactivity in one spiecies, might not be present in 
another spiecies. For these reasons one should be careful in extrapolating 
immunohistochemical results from one spiecies to another. 
As already recapitulated before, bladders from animals, which had previous 
surgical damage to the bladder neck, show distinct differences, compared to 
control. The denervation and the loss of a ganglionic network in the guinea pig 
must have profound effects on the properties and control of the bladder wall. 
We observed that there are changes in the number and distribution of M3 
receptors on the ICs in denervated bladders. There appears to be little change to 
the network of SU-ICs but the number of ICs distributed in the lamina propria 
and within the muscle layers is increased. In addition, there also seems to be an 
increase in the ICs nodes in bladders with previous surgicical damage to the 
bladder neck (Chapter 7). These ICs express M3 receptors and therefore may be 
regulated by cholinergic mechanisms. Despite the denervation of the muscle 
bundles, nerve profiles are associated with these nodes, indicating that they are 
innervated. This might indicate an activation of the cholinergic receptors on 
their surface resulting in modulation of the IC network. These bladders 
demonstrate large phasic contractions and appeared to have an increased 
sensitivity to cholinergic stimuli [4]. The loss of intra-mural ganglia and the 
upregulation of M3 receptors in muscle ICs may be linked to these functional 
changes. Since the IC network may be involved in the generation of phasic 
activity and the modulation of sensation its potential role in the increased 
sensation of urgency and frequency are obvious. The observation that M3 
receptors are located on SM-ICs adds to this concept by suggesting that the 
network of ICs may be regulated by cholinergic mechanisms. This increased 
activity could contribute to increased motor/sensory activity. The cholinergic 
component of this modulated sensory system is up regulated by the pathology 
and, may be one of the therapeutic targets for the anticholinergic drugs. 
Summarizing Discussion Sc Conclusions | 132 
The studies in this thesis suggest that there is a complex interaction between the 
urothelium and ICs in the sub-urothelium. The urothelium has been shown to 
release PG [8], ATP [18], NO [18] and ACh [31] primarily in response to 
stretch. This release is thought to be the initial step involved in a system for 
detecting bladder volume. As the bladder fills the urothelium is stretched and 
substances are released which results in the activation and modulation of 
afferent nerves [32], There is experimental evidence demonstrating ATP 
modulation of afferent nerve firing and indirect evidence for the involvement of 
NO and ACh in the modulation of the afferent limb of the micturition reflex 
[32]. PG, ATP, ACh and NO appear to be released from the urothelium of the 
lateral wall and dome. In these regions the density of afferent nerves is low. 
Therefore, is seems likely that substances released in these regions sub-serve 
functions other than direct neuro-activation or neuro-modulation. 
For example, it has been suggested that there are specialized cells in the lamina 
propria, which lie in close proximity to afferent nerve fibres. These LP-ICs 
respond to ATP, which has led to the idea that the LP-ICs contract in response 
to ATP so distorting and activating the adjacent afferent nerves. Although an 
interesting concept, there is no direct experimental evidence for the operation of 
such an arrangement in the bladder wall. Based on the original description of 
LP-ICs it seems unlikely that the SU-ICs are the same sub-type as the LP-ICs. 
A further aspect, suggesting that LP-ICs and SU-ICs are different, is that the 
SU-ICs layer in the lateral wall is poorly innervated with sensory fibres. 
The absence of nerves in the sub-urothelial layer further suggests that the SU-
ICs do not have an efferent supply and so are not under the influence of any 
significant neural control. The SU-ICs most likely will be activated by signals 
from the urothelium. The network of SU-ICs extends from the bladder base, 
over the lateral wall and into the dome. The cells, which lie in the sub-
urothelium of the bladder, were first described by Smet as a population of cells 
that responded to exogenous NO with a rise in cGMP [33]. The physiological 
role of these cells and the significance of this responsiveness were not 
investigated. Subsequent work has confirmed the sensitivity of this cell layer to 
NO and shown that they lie in close proximity to cells in the basal urothelium 
which express nNOS [3]. This suggested that there is a transfer of signals 
between the urothelium and SU-ICs. 
It has been shown that, in the guinea pig, the basal and intermediate cells of the 
urothelium express COX I [23]. Therefore these cells are likely to be 
responsible for the production of PGs in the urothelium. The cellular targets for 
the PGs are not known but there is preliminary data suggesting that the SU-ICs 
express the type 2 PG receptor (EP2) [34]. In other tissues the EP2 receptor is 
linked to adenylate-cyclase and, when activated, generates a rise in intracellular 
cyclic adenosine monophosphate (cAMP). Thus, another diffusible urothelial 
derived signal, PGs, has the potential to interact with the SU-ICs and to 
generate a second cascade of intracellular signals. 
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This thesis shows that these SU-ICs also express M3 receptors suggesting that 
they can respond to ACh. It has been shown that ACh is released from the 
urothelium in response to stretch [35]. Data from human studies suggests that 
the outer cells of the urothelium express the enzyme choline acetyltransferase 
(ChAT) and are thus responsible for the synthesis of ACh [35]. For this reason, 
the M3 receptor on the SU-ICs is most likely activated by ACh secreted from 
the urothelium in response to stretch. The M3 receptors belong to the sub-set of 
muscarinic receptors that couple to G proteins and when activated result in a 
rise in diacylglycerol and inositol-trisphosphate (IP3) [36]. The EP3 generated 
might subsequently initiate the release of intracellular calcium, which results in 
further activation of signalling pathway(s) in these cells. 
Recent evidence strongly suggests that the ICs of the detrusor are heterogeneous 
and form a network [3]. These cells might subserve the functions of pacemaker 
and of a coordinating network controlling contraction waves in the detrusor. In 
the guinea pig and mouse, the responsiveness of ICs to NO with the subsequent 
increase in synthesis of cGMP has been used to identify subtypes and their 
distribution. In the guinea-pig three types of ICs have been identified associated 
with the outer muscle layer: cells running on the outer margin of the bladder 
wall (MC-ICs), cells on the surface of the muscle bundles (SM-ICs) and cells 
within the muscle bundles (intramuscular interstitial cells; IM-ICs) [37]. In the 
mouse there appear to be only two types of IC associated with the outer muscle 
layers: IM-ICs and SM-ICs [38]. In both guinea pig and mouse the IM-ICs and 
SM-ICs come into close contact with nerve fibres, suggesting that activity in 
these cells might be under neural control. The concept that is evolving is that 
cholinergic nerve-mediated activity in the network of ICs is transferred to the 
underlying muscle bundles resulting in coordinated episodic waves of 
contractile activity. There is a report showing that NO selectively reduced the 
phasic activity in the isolated mouse bladder [39]. In the mouse bladder ICs are 
the major cell type sensitive to NO , which suggests that these cells play an 
integral part in the generation of phasic activity. 
The autonomous bladder hypothesis suggests that the muscle ICs are involved 
in the activation and co-ordination of complex phasic activity (autonomous 
activity). This activity is the motor component of the motor sensory system 
[40]. The amplitude and frequency of the autonomous activity is increased by 
cholinergic agonists and ATP. If this type of activity is generated within an IC 
network this points out that there are M3/ATP activated pacemaker cells linked 
to a distributed network. Possibly the SU-ICs play a role in the pacemaker 
function. The location and nature of a potential pacemaker mechanism is not 
known. In the guinea pig, a recent study showed the presence of a suburothelial 
ganglionic network [41]. The neurones in these ganglia are contacted by 
different types of nerve fibre. There is evidence for a suburothelial ganglionic 
network with the potential to receive inputs from the urothelium and adjacent 
ganglia and which has outputs to the muscle layers [41]. It has been speculated 
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that such a network might play a role in the local reflexes in the bladder wall 
linking urothelial distortion to phasic contractile activity. In the context of this 
discussion it is notable that the suburothelial ganglion cells receive inputs from 
two types of nerve fibres that are likely to be cholinergic suggesting that the 
ganglionic cells express cholinergic receptors [41]. Application of exogenous 
muscarinic agonists might be expected to activate these ganglia. If these ganglia 
are associated with reflex activation of phasic activity then the direct activation 
with an exogenous muscarinic agonist will also generate phasic activity. 
Therefore, there is evidence to suggest a role for the suburothelial ganglionic 
network, the pacemaker, and the different types of ICs, a heterogeneous 
network carrying pacemaker activity to the muscle layer. 
In relation to this it is worth speculating about the origin of sensation in the 
bladder. It has been pointed out that sensations of bladder volume increase 
appear to be different at different stages of filling [42]. In the early stages of 
bladder filling weak sensations are felt in the general region of the bladder and 
lower abdomen [43, 44]. However, as the volume increases these sensations 
become more intense, sometimes described as urgency, and appear to come 
from lower down in the LUT in the region of the bladder neck and urethra [44]. 
These sensations are then mostly felt in the region of the external genitalia. A 
growing number of observations suggest that regional differences in the sensory 
innervation of the bladder wall may provide a structural correlation for these 
different sensations [45]. Furthermore, it has been demonstrated by Barrington 
some 80 years ago that activation of sensory fibres from different regions of the 
LUT contributed to different reflexes (the 7 Barrington's reflexes) [46]. The 
finding of different types of nerve fibres in the same region and different 
patterns of innervation in different regions might also provide structural 
correlates with Barrington's functional data. 
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Figure 1. A schematic 
diagram suggesting 
possible mechanisms in 
the normal and 
pathological bladder to 
account for autonomous 
activity and the actions 
of arceaidine. The 
concept is proposed that 
there are two means to 
activate the detrusor: 
motor nerves of the 
postganglionic component 
of the parasympathetic 
system, and a network of interstitial cells. The motor nerves are used to activate the micturition 
event while the interstitial cell network is involved in the generation, modulation and 
distribution of activity which underlies phasic non-micturition activity (autonomous activity). 
The network of interstitial cells is complex and heterogeneous [34,35]. Functionally different 
elements can be identified: (i) a pacemaker and a distribution network. Activity in the 
pacemaker is driven by multiple inputs which include a cholinergic component. In the control 
group this mechanism involves M3 muscarinic receptors. Also, based on data from the control 
group, activity within the distributing interstitial cell network is increased by muscarinic 
stimulation. The concept proposed is that muscarinic stimulation increases the spread of activity 
in the network and leads to a recruitment of muscle bundles and consequently larger increases in 
pressure. Activity in the interstitial cell network is conveyed to the individual muscle bundles 
directly by a mechanism possibly involving gap junctions. The same basic functional 
arrangement is present in the other groups, but the pacemaker mechanism appears to be altered 
and has a greater sensitivity to muscarinic agonists. The distribution of activity is also altered in 
the operated groups, such that it is fully activated in the unstimulated bladder. In this respect the 
autonomous activity in the operated groups is similar to the activity produced by the nicotinic 
ligand lobeline. Interestingly, excessive activity after muscarinic agonists or during exposure to 
adrenergic stimulation has the effect of uncoupling the network, affecting the spread of activity 
and so reducing the amplitude of the contractions. The hypothesis is proposed that the changes 
in bladder function after damage to the bladder neck are the result of changes to the network of 
interstitial cells. These changes affect two functions of the network, its pacemaker role and 
distribution of activity. 
Conclusion 
This thesis confirms that the SU-ICs, SM-ICs and MC-ICs appear to be distinct 
populations. The SU-ICs express receptors to acetylcholine (M3), prostaglandin 
(EP2) and atrial naturetic peptide. M3 receptors play a role in the autonomous 
contractions of the bladder. Changes in these autonomous contractions are 
associated with bladder dysfunction, causing a sensation of urgency during the 
filling phase and an increased frequency of voiding [4]. These observations are 
in line with the above hypothesis. This leads to the suggestion that M3 receptors 
on SU-ICs are important in the activation of the phasic bladder contractions. 
Therefore, M3 specific anticholinergic drugs are effective in treating urge 
symptoms in the OAB syndrome [28]. Thus it can be concluded that the ICs 
expressing the M3 receptor play a key role in the motor sensory system. 
Phasic activity occurs in the normal bladder in vivo as non-micturition activity 
[48]. Such activity has been suggested to play a central role in a motor/sensory 
system involved in the generation and regulation of bladder afferent nerve 
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activity and sensation. Evidence is thus accumulating to link cholinergic driven 
ICs with phasic activity and in vivo to link phasic activity with the generation of 
sensation [39, 49]. Thus, ICs play a key role in the motor/sensory mechanisms 
of the bladder. 
We want to hypothesize that the increased pressure on the bladder neck and 
base by the increased size of the prostate inflicts a damage to the bladder neck. 
This damage might be due to pressure on efferent/afferent innervation running 
through these parts of the urinary bladder. As the data in this thesis suggest, the 
LP-ICs and SM-ICs constitute a network of ICs extending throughout the 
bladder, and these cells appear to be particularly sensitive to activation 
following bladder neck damage. Thus, it would be possible that an initial local 
activation could be rapidly propagated through this network resulting in 
activation of the entire network. This pathological change might be the first 
cause for changes in the autonomous activity. On the other hand the 
mechanism(s) of generating autonomous activity, controlling the pacemaker 
functions and facilitating the propagation throughout the bladder, are still not 
known. Nevertheless, the changes in network properties might subsequently 
trigger changes in the other cellular systems in the bladder wall resulting in the 
observed global pathology. 
Future work 
SU-ICs receive multiple inputs via the urothelial-derived signals [23]. These 
signals are likely to be involved in the activation or modulation of different 
pathways within the SU-ICs. These systems may act synergistically to produce 
or modulate a specific response. Alternatively, they may be antagonistic and, 
depending upon their level, integrated to produce a specific response. The SU-
ICs may therefore be a point of integration of signals derived from the 
urothelium. Further research is necessary in order to establish if this indeed is 
the case. The signals generated by the urothelium and the receptors and 
pathways hypothesised in this thesis are illustrated in the cartoon below. 
New drugs are being developed, such as the beta-3 adrenergic agonists. It has 
been suggested that these drugs may modulate afferent activity, which improves 
OAB symptoms, with lower risk of affecting voiding function. However the 
exact location where beta-3 adrenergic agonists work is not known. Further 
research is necessary in order to identify the location of the beta-3 receptor. We 
can speculate on what cell type this could be located. This receptor must be 
located on a cell type that plays a major role in the sensory/motor system. Since 
beta-3 adrenergic agonists do not alter micturition the receptors must be located 
on a cell type that influences autonomous activity, e.g. SU-ICs, LP-ICs or 
(intramural) ganglion cells. The results of our studies point to a control of the 
motor/sensory system in order to control sensory/afferent signalling and relieve 
symptoms of OAB. 
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Figure 2. Cartoon illustrating the output of urothelial signals and possible interactions of 
these signals on the sub-urothelial interstitial cells in the guinea pig bladder. The output of 
the urothelium including prostaglandin (PG), nitric oxide (NO), acetylcholine (ACh), and 
adenosine trisphosphate (ATP) is all well documented [8, 16, 18, 31, 52, 53]. This thesis presents 
data that the M3 receptors are on the SU-ICs. EP2 receptors have been demonstrated immuno 
histochemically and ANP receptors inferred from the actions of exogenous ANP [34, 54]. NO and 
ANP induce a rise in cGMP. Based on published data activation of EP2 generates a rise in cAMP 
via adenylate cyclase (AC) and activation of M3 causes a rise in intracellular Ca2+ from 
intracellular stores and diacylglycerol (DAG) [36, 55], The physiological system underpinned by 
these signalling elements on the SU-ICs has yet to be identified. 
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Summary 
The overactive bladder syndrome (OAB) is a common condition affecting 17% 
of the populations of Europe and the USA.OAB is characterised by urgency, 
frequency and nocturia. Nocturia means that a patient needs to go to the 
bathroom at least one time each night. Frequency means that a patient needs to 
urinate at least 8 times each day. Urgency means the extreme urge to go to 
urinate. The urgency can be so severe that leakage occurs and thus patients 
show urge incontinence. Incontinence has a great impact on daily life. People 
become isolated, due to the fear of incontinence in public situations. 
Urgency incontinence is mostly caused by involuntary contractions of the 
bladder. When the pressure in the bladder supresses the sphincter pressure due 
to these contractions, incontinence occurs. Patients with urgency incontinence 
feel the need to go to the bathroom, but can not make it in time. Urge 
incontinence is mostly caused by a dysfunction of the bladder. Only little is 
know about what causes this dysfunction, how this mechanism works and how 
this problem can be treated. It has been shown in animal experiments and some 
human studies that the bladder shows autonomous contractions which might 
play a role in the bladder control mechanism. This control mechanism is 
influenced by interstitial cells (ICs) and nerve fibers. When it is known how this 
control mechanism works, only then specific treatment can be developed. This 
thesis deals predominantly with the interstitial cells in the urinary bladder: a cell 
type of which it is more and more recognized that they are part of the control 
mechanism of the bladder. 
Interstitial cells of the bladder 
In chapter 2 an overview is given on what is known about the ICs of the 
bladder. It is known that the ICs show structural similarities with the ICs of the 
gut, but the immunohistochemical marker (C-kit) of the ICs of the gut is only 
sporadically found in the ICs of the bladder. In our studies we used vimentin as 
a marker for the ICs of the bladder. Vimentin is a cytoskeletal protein of 
fibroblasts. Since interstitial cells are a subtype of fibroblasts, it is possible to 
identify these cells with markers against vimentin. 
In chapter 3 describes our study on the ICs and nerves in the area between the 
bladder and the urethra; the bladder neck. The distribution of the sub-urothelial 
ICs (SU-ICs) at the location of the bladder neck is different compared to the 
bladder wall and the urethra. No SU-ICs were noted in the bladder neck, while 
in the bladder wall these cells form a layer of 1 -3 cells thick directly below the 
urothelium. Another interesting finding was the location of clusters of ICs in the 
bladder-urethral junction. We noted also that nerve fibres are distributed in the 
urothelium of the bladder neck. Our study points out the regional differences in 
the bladder neck compared to the lateral wall of the bladder and the urethra. The 
fact that this area shows structural differences points out that this area must 
serve a specialised function. 
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In chapter 4 the different locations of prostaglandin production in the bladder 
are discussed. The bladder generates spontaneous contractions, which are called 
autonomous contractions. These autonomous contractions play a role in the 
motor/sensory system of the bladder, which registers the state of filling of the 
bladder. Autonomous contractions are influenced by prostaglandins. For this 
reason it is important to know which cells are able to produce prostaglandins 
and thus are able to influence the autonomous contractions. One 
immunohistochemical study on the location of cyclo-oxygenase enzyme type I 
(COX I), an enzyme which is responsible for prostaglandin production, shows 
this enzyme in three areas of the bladder wall. These areas are: 1) the urothelial 
cells, 2) in ICs and 3) in unclassified cells located in the lamina propria. These 
unclassified cells are located in close proximity of a network of ICs which 
spreads from the lamina propria towards the outer muscle layer. The ICs located 
in the inner muscle layer contain also COX I, while the ICs located in the outer 
muscle do not contain COX I. This study points out that a subpopulation of ICs 
is able to produce prostaglandins. 
In chapter 5 the response of the IC network of the bladder to bladder outlet 
obstruction is described. A bladder outlet obstruction is an obstruction of the 
urethra, which in patients often occurs due to benign prostatic enlargement. A 
bladder outlet obstruction causes bladder overactivity. In our study we create a 
bladder outlet obstruction by placing a ring around the urethra. In sham 
operated animals the same procedure took place as in the obstructed bladders, 
but only without implanting the ring around the urethra. The structures of the 
sham operated and control bladders were compared with the obstructed 
bladders. Ubiquitin hydrolase (UBH) is an enzyme which plays a role in the 
ubiquitin-proteasome system. This enzyme is also known as protein PGP 9.5, 
which has been used as a marker for nerve cells and fibers. We found UBH in 
nerves of control, sham and obstructed bladders. In the control bladders mainly 
the nerves contained UBH, while in the sham and obstructed bladders also a 
subpopulation of ICs contained UBH. These ICs were located in the lamina 
propria (lamina propria ICs, LP-ICs), around the muscle bundles (surface 
muscle ICs, SM-ICs) and in the serosa (muscle coat ICs, MC-ICs). The number 
of ICs which contained UBH was profoundly more in the obstructed bladders 
compared to sham bladders. This finding suggests a relationship between UBH 
upregalation and the severity of bladder neck damage. Activation of UBH in the 
ICs points out that these cells are actively involved in tissue remodelling as a 
result of bladder outlet obstruction. These observations in this study point out 
that a subtype of ICs plays a role in the coordination of the changes in the 
bladder as a result of damage to the bladder neck. 
In chapter 6 the location of the muscarinic receptor type M3 is discussed in 
normal bladders. M3 receptors play a central role in the function of the bladder. 
Activation of M3 receptors by acetylcholine in the bladder results in a bladder 
contraction. The precise location of the M3 receptors in the bladder is not 
known. We describe the location of the M3 receptor on a subpopulation of ICs, 
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These ICs are located directly below the urothelium (SU-ICs), There is a 
difference in the distribution of both the M3 receptors and the SU-ICs in de 
bladder neck compared to the lateral wall. In the bladder neck there were less 
SU-ICs. The SU-ICs in this region did not contain the M3 receptor, while the 
SU-ICs in the lateral wall did contain this receptor. The fact that a subset of the 
SU-ICs poses the M3 receptor points to a further subdivision of these cells. The 
SU-ICs which contain the M3 receptor will probably serve a different function 
compared to the SU-ICs that do not have this receptor. 
Chapter 7 describes the location of the muscarinic receptor type M3 in sham 
and obstructed bladders. Obstructed bladders show detrusor overactivity, which 
means that they show severe autonomous contractions. These contractions are 
influenced by acetylcholine, which works through the activation of the M3 
receptor. The M3 receptor is located on a sub-population of nerves in the lamina 
propria and in the muscle layers. The M3 receptor was also associated with a 
subpopulation sub-urothelial ICs, ICs around the muscle bundles (SM-ICs) and 
ICs inside the muscle bundles (intra-muscular ICs, IM-ICs). The obstructed 
bladders were hypertrophied compared to normal bladders. They also had less 
nerves and ganglia. There was no difference noted in the SU-ICs, while there 
was an increase in number of LP-ICs, SM-ICs and IM-ICs in the obstructed 
bladders. Thus, in obstructed bladders there is a decrease in nerves and a 
(possibly compensatory) increase in the number of ICs that contained the M3 
receptor. Since there is an increase in the number of M3 receptors in the bladder 
a small amount of acetylcholine can cause a strong contraction; a cholinergic 
hypersensibilisation. This might explain why an obstructed bladder shows 
overactive contractions. 
In conclusion, this thesis confirms that the SU-ICs, SM-ICs and MC-ICs are 
distinct sub-populations of interstitial cells. The SU-ICs express M3 muscarinic 
receptors, which plays a role in the autonomous contractions of the bladder. 
Changes in these autonomous contractions are associated with bladder 
dysfunction, causing a sensation of urgency during the filling phase and an 
increased frequency of voiding. Thus M3 receptors on SU-ICs are important in 
the activation of the phasic bladder contractions and the M3 specific 
anticholinergic drugs may have an effect on these cells. 
Furthermore this thesis hypothesizes that the increased pressure on the bladder 
neck and base by the increased size of the prostate inflicts damage to the 
bladder neck. This damage activates the network of LP-ICs and SM-ICs 
throughout the bladder. This pathological change might be the first sign of 
changes in the autonomous activity. However the mechanism(s) of generating 
autonomous activity, controlling the pacemaker functions and facilitating the 
propagation throughout the bladder are still not known. Nevertheless, the 
changes in network properties might subsequently trigger changes in the other 
cellular systems in the bladder wall resulting in the observed global pathology. 
Further research is necessary in order to unravel the function of the ICs in the 
bladder. The SU-ICs receive multiple inputs via the urothelial-derived signals. 
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These signals are likely to be involved in activating or modulating different 
pathways within the SU-ICs. These systems may act synergistically to produce 
or modulate a specific response. The SU-ICs may therefore be a point of 
integration of signals derived from the urothelium. 
Beta-3 adrenergic agonists are new drugs developed for the treatment of OAB. 
These drugs moderate afferent activity, which improves OAB symptoms. The 
location of the beta-3 receptor in the bladder is not known. This receptor must 
be located on a cell type that plays a major role in the sensory/motor system, 
e.g. SU-ICs, LP-ICs or (intramural) ganglion cells. 
Samenvatting 
Het overactieve blaassyndroom wordt gekenmerkt door urgency, frequency en 
nycturie. Nycturie houdt in dat iemand minimaal 1 keer per nacht moet opstaan 
om naar het toilet te gaan. Frequency houdt in dat iemand meer dan 8x per dag 
naar het toilet moet. Bij urgency bestaat er een onbedwingbare aandrang om te 
urineren. Dit kan zelfs zo erg zijn dat er urgency incontinentie optreedt. 
Incontinentie kan een grote impact hebben op het dagelijkse leven van de 
patiënt. Het kan zo erg zijn dat mensen er door geïsoleerd raken, omdat zij bang 
zijn om in het openbaar urine te verliezen. 
Urgency incontinentie houdt in dat de blaas onvrijwillig samentrekt waardoor 
de druk in de blaas hoger wordt dan de sluitspier aankan, waardoor 
incontinentie ontstaat. Dit komt door een stoornis in de functie van de blaas. 
Onze kennis van de pathofysiologie van deze stoornis en wat eraan gedaan kan 
worden is tot nu toe nog zeer beperkt. De vrijwel lege blaas laat kleine 
kontrakties zien die hoogswaarschijnlijk een rol spelen bij de controle over de 
blaas. Als de exacte werking van het controle mechanisme van de blaas 
ontrafeld is, pas dan kunnen op rationele grondslag medicijnen ontwikkeld 
worden die specifiek gericht zijn tegen overactiviteit van de blaas. Het doel van 
deze thesis is om mee te bouwen aan het inzicht in het controle mechanisme van 
de blaas. Dit is hoofdzakelijk gedaan door middel van immunohistochemische 
studies naar een belangrijk onderdeel in dit mechanisme: de interstitiële cellen. 
Interstitiële cellen van de blaas 
Interstitiële cellen zijn cellen die in verschillende weefsels in het lichaam 
voorkomen en een scala aan functies vervullen. Zo is beschreven dat 
interstitiële cellen een belangrijke rol spelen in het vernieuwen van weefsel, 
maar ook dat zij een functie hebben in de beweging van de darm. Er zijn nogal 
wat aanwijzingen in de literatuur dat de interstitiële cellen van de blaas 
betrokken zijn bij het tot stand komen van de contracties die de blaas maakt in 
rusttoestand; met deze contracties 'voelen' we als het ware hoe vol onze blaas 
zit (autonome activiteit). Interstitiële cellen spelen een centrale rol in dit 
mechanisme. 
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In hoofdstuk 2 wordt een overzicht gegeven van wat er tot nu toe bekend is 
over de interstitiële cellen van de urine blaas. Het is bekend dat zij qua structuur 
erg veel lijken op de interstitiële cellen van de darm, echter de 
immunohistochemische marker (C-kit) die gebruikt wordt om interstitiële cellen 
van de darm mee te identificeren wordt maar sporadisch in de interstitiële cellen 
van de blaas aangetroffen. Er is gezocht naar een specifieke 
immunohistochemische marker voor de interstitiële cellen van de blaas. In onze 
studies gebruiken wij vimentine als marker voor interstitiële cellen. Vimentine 
is een eiwit dat voorkomt in het cytoskelet van fibroblasten, en aangezien 
interstitiële cellen een subtype van de fibroblasten zijn, is het dus mogelijk om 
aan de hand van antilichamen gericht tegen het vimentine eiwit, de interstitiële 
cellen te bestuderen. 
In hoofdstuk 3 wordt een studie beschreven naar interstitiële cellen en de 
innervatie in het overgangsgebied van de blaas naar urethra; de blaashals. De 
distributie van de direct onder het urotheel gelegen interstitiële cellen (sub-
urotheliale interstitiële cellen, SU-ICs) ter hoogte van de blaashals is volledig 
anders ten opzichte van de blaas. Op deze locatie bevinden zich slechts 
sporadisch SU-ICs, terwijl er zich in de blaas een cellaag van 1-3 cellen dik 
onder het urotheel bevindt. Daarnaast vindt men in de blaashals een cluster van 
zeer veel interstitiële cellen ter hoogte van de spierlaag. Een andere interessante 
bevinding van deze studie was het voorkomen van zenuwvezels in het urotheel 
van de blaashals. Deze studie toont dus aan dat er duidelijke regionale 
verschillen in de blaashals zijn ten opzichte van de blaas en urethra. Het feit dat 
dit gebied qua structuur totaal anders is wijst erop dat dit gebied een 
gespecialiseerde functie heeft. 
In hoofdstuk 4 worden de verschillende locaties van prostaglandine productie 
in de blaas besproken. De blaas laat in rusttoestand kleine contracties zien, die 
autonome contracties genoemd worden. In ons concept maken deze autonome 
contracties deel uit van tot een senso-motor systeem van de blaas waarmee de 
vullingtoestand van de blaas wordt waargenomen. Het senso-motor systeem is 
een mechanisme waarbij de blaas actief door een beetje samen te trekken 
(autonome contracties) voelt hoe ver deze gevuld is. De autonome contracties 
worden beïnvloed door prostaglandinen. Daarom is het belangrijk om te weten 
welke cellen in staat zijn om prostaglandines te produceren en dus de autonome 
contracties beïnvloeden. Een immunohistochemische studie naar de locatie van 
cyclo-oxygenase enzym type I (COX I), een enzym dat verantwoordelijk is voor 
de productie van prostaglandinen, toont aan dat dit enzym zich op drie plaatsen 
in de blaaswand bevindt. Deze drie plaatsen zijn: 1) in urotheliale cellen (cellen 
die de binnenbekleding van de blaaswand vormen), 2) in interstitiële cellen en 
3) in nog niet nader gekarakteriseerde cellen in de lamina propria. Deze nog 
ongekarakteriseerde cellen liggen dichtbij het netwerk van interstitiële cellen 
dat zich uitbreidt van de lamina propria tot in de buitenste spierlaag. De 
interstitiële cellen gelegen in de binnenste spierlaag bevatten ook COX I, terwijl 
de interstitiële cellen gelegen in de buitenste spierlaag geen COX I bevatten. 
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Deze studie toont dus aan dat een subpopulatie van interstitiële cellen de 
mogelijkheid bezitten om prostaglandinen te produceren. 
In hoofdstuk 5 wordt beschreven hoe de subpopulaties van interstitiële cellen in 
de blaas reageren op een blaasuitgangsobstructie. Een blaasuitgangsobstructie is 
een obstructie van de piasbuis, welke bij mannelijke patiënten vaak veroorzaakt 
wordt door een vergroting van de prostaat. Een blaasuitgangsobstructie 
veroorzaakt overactiviteit van de blaas. In ons onderzoek wordt een 
blaasuitgangsobstructie gemaakt door een ringetje teplaatsen rondom de 
piasbuis. Bij een zogenaamde sham geopereerde blaas wordt dezelfde procedure 
uitgevoerd, alleen wordt er geen ringetje geplaatst. Een controle blaas ondergaat 
uiteraard geen operatie. 
Ubiquitin hydrolase (UBH) is een enzym dat deel uit maakt van het ubiquitin-
proteasoom systeem. Dit systeem speelt o.m. een rol in de regulatie van celgroei 
en differentiatie. Tevens is dit systeem aanwezig in zenuwcellen. Wij vonden 
UBH in zenuwvezels van controle, sham en geobstrueerde blazen. In de 
controle blazen bevatten voornamelijk de zenuwvezels UBH, terwijl in de sham 
en geobstrueerde blazen ook een subpopulatie van interstitiële cellen UBH 
bevatten. Deze interstitiële cellen bevonden zich in een laag onder het urotheel; 
de lamina propria (lamina propria interstitiële cellen, LP-ICs), rond de 
spierbundels (surface muscle interstitiële cellen, SM-ICs) en in een laag tegen 
de spierbundels aan; het serosa (muscle coat interstitiële cellen, MC-ICs). Het 
aantal interstitiële cellen dat UBH bevatten was beduidend meer in de 
geobstrueerde blazen vergeleken met de sham geopereerde blazen. Deze 
bevinding suggereert dat er een relatie is met de verhoogde activiteit van UBH 
in interstitiële cellen en de ernst van beschadiging in de blaashals. De toename 
van UBH in de interstitiële cellen duidt erop dat deze cellen actief betrokken 
zijn bij weefsel veranderingen als gevolg van blaasuitgangsobstructie. De 
observaties gedaan in deze studie wijzen erop dat een subtype van interstitiële 
cellen een rol speelt bij de coördinatie van de veranderingen in de blaas als 
gevolg van blaashals beschadiging. 
In hoofdstuk 6 wordt de locatie van de muscarine receptor type M3 beschreven 
in de normale blaas van de cavia. Muscarine speelt een belangrijke rol in de 
activiteit van de blaas. Muscarine activeert M3 receptoren, welke dus een 
centrale rol spelen in de functie van de blaas. Activatie van de M3 receptoren 
door acetylcholine veroorzaakt een blaascontractie. De locatie van de M3 
receptoren in de blaas is tot op heden nog niet beschreven. In deze studie 
beschrijven wij de locatie van de M3 receptor en identificeren we de celtypen 
die in het bezit zijn van deze receptor. De meest opvallende bevinding was dat 
de M3 receptor geassocieerd was met de suburotheliale interstitiele cellen (SU-
ICs). Er is een verschil in distributie van zowel de M3 receptor als de SU-ICs in 
de blaashals ten opzichte van de laterale wand. In de blaashals waren beduidend 
minder SU-ICs cellen aanwezig. De SU-ICs in deze regio waren niet in het 
bezit van de M3 receptor, terwijl de SU-ICs in de laterale wand wel in het bezit 
zijn van de M3 receptor. Het feit dat sommige SU-ICs in het bezit zijn van de 
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M3 receptor wijst op een verdere onderverdeling en verschil in functie van deze 
cellen. 
Hoofdstuk 7 beschrijft de locatie van de muscarine receptor type M3 
beschreven in sham geopereerde blazen en blazen met een uitgangsobstructie. 
Obstructieve blazen vertonen overactiviteit, dat wil zeggen dat zij meer en 
heftigere autonome contracties vertonen. Deze contracties worden onder andere 
beïnvloed door acetylcholine (een stof dat muscarine receptoren beïnvloed), dat 
zorgt voor activatie van de M3 receptor. De M3 receptor is waargenomen op een 
sub-populatie zenuwvezels en neuronen in de lamina propria en in de 
spierlagen. Ook was de M3 receptor geassocieerd met een subpopulatie van sub-
urotheliale interstitiële cellen, interstitiële cellen rond de spierbundels (SM-ICs) 
en interstitiële cellen in de spierbundels (inta-muscular interstitiële cellen, IM-
ICs). De blazen die een blaasuitgangsobstructie hadden en dus overactief waren, 
hadden een duidelijke toegename in blaaswand dikte ten opzichte van normale 
blazen. Ook hadden zij beduidend minder zenuwvezels en ganglia. Er was geen 
verandering waarneembaar ten aanzien van de SU-ICs, terwijl er een toename 
was in het aantal LP-ICs, SM-ICs en EM-ICs. Dus na een 
blaasuitgangsobstructie is er een afname van zenuwen en een mogelijk 
compensatoire toename van interstitiële cellen, welke in het bezit zijn van de 
M3 receptor. Aangezien er een toename is in het aantal M3 receptoren in de 
blaas, kan dus een kleinere hoeveelheid acetylcholine een krachtigere contractie 
teweeg brengen. Dit kan mogelijk verklaren waarom een blaas met een 
uitgangsobstructie als het ware overgevoelig is en overactieve contracties 
vertoont. 
Concluderend, deze thesis bevestigd dat SU-ICs, SM-ICs en MC-ICs 
specifieke subpopulaties van interstitiële cellen zijn. De SU-ICs zijn in het bezit 
van een receptor door acetylcholine (M3), Deze receptor speelt een rol bij de 
autonome contracties in de blaas. Veranderingen in deze contracties zijn 
geassocieerd met urgency en frequency. Dus de M3 receptoren op de SU-ICs 
spelen een rol bij autonome blaascontracties en M3 specifieke anticholinege 
medicatie heeft mogelijk een effect op de SU-ICs. 
Deze thesis brengt de hypothese naar voren dat een verhoogde druk op de 
blaashals, veroorzaakt door benigne prostaat hypertrofie, resulteert in een 
beschadiging van de blaashals. Deze beschadiging activeert het netwerk van 
LP-ICs en SM-ICs in de blaas. De pathologische veranderingen in deze cellen 
dragen mogelijk bij aan de veranderde autonome activiteit. Het mechanisme van 
het ontstaan en de regulatie van de autonome activiteit is tot op heden 
onbekend. De opregulatie van het netwerk van interstitiële cellen kan 
verantwoordelijk zijn voor de veranderingen in de gehele blaas. 
Verder onderzoek is nodig om de functie van interstitiële cellen in de blaas te 
ontrafelen. De SU-ICs ontvangen signalen vanuit het urotheel. Deze signalen 
hebben een functie in de activatie en modulatie van deze cellen. Dus de SU-ICs 
hebben een functie in de verwerking van urotheliale signalen. 
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Beta-3 adrenerge agonisten zijn nieuw ontwikkelde farmaca voor de 
behandeling van OAB. Deze farmaca beïnvloeden de afferente activiteit, 
waardoor een vermindering van de symptomen teweeg wordt gebracht. De 
locatie van de beta-3 receptor in de blaas is tot op heden niet goed bekend. Deze 
receptor moet gelegen zijn op een celtype welke een belangrijke rol speelt in het 
motor/sensor systeem van de blaas; dus op SU-ICs, LP-ICs of (intramurale) 
ganglion cellen. 
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